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ABSTRACT 
Independent Effects of Paternal Age and Neuregulin1 Expression in Mice in 
Relation to Schizophrenia 
 
Heather El-Amamy 
 This thesis work is divided into two parts, both guided by the overwhelming 
evidence that hereditary factors influence neurodevelopment. The first section is focused 
on advanced paternal age, which may modulate an offspring’s place on the continuum of 
normal behavior, as well as conferring increased risk for the development of certain 
disorders, such as schizophrenia. By using a mouse model to examine the difference 
between old and young father offspring, we have been able to flesh out this phenotype. 
Additionally, by examining the female and male offspring separately, we discovered 
gender-specific differences between the groups. Ongoing work is seeking to identify 
changes in methylation between the old and young father offspring that may explain 
these differences. 
 The second section deals with a specific gene that has been linked to 
schizophrenia, namely Neuregulin1. This gene plays several roles in neurodevelopement, 
notably including the proliferation of interneurons and their incorporation into the cortex 
and olfactory bulb. We used heterozygous mice to explore the effects of a change in gene 
expression of the proliferation of new neurons from the subventricular zone, their 
migration through the rostral migratory stream, and differentiation into various 
interneuron subtypes in the olfactory bulb. The heterozygotes appeared to have decreased 
turnover of a subset of calretinin-expressing interneurons of the granule cell layer. We 
also treated subgroups of these mice with clozapine, however this did not seem to have 
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any effect. We looked at the olfactory system in this work since this is a model of 
neurogenesis that continues into adulthood. Yet the regions that produce cortical 
interneurons during early development give rise to the subventricular zone. Therefore the 
findings related to subventricular zone neurogenesis may have similar implications for 
cortical development. 
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CHAPTER 1: INTRODUCTION 
 
One of the recurring themes of neuroscience is what the diseased brain reveals 
about normal brain function. Rather than being a simple input-output system, the central 
nervous system (CNS) has multiple parallel and interlocking systems covering systems as 
basic as breathing and blood flow, and as complex as specific declarative memory. The 
existence of schizophrenia provides a window into the functions that are required for 
normal behavior and cognition. On one hand, the gross anatomy and pathology of the 
brain was historically not thought to be disturbed in schizophrenia, in contrast to the large 
structural alterations found in dementia, degenerative movement disorders, tumor, stroke, 
and traumatic injury. However, as exploration of this syndrome has advanced, distinct 
recurring features of anatomy, cellular histology, and circuit function have revealed 
differences between the brain in schizophrenia and in normal controls. That these 
seemingly small differences result in such strong changes in behavior and cognitive 
function is surprising. Yet this has facilitated the exploration of brain mechanisms for 
understanding salient information from all the multiple stimuli present in the 
environment, as well as an exploration of which aspects of brain development are critical 
for these functions. 
In this thesis, I will discuss biological mechanisms that add to inter-individual 
variability, but can also contribute to schizophrenia vulnerability in cases where they are 
dysfunctional. Schizophrenia is a severely debilitating, chronic psychiatric disorder that 
affects roughly 1% of the population worldwide and is characterized by an abnormal 
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perception of reality (D. A. Lewis & Lieberman, 2000). While features of the disorder 
may include hallucinations, delusions, social withdrawal, lack of motivation, 
disorganized thought or behavior, deficits in attention and memory, and difficulty 
processing information, there is a great deal of heterogeneity in the clinical presentation 
(van Os & Kapur, 2009). Patients will vary in the constellation of symptoms displayed 
and the severity and course of the disorder. Although these clinical symptoms do not 
appear until adolescence or early adulthood, there is now increasing evidence that 
schizophrenia may emerge from neurodevelopmental abnormalities that occur long 
before the onset of clinical symptoms that appear in adolescence or early adulthood. I 
will therefore address possible causes and impacts of genetic and epigenetic factors that 
may contribute to schizophrenia vulnerability. This introductory chapter will address two 
main aspects of schizophrenia etiology, namely, the epidemiological evidence for a 
neurodevelopmental origin of the disorder and the role of specific genetic alterations in 
causation of schizophrenia. In regards to the first, advanced paternal age will be explored 
as described in the literature and as modeled in animals, while the second will be 
explored as a historical concept and as related to the specifics of Neuregulin1 function. 
Modeling of mutant Neuregulin1 function in mice will then be described in Chapter 3. 
EPIDEMIOLOGICAL ETIOLOGY OF SCHIZOPHRENIA  
 
 Several environmental factors that alter risk for schizophrenia have been 
identified through epidemiology, and epigenetic alterations are a probable mechanism for 
these environmental influences to modulate vulnerability by controlling gene expression. 
While the clinical phenotype of schizophrenia does not emerge until early adulthood, 
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environmental exposures that occur throughout development have been linked to the 
disorder. Risk factors that likely act prenatally include advanced paternal age, fetal 
hypoxia, nutritional deficiency, and maternal stress or infection (Brown et al., 2007; 
Brown & Susser, 2008; Khashan et al., 2008; Malaspina, 2001; Malaspina et al., 2001; 
Mittal, Ellman, & Cannon, 2008; Nicodemus et al., 2008; Perrin, Brown, & Malaspina, 
2007; Susser et al., 1996; M. Q. Xu et al., 2009). During early life, childhood trauma, 
migration, an urban environment, chronic stress, and cannabis use can all contribute to 
schizophrenia risk (M. Cannon & Clarke, 2005; T. D. Cannon, Mednick, & Parnas, 1990; 
Cantor-Graae & Selten, 2005; Henquet, Di Forti, Morrison, Kuepper, & Murray, 2008; 
Howes et al., 2004; Krabbendam & van Os, 2005; Luzi, Morrison, Powell, di Forti, & 
Murray, 2008; Moore et al., 2007; Murray, Morrison, Henquet, & Di Forti, 2007; 
Nicodemus et al., 2008; Schreier et al., 2009; Tienari et al., 2004). As there is 
considerable heterogeneity in individual response to these risk factors, they are thought to 
represent gene-environment interactions. A person’s vulnerability to these exposures is 
thought to depend on preexisting genetic or epigenetic differences (Caspi & Moffitt, 
2006). 
 There is mounting evidence that schizophrenia is a developmental disorder. This 
is in part supported by evidence of congenital abnormalities suggestive of 
neurodevelopmental defects in schizophrenia. Minor physical anomalies (MPAs) are 
subtle malformations that indicate altered morphogenesis in the first or second trimester. 
These include reduced facial symmetry, lowered orbital landmarks and eye fissures, and 
asymmetrical ear shapes (M. F. Green, Bracha, Satz, & Christenson, 1994; Gualtieri, 
Adams, Shen, & Loiselle, 1982; O'Callaghan, Larkin, Kinsella, & Waddington, 1991; 
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Tarrant & Jones, 1999). As MPAs derive from the ectoderm, which shares its 
embryological origins with the brain, the above facial irregularities seem to be linked to 
brain abnormalities. (Ismail, Cantor-Graae, & McNeil, 1998; Sperber, 1992). In fact, 
these biological markers of developmental disturbance are not specific to schizophrenia, 
but have been linked to a broad range of mental disorders, including autism, 
hyperactivity, epilepsy, learning disabilities, poor motor coordination, mental retardation, 
attention deficit disorder, cerebral palsy, and affective disorders (Lloyd et al., 2008; Lohr 
& Flynn, 1993; J. J. McGrath et al., 1995; McNeil, Cantor-Graae, & Ismail, 2000). 
The neurodevelopmental theory of schizophrenia asserts that abnormalities 
present in utero lead to pathological processes in early adulthood with the emergence of 
schizophrenia as the end result. Since brain development continues into young adulthood, 
Keshavan has built on the neurodevelopmental theory by proposing a “2-hit model” in 
which abnormalities occur in both early development and adolescence. Dysfunction at 
these two critical time points can combine to elicit the symptoms of schizophrenia 
(Keshavan & Hogarty, 1999). This view may explain the premorbid symptoms apparent 
in individuals who later go on to develop schizophrenia. 
Neurodevelopmental defects, such as minor physical anomalies (MPAs) and 
neurological soft signs (NSS), are present not only in schizophrenia patients, but also in 
their relatives. A recent meta-analysis of MPAs in patients with schizophrenia and their 
unaffected first-degree relatives found that MPAs were more prevalent in schizophrenia 
patients than in their relatives. However, MPAs were, in turn, more prevalent in the first-
degree relatives than in healthy controls (T. Xu, Chan, & Compton, 2011). A meta-
analysis of NSS in unaffected first-degree relatives of schizophrenia patients showed the 
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same pattern. It found that NSS were significantly more common in these relatives than 
in controls. They were also more common in those with schizophrenia than in their 
relatives (Neelam, Garg, & Marshall, 2011). The presence of these developmental 
abnormalities in unaffected siblings, parents or children of individuals with schizophrenia 
may suggest a familial basis. 
In fact, MPAs and NSS are not the only traits associated with schizophrenia that 
are more prevalent in the unaffected first-degree relatives of patients than in the general 
population. Several abnormalities in brain structure have been identified in schizophrenia. 
The most robust anatomical finding has been an increase in volume of the CSF-filled 
spaces of the lateral and third ventricles and the cortical sulci, as well as a reduction in 
cortical gray matter. White matter abnormalities have also been found, with evidence of 
increased orbitofrontal white matter in patients. Regional volume reductions are also seen 
in frontal lobes and temporal and limbic structures, possibly implicating dysfunction in 
circuitry that includes the cortex, thalamus, limbic areas, and basal ganglia in 
schizophrenic pathology (Barta, Pearlson, Powers, Richards, & Tune, 1990; Buchanan & 
Carpenter, 1997; Buchanan, Vladar, Barta, & Pearlson, 1998; T. D. Cannon, 1996; T. D. 
Cannon et al., 1998; Fan et al., 2008; Johnstone, Crow, Frith, Husband, & Kreel, 1976; 
Pearlson, Garbacz, Moberg, Ahn, & DePaulo, 1985; Pearlson & Marsh, 1999; 
Pfefferbaum & Marsh, 1995; Zipursky, Lambe, Kapur, & Mikulis, 1998; Zipursky et al., 
1994). Some of these structural differences are also shared with family members to a less 
marked degree, such as gray matter reductions in the frontal and temporal lobes, 
decreased hippocampal volume, and increased white matter in the orbitofrontal area (T. 
D. Cannon et al., 1998; Diwadkar, Montrose, Dworakowski, Sweeney, & Keshavan, 
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2006; Fan et al., 2008; Job et al., 2003; McDonald et al., 2005; McIntosh et al., 2006; 
Staal et al., 2000; Whalley, Harris, & Lawrie, 2007).  
Several studies have also found subtle cognitive deficits in nonpsychotic relatives 
of patients with schizophrenia. Cognitive impairment is one of the core features of 
schizophrenia, and these findings suggest that a similar but milder impairment is present 
in family members. These deficits included verbal memory, spatial working memory, 
language ability, attention, and response inhibition (Appels, Sitskoorn, Westers, Lems, & 
Kahn, 2003; Cosway et al., 2000; Faraone et al., 1995; Grove et al., 1991; Park, 
Holzman, & Goldman-Rakic, 1995; Scala, Lasalvia, Cristofalo, Bonetto, & Ruggeri, 
2012; Snitz, Macdonald, & Carter, 2006). There is also some evidence that the symptoms 
apparent in family members may reflect the specific pathology of the proband. For 
example, the deficit subtype of schizophrenia is characterized by more severe negative 
symptoms, cognitive deterioration, and structural brain abnormalities (Amador et al., 
1999; Buchanan, Kirkpatrick, Heinrichs, & Carpenter, 1990; Buchanan et al., 1994; 
Kirkpatrick & Galderisi, 2008; Tek, Kirkpatrick, & Buchanan, 2001). When comparing 
relatives of patients with deficit versus non-deficit schizophrenia, only relatives of the 
deficit subtype displayed impairment in executive functioning, increased levels of 
negative symptoms, and higher levels of social isolation (Kirkpatrick, Ross, Walsh, 
Karkowski, & Kendler, 2000; Scala et al., 2013).  
These subtle traits associated with schizophrenia prompted Gottesman and 
Shields to coin the term “endophenotypes,” to describe internal or intermediate 
phenotypes that could only be discovered by a “biological test or microscopic 
examination” (Gottesman & Shields, 1973). Such intermediate phenotypes, called 
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endophenotypes, are defined as measurable biological traits that vary continuously in 
expression among individuals, but appear at higher rates in those at risk for the disorder 
than in the general population. They are typically functionally related to aspects of the 
clinical disorder, even though they manifest in individuals regardless of whether the 
illness is present. Endophenotypes that show abnormal expression in healthy relatives and 
are also perceptible before the onset of the first episode of psychosis are more likely to be 
a part of the causal path of the disorder. They can also transcend clinical categorizations 
and reveal shared mechanisms of causation in multiple disorders (T. D. Cannon & Keller, 
2006; Gottesman & Gould, 2003; Preston & Weinberger, 2005). For example, this was 
apparent in the discussion of MPAs and NSS above, which have been associated with 
multiple developmental disorders. These endophenotypes have been exceedingly useful 
in exploring the still-unknown etiology of schizophrenia, a disorder where the clinical 
presentation can vary widely from patient to patient. The study of endophenotypes allows 
the exploration of biological mechanisms upstream of clinical symptoms that may 
modulate risk for schizophrenia. This is useful in assessing congenital risk factors, as the 
increased prevalence of endophenotypes in first-degree relatives who themselves do not 
display a clinical phenotype, and the tendency of the disorder and endophenotypes to 
cluster within families, suggest a degree of heritability. 
DEVELOPMENTAL PROCESSES THAT CAN AFFECT ADULT FUNCTION 
 
One possible type of developmental dysfunction, proposed by Feinberg in 1982, 
is that abnormal synaptic pruning may be involved in the etiology of schizophrenia 
(Feinberg, 1982). In the healthy human newborn, there is a dramatic increase in the 
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number of cortical synapses formed  until synaptic density reaches its maximum between 
ages 2 and 4 (Huttenlocher, 1979; Huttenlocher & Dabholkar, 1997). After reaching 
roughly 150% the number of synapses seen in adulthood, there is then a decline in 
synaptic density until the late teens or early adulthood (Huttenlocher, 1979; Petanjek et 
al., 2011). Developing synapses are either stabilized by neuronal activity or pruned away 
(Hua & Smith, 2004). However, in schizophrenia, studies have found decreased 
presynaptic protein markers and decreased cortical spine density relative to controls, 
without a difference in neuronal density (Broadbelt, Byne, & Jones, 2002; Faludi & 
Mirnics, 2011; Garey, 2010; Glantz & Lewis, 2000; Kalus, Muller, Zuschratter, & Senitz, 
2000). Returning to the “2-hit model,” if synaptic development is somewhat suppressed 
during development, the synaptic pruning and decreased plasticity that occurs in 
adolescence could exacerbate abnormalities, leading to the schizophrenic phenotype. 
However, synaptogenesis could alternatively be unimpaired during development, and 
accelerated pruning during adolescence could elicit the clinical phenotype. 
Although abnormal synaptic pruning has not been proven to be a part of the 
etiology of schizophrenia, another area of focus is cortical development and migration of 
new neurons, particularly interneurons. The production of interneurons is a key 
developmental process in the formation of cortical circuitry. Interneurons form 
connections between other neurons and modulate the activity of excitatory neurons 
through the release of GABA and glycine (Dreifuss, Kelly, & Krnjevic, 1969; Fonnum & 
Storm-Mathisen, 1969; Somogyi, Freund, Wu, & Smith, 1983). They can make multiple 
synaptic connections with excitatory neurons and control activation through the use of 
feed-forward and feedback inhibition (Berger, Silberberg, Perin, & Markram, 2010; 
	  9	  	  
Silberberg, Gupta, & Markram, 2002; Somogyi, Tamas, Lujan, & Buhl, 1998; Wang et 
al., 2004). In fact, these interneurons do seem to be impaired in schizophrenia, as 
schizophrenia is associated with a 45% decrease in GAD67, an enzyme that synthesizes 
GABA, in a subset of interneurons that express parvalbumin (Akbarian et al., 1995; T. 
Hashimoto et al., 2003; Volk, Austin, Pierri, Sampson, & Lewis, 2000). 
GENETIC AND EPIGENETIC ETIOLOGIES OF SCHIZOPHRENIA 
 
There is strong evidence of a genetic component of schizophrenia. The results of 
several family studies have illustrated that the risk of developing schizophrenia increases 
as the proportion of genes in common with a schizophrenic individual increases. In the 
general population, 1% of people suffer from schizophrenia. If a third-degree relative has 
schizophrenia, an individual’s risk rises to 2%. If someone with schizophrenia is a 
second-degree relative, the risk rises to around 2-6%. For first-degree relatives, this risk 
increases further to between 6% and 17%. Identical twins share 100% of their DNA. If 
one twin develops schizophrenia, the risk of the other twin also having it is 48% 
(Gottesman & Erlenmeyer-Kimling, 2001).  
Adoption studies also point to genetic inheritance. Offspring of schizophrenic 
parents show similar elevated risk whether they are raised with their biological parents or 
in an adoptive home, and regardless of whether parents developed the disorder before or 
after the adoption. Offspring of nonpsychotic biological parents also do not show an 
elevated risk if they are raised by schizophrenic adoptive parents (Heston, 1966; Higgins, 
1976; Tienari, 1991; Tienari et al., 1985; Tienari et al., 1994; Wender, Rosenthal, Kety, 
Schulsinger, & Welner, 1974). This indicates that a genetic risk is conferred and the 
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increased incidence of schizophrenia is not simply due to environment. In fact, in 
monozygotic twins discordant for the disease, offspring of the unaffected twin show 
similar risk of developing schizophrenia as offspring of the schizophrenic twin 
(Gottesman & Bertelsen, 1989; Kringlen & Cramer, 1989). There seems to be a 
hereditary risk even in the absence of the disorder. 
 The high heritability of schizophrenia has motivated decades of research 
attempting to unravel the genetics of schizophrenia. Early researchers began a search for 
a major single gene that may be responsible for transmission. However, it became 
apparent that the disorder did not show a Mendelian inheritance pattern (Risch & Baron, 
1984; Tsuang, Bucher, & Fleming, 1982). In fact, although a positive family history is a 
strong indicator of increased risk, most individuals with schizophrenia have no first-
degree relatives who exhibit the disorder. This signifies a more complex genetic 
component (Kendler, 1987; J. Yang, Visscher, & Wray, 2010). 
 More recently, genome wide association studies (GWAS) or linkage studies have 
been used to discover possible candidate genes. These studies take advantage of the 
concept of linkage disequilibrium. Alleles from neighboring genetic markers tend to be 
inherited together. The entire genome can be systematically surveyed by doing a case-
control comparison for single-nucleotide polymorphisms (SNPs), or base pair variations 
that occur throughout the genome. SNPs associated with a disorder indicate areas of the 
genome that may be relevant to its etiology (Hardy & Singleton, 2009; McCarthy et al., 
2008). This allows multiple susceptibility loci to be identified at once without prior bias. 
In linkage studies, this analysis is performed between cases and controls in a family, 
while association studies compare cases and controls among the general population. 
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These studies detect common polymorphisms that show an association with 
schizophrenia, and several pertinent loci have been detected. Many of the implicated 
genes also have functions that could potentially be relevant to the etiology of 
schizophrenia. These include factors involved in neurodevelopmental (e.g. Nrg1, 
PTPN21, RELN, EFHD1, EML5, ANK3, VRK2, SHISA9, LNX2, TCF4, C1orf187), 
neuroendocrine (e.g. NRGN, PAM) and immune (e.g. HLA-DRB1, HLADQA1, SPA17, 
PTGS2, PLAA, PRSS16, TLR4, CSF2RA, IL3RA) systems. Although these can combine 
to make a substantial contribution to schizophrenia risk, all of these polymorphisms also 
presented small odds ratios individually. This indicates that, although these variants are 
common, they only have a weak effect on relative risk for schizophrenia. However, this 
may be expected, as the decreased reproductive fitness in schizophrenia would cause the 
negative selection of any risk alleles of large effect size, making them exceedingly rare 
(Alkelai et al., 2011; Alkelai et al., 2012; Athanasiu et al., 2010; J. Chen et al., 2011; 
Hosak, Silhan, & Hosakova, 2012; Ikeda et al., 2011; International Schizophrenia et al., 
2009; Kirov, Zaharieva, et al., 2009; Lencz et al., 2007; X. Ma et al., 2011; Need et al., 
2009; O'Donovan et al., 2008; Rietschel et al., 2012; Shi et al., 2009; Shifman et al., 
2008; Stefansson et al., 2009; Sullivan et al., 2008; Walsh et al., 2008; Yamada et al., 
2011). 
 Because of the pressure of negative selection, rare mutations that confer 
schizophrenia risk with higher penetrance are likely recent de novo mutations or older 
mutations of intermediate effect size that have not yet been selected out. Such mutations 
do seem to exist in the form of copy number variants (CNVs). CNVs are genomic 
insertions, duplications, translocations or deletions of sections of DNA that can be from a 
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few kilobases to several megabases in length. These structural variants can have effects 
on phenotype if, for example, the mutation occurs in dosage-sensitive genes or in regions 
containing regulatory sequences (Mulle, 2012; Owen, 2012). Whole genome scans have 
revealed that rare, large CNVs are three to eight times more frequent in cases with 
schizophrenia than in unaffected controls. There is evidence for the involvement of 
CNVs in the pathogenesis of other neurodevelopmental disorders, such as autism, mental 
retardation, epilepsy, and ADHD. These structural variants may be playing a similar role 
in schizophrenia (Kirov, Grozeva, et al., 2009; Walsh et al., 2008; B. Xu et al., 2008). 
GWAS analyses have also identified specific CNV loci on several different chromosomes 
that, although not fully penetrant, confer a relatively high degree of risk for 
schizophrenia. Some structural variants associated with schizophrenia have also been 
linked to several different psychiatric disorders, indicating a possible etiological overlap. 
For example, the Neurexin1 (NRXN1) deletion has been strongly associated with 
schizophrenia, as well as autism, epilepsy, and mental retardation. NRXN1 encodes a 
presynaptic neuronal cell adhesion molecule that induces postsynaptic differentiation in 
dendrites, so its implication points to a potential role of synaptic dysfunction. While some 
of the CNVs linked to schizophrenia are confined to a single gene, others span multiple 
genes, making it difficult to determine which genes are involved in the pathogenesis. 
However, the use of pathway analysis on identified genes to determine whether genes 
from specific functionally defined pathways were overrepresented in the sample revealed 
that a disproportionate number of disrupted genes were involved in neurodevelopment or 
synaptic transmission in cases but not controls. One notable example is the Neuregulin1 
signaling pathway. Neuregulin1 (Nrg1) binds to the ErbB4 receptor, and this complex 
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plays a role in the regulation of neurotransmitter receptor expression, myelination, 
synaptic plasticity, and neuronal survival, migration, and differentiation. ErbB4 interacts 
with MAGI2 at neuronal synapses, and both of these have been identified as structural 
variants associated with schizophrenia (Doherty, O'Donovan, & Owen, 2012; Duan, 
Sanders, & Gejman, 2010; Gejman, Sanders, & Kendler, 2011; International 
Schizophrenia, 2008; Kirov, Grozeva, et al., 2009; Kirov et al., 2008; Mulle, 2012; Need 
et al., 2009; Raychaudhuri et al., 2009; Stefansson et al., 2008; Sudhof, 2008; Tam, 
Redon, Carter, & Grant, 2009; Walsh et al., 2008; B. Xu et al., 2008). 
 In addition to genetic mutations, epigenetic mechanisms can regulate genomic 
functions, including gene expression, through the covalent modifications of DNA and 
histones. In chromatin, DNA is wrapped around histone cores to form nucleosomes. 
Epigenetic mechanisms then alter the access of transcription factors to DNA binding 
sites. In DNA methylation, DNA methyltransferases (DNMTs) attach a methyl group to 
the C5 position of the cytosine in a CpG dinucleotide, which generally promotes a closed, 
transcriptionally repressed state and leads to gene silencing. Histone modifications 
include methylation, acetylation, phosphorylation, ubiquitination, and sumoylation and 
can cause either gene activation or repression (Feng & Fan, 2009; Jenuwein & Allis, 
2001). 
 These epigenetic mechanisms have been associated with the pathogenesis of 
schizophrenia. Aberrant methylation is present in numerous loci in the frontal cortex of 
schizophrenic individuals. These include several genes implicated in the disease etiology, 
such as those involved in neurodevelopment or glutamatergic and GABAergic 
neurotransmission (Mill et al., 2008). S-adenosylmethionine (SAM) is the methyl donor 
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used by DNMTs to transfer the methyl group to a cytosine residue. In the schizophrenic 
prefrontal cortex, levels of SAM are twice as high as healthy controls. This is also 
associated with an increase in DNMT1, which may contribute to the hypermethylation 
and downregulation of certain cortical genes (Guidotti et al., 2007). Global methylation 
patterns in the peripheral blood are also a marker for schizophrenia, with patients 
showing significant hypomethylation (Melas et al., 2012). 
An analysis of copy number discordance between monozygotic twins discordant 
for schizophrenia found that these twins did not differ in their structural variants (Ono et 
al., 2010). However, monozygotic twins do differ in their peripheral blood methylation 
patterns based on whether they have the disorder. Genome-wide DNA methylation 
profiling has identified numerous differentially methylated CpG sites, mostly in regions 
containing promoters. These included methylation differences in genes that have 
previously been implicated in schizophrenia, such as the dopamine D2 receptor and the 
catechol-O-methyltransferase (COMT) gene. The affected twin also had a methylation 
pattern that was more similar to unrelated schizophrenic individuals than to the 
unaffected co-twin (Dempster, Mill, Craig, & Collier, 2006; Dempster et al., 2011; 
Kinoshita et al., 2013; Petronis et al., 2003). As the concordance rate of schizophrenia 
between monozygotic twins is only 48%, epigenetic factors could account for this 
difference. 
 DNA methylation is dynamic and there appears to be some correlation between 
levels of methylation and the severity of symptoms. In the early 1960s, schizophrenics 
were given high doses of methionine in an attempt to treat the disorder. This instead led 
to an exacerbation of their symptoms (Brune & Himwich, 1962; Pollin, Cardon, & Kety, 
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1961; Tremolizzo et al., 2002). Methionine is converted to SAM, and there is some 
evidence that high methionine can cause hypermethylation in specific regions of the 
genome, which may be responsible for the negative effects on schizophrenia (Dong et al., 
2005; Waterland, 2006). Methionine is metabolized through removal of a C1 methyl 
group to homocysteine, which can be remethylated to methionine by the enzyme 
methionine synthase. Homocysteine levels are elevated in schizophrenia (Adler Nevo et 
al., 2006; Applebaum, Shimon, Sela, Belmaker, & Levine, 2004; Haidemenos et al., 
2007; Levine, Sela, Osher, & Belmaker, 2005; Levine et al., 2002; Regland, Johansson, 
Grenfeldt, Hjelmgren, & Medhus, 1995; Susser, Brown, Klonowski, Allen, & 
Lindenbaum, 1998), and high homocysteine levels in pregnant women even increase the 
schizophrenia risk for their children (Brown et al., 2007). Plasma homocysteine levels 
also correlate positively with the severity of both positive and negative symptoms in 
schizophrenia, as levels rise during exacerbation of the illness and fall during remission 
(Petronijevic et al., 2008). This may be due to the fact that elevated homocysteine levels 
are associated with aberrant methylation in 1,338 CpG sites in the peripheral leukocytes 
of patients with schizophrenia. Significant positive correlations were observed at 580 
sites, while negative correlations were seen at 758 sites. As areas with higher CpG 
content were more likely to show positive correlations, the effect of homocysteine on 
methylation may depend on CpG density (Kinoshita et al 2013). Given the association of 
high homocysteine levels with schizophrenia, studies have also investigated the possible 
ameliorating effects of decreasing homocysteine. Folic acid, vitamin B6, and vitamin B12 
are all involved in the metabolism of homocysteine, and combined treatment with these 
vitamins has been shown effective at reducing plasma homocysteine levels (Spence et al., 
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2001). Treatment of schizophrenic patients with these vitamins leads to a decrease in both 
homocysteine levels and clinical symptoms (Levine et al., 2006). These results suggest 
that hyperhomocysteinemia may play a role in schizophrenia pathogenesis through its 
impact on DNA methylation.  
MODELING ADVANCED PATERNAL AGE AS A WINDOW TO 
SCHIZOPHRENIA PATHOLOGY  
 
 The effects of advanced paternal age have become increasingly relevant in recent 
years as the trend of older parenthood gains popularity. In England, for example, the 
percentage of fathers aged 35 to 54 grew from 25% in 1993 to 40% in 2003 (Bray, 
Gunnell, & Davey Smith, 2006). Over the past century, advanced paternal age has been 
increasingly linked to the development of genetic disorders in offspring. The first 
evidence of such a link came in 1912, when Wilhelm Weinberg observed that children 
with a later birth order were more likely to display a sporadic case of skeletal disorder 
achondroplasia (Crow, 2000b). It wasn’t until 1957 that Penrose distinguished between 
the effects of birth order, maternal age, and paternal age, to show that the increased 
incidence of de novo achondroplasia was solely linked to paternal age (Penrose, 1957). 
We now know that this disease is caused by an autosomal dominant mutation in the 
FGFR3 gene that is inherited from the father (Rousseau et al., 1994).  
Since Weinberg’s finding, several other autosomal dominant disorders have been 
linked to advanced paternal age. Risch compared the distribution of parental ages in cases 
of these disorders with the distribution in the general population to calculate the ratio of 
observed to expected cases for each parental age range (Risch, Reich, Wishnick, & 
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McCarthy, 1987). In addition to achondroplasia, Apert, Crouzon, and Pfeiffer showed a 
strong paternal age effect in which incidence increased exponentially with increasing 
paternal age. Risk of the offspring having these mutations increased more sharply when 
the father was over 40 years old. 
Penrose(Penrose, 1955) first introduced the copy-error hypothesis in 1955 to 
explain this paternal age effect. He posited that these mutations were due to mistakes in 
DNA replication. In males, gonadocytes divide 30 times before puberty to give rise to 
spermatogonial stem cells, which will then divide every 16 days during spermatogenesis. 
This adds up to 610 cell divisions by age 40 and 840 by age 50. Females, meanwhile, 
have only 24 cell divisions during oogenesis, and this number remains constant with 
increasing age (Crow, 1997). The copy error hypothesis would therefore predict a greater 
number of mutations to derive from the paternal cell line due to the greater number of cell 
divisions. The autosomal dominant disorders linked to paternal age are thought to be 
caused by nucleotide substitutions in hypermutable "hotspots" on the paternal 
chromosome. The FGFR3 nucleotide 1138 that is mutated in achondroplasia has one of 
the highest mutation rates, at 10²-10³ times the normal mutation rate (Wilkin et al., 1998). 
 Recently, more complex disorders have been linked to advanced paternal age. 
Alzheimer's Disease(Bertram et al., 1998), schizophrenia(Malaspina et al., 2001; 
Tsuchiya et al., 2005), bipolar disorder(Dalman, 2009), and autism spectrum 
disorders(Kolevzon, Gross, & Reichenberg, 2007; Reichenberg et al., 2006) all increase 
in frequency with increasing paternal age. These disorders are much more common than 
the autosomal dominant disorders, with a frequency on the order of 0.1-1%, as opposed 
to the 1/25,000 frequency of achondroplasia. They have also not been conclusively linked 
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to a single locus, and probably involve multiple genes. Given the relatively high rate of 
incidence and the observation that the incidence roughly triples with advanced paternal 
age(Croen, Najjar, Fireman, & Grether, 2007; Frans et al., 2008; Malaspina et al., 2001), 
the copy error hypothesis may be insufficient to explain this paternal age effect. A 2009 
study has even linked increasing paternal age to decreasing intelligence, measured at 8 
months, 4 years, and 8 years in children (Saha et al., 2009). If paternal age can affect a 
continuous trait like intelligence, a rare mutational mechanism seems an unlikely and 
inadequate explanation. Epigenetic mechanisms may therefore be a more likely 
explanation for the paternal age effect. 
 Epigenetic mechanisms such as DNA methylation alter the access of transcription 
factors to DNA binding sites. DNA methyltransferases attach a methyl group to the C5 
position of the cytosine in a CpG dinucleotide, which generally promotes a closed, 
transcriptionally repressed state and leads to gene silencing (Feng & Fan, 2009). DNA 
methylation during spermatogenesis is an active process and a gradual loss of fidelity 
across replication cycles results in altered methylation patterns, which can be propagated 
to subsequent generations. It is possible that the effects of paternal age on offspring 
behavior are due to aberrant methylation patterns propagated from father to offspring. 
For some time, it was thought that total epigenetic reprogramming occurred during early 
embryogenesis. However, there is evidence that this erasure is not complete. One 
example of incomplete erasure comes from studies of the agouti viable yellow gene in 
mice, which encodes a yellow coat color. In a study by Chong et al, the level of 
methylation of a near-by transposon affects expression levels of the agouti gene (S. 
Chong et al., 2007). Female mice with one copy of the agouti viable allele were bred with 
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either wild-type males or males with heterozygous mutations of genes involved in 
epigenetic modification (Smarca5 or Dnmt1). Offspring of the heterozygotes that were 
wild-type for Smarca5 and Dnmt1 were genetically identical to the offspring of the wild-
type males. However, the offspring of heterozygous fathers were more likely to be 
yellow. This suggests that disruptions of the male epigenome can be passed on through 
the germ line and go on to affect the phenotype of the offspring. 
Even behavioral phenotypes can be transmitted epigenetically through the male 
germ line (Alter et al., 2009). In an inbred strain of Balb/cJ mice, paternal open field 
behavior was correlated with open field behavior of female offspring. Mice were 
genetically identical, and the fathers were removed after conception, making the 
inheritance of a mutation or an environmental impact on offspring behavior less likely. 
Presumably, all that was passed on from father to offspring in these mice was contained 
in the sperm, so the inheritance of some epigenetic modification that can cause reduced 
open field activity is the most likely explanation.  
There is also some evidence that paternal age may affect males and females 
differently. One study on longevity showed an inverse relationship between paternal age 
and lifespan of female offspring but not male offspring (Gavrilov et al., 1997). Daughters 
showed a 4.4-year reduction in lifespan when their fathers were over 50 years old, 
suggesting that the paternal age effect might be stronger for female offspring. Consistent 
with this hypothesis is evidence that the male to female ratio for autism spectrum disorder 
decreases with increasing paternal age (Anello et al., 2009). Autism generally occurs in 
males at four times the rate seen in females. However, the rate is 6.2:1 for offspring of 
fathers under age 30, and 1.2:1 for offspring of fathers over age 45. Another possibility is 
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that multiple disease mechanisms are at work, and the mechanism linked to paternal age 
is less sensitive to gender differences. In either case, further comparison of the effects of 
paternal age on males and females would provide valuable insights into the processes at 
work and the implications of these findings. 
The exploration of abnormal methylation patterns in neuropsychiatric disorders is 
just beginning. In 2008 Mill et al published the first whole-genome methylation profile of 
psychosis, analyzing the frontal cortex of schizophrenia and bipolar patients (Mill et al., 
2008). They found methylation differences in over 100 loci, including several genes 
involved in glutamatergic and GABAergic signaling and others that were previously 
linked to these disorders. Interestingly, the psychosis-related methylation changes 
presented with vastly different patterns in male and female subjects. Given the sexual 
dimorphism in the frequency and presentation of these disorders, this finding is not 
completely unexpected. 
In schizophrenia, for example, there are gender differences in the course of 
schizophrenia. These differences are even apparent during the premorbid phase of the 
disorder. Females exhibit higher levels of premorbid functioning, particularly in social 
interaction (Amminger et al., 2006; Childers & Harding, 1990; McGlashan & 
Bardenstein, 1990; V. A. Morgan, Castle, & Jablensky, 2008; Nordentoft et al., 2006; 
Norman, Malla, Manchanda, & Townsend, 2005; Shtasel, Gur, Gallacher, Heimberg, & 
Gur, 1992). The decreased premorbid functioning in males seem to be related to the 
significantly higher levels of negative symptoms also found in males (Chaves, Seeman, 
Mari, & Maluf, 1993; R. K. Willhite et al., 2008). In general, the course of schizophrenia 
appears to be milder in women, as they are less likely to be institutionalized, show higher 
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rates of remission and lower rates of relapse, and have a better treatment response to 
antipsychotics (Goldstein, Cohen, et al., 2002; Uggerby, Nielsen, Correll, & Nielsen, 
2011; Usall, Ochoa, Araya, Marquez, & Group, 2003; Usall, Suarez, Haro, & Group, 
2007). 
There are also brain structural differences between the sexes in schizophrenia. 
Male schizophrenic patients have larger lateral and third ventricles, as well as decreased 
frontal and temporal lobe volumes, when compared to controls. However, female 
schizophrenic patients generally do not show this difference or display a much slighter 
effect (Andreasen et al., 1990; Gur et al., 2000; Reite et al., 1997). Sex-specific regional 
differences have also been identified, especially in corticolimbic structures. For example, 
in female schizophrenic patients relative to healthy female controls, there was a 
significant decrease in anterior cingulate volume determined by MRI. Male patients, 
though, did not show a difference from controls in this area (Goldstein, Seidman, et al., 
2002; Takahashi et al., 2003). Also, the ratio of orbitofrontal cortex to amygdala volume 
was disturbed as men with schizophrenia had a higher ratio than healthy men, while 
women with schizophrenia had a lower ratio than healthy women (Gur et al., 2004).  
Males are also 40% more likely to develop schizophrenia and display the clinical 
phenotype an average of 3 to 4 years earlier than females, with the peak incidence for 
females and males ages 20-29 years and ages 15-24 years, respectively (Aleman, Kahn, 
& Selten, 2003; Angermeyer & Kuhn, 1988; Hafner, Behrens, De Vry, & Gattaz, 1991; 
Hafner, Maurer, Loffler, & Riecher-Rossler, 1993; J. McGrath et al., 2004; Munk-
Jorgensen, 1987). These sex differences may be due to a possible protective effect of 
estrogen. This is also supported by findings that earlier puberty in women is associated 
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with delayed age of onset (R. Z. Cohen, Seeman, Gotowiec, & Kopala, 1999). A smaller 
peak in age of onset is also seen from ages 45-54, only in women (Hafner et al., 1991; 
Hafner, Riecher-Rossler, et al., 1993; Munk-Jorgensen, 1987). This suggests that the 
higher estrogen levels between adolescence and menopause may play some protective 
role. In fact, there is evidence that the course of schizophrenia in women may fluctuate 
with levels of estrogen. Estrogen levels vary throughout a woman’s menstrual cycle, and 
phases with lower estrogen have been associated with greater symptom severity 
(Bergemann, Parzer, Runnebaum, Resch, & Mundt, 2007; Hallonquist, Seeman, Lang, & 
Rector, 1993; Riecher-Rossler, Hafner, Stumbaum, Maurer, & Schmidt, 1994; L. H. 
Rubin et al., 2010). Women are also more prone to psychotic episodes during the 
estrogen withdrawal phases following childbirth, abortion, or termination of estrogen 
therapy (Bergemann et al., 2002; Kendell, Chalmers, & Platz, 1987; Mahe & Dumaine, 
2001). Conversely, an improvement in psychotic symptoms can result from increased 
estrogen, whether the increase is due to pregnancy, postmenopausal estrogen 
replacement, or hormonal contraceptives (Felthous, Robinson, & Conroy, 1980; Kendell 
et al., 1987; Lindamer, Lohr, Harris, & Jeste, 1997). In sum, higher estrogen levels are 
associated with decreased lifetime incidence or schizophrenia, delayed onset, and reduced 
symptom severity. Because treatment with estrogen can alter the course of schizophrenia, 
it is likely that estrogen has a direct mitigating influence on psychotic symptoms. The 
mechanism for estrogen’s effects is not entirely clear. Estradiol does interact with the 
dopaminergic, glutamatergic, and serotonergic systems, so it may function similarly to 
atypical antipsychotics (Hughes et al., 2009; Taylor, Maloney, Dearborn, & Weiss, 
2009). It may also have epigenetic effects, as both testosterone and estradiol are ligands 
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for nuclear transcription factors that can recruit activator or repressor complexes to 
regulate DNA or histone methylation (Ceschin et al., 2011).  
Both the genetic and epigenetic changes described can result in changes in gene 
expression that may contribute to complex disorders like schizophrenia, which have high 
heritability and are also susceptible to environmental modulation. Epigenetic 
modifications found in the parents can sometimes be passed on to the children, and even 
environmental influences on the epigenome can persist transgenerationally (Anway, 
Cupp, Uzumcu, & Skinner, 2005; Lane et al., 2003; H. D. Morgan, Sutherland, Martin, & 
Whitelaw, 1999; Rakyan et al., 2003). The epigenome is also especially sensitive to 
environmental insults during the prenatal period of rapid cell division, as epimutations 
can also be maintained through mitotic cell division (Dolinoy, Weidman, & Jirtle, 2007). 
Postnatally, people remain susceptible to social, psychological, and chemical stressors 
such as migration, urbanicity, and cannabis use, which modulate schizophrenia risk 
(Rutten & Mill, 2009; van Os, Kenis, & Rutten, 2010; van Os, Pedersen, & Mortensen, 
2004). While this mechanism is not entirely clear, epigenetic misregulation is a 
possibility, since regulation of DNA methylation by such environmental factors continue 
in differentiated cortical neurons throughout life (Marutha Ravindran & Ticku, 2004; 
Numachi et al., 2007; Rampon et al., 2000; Siegmund et al., 2007). 
NEUREGULIN 1 VARIATION AS AN ETIOLOGY FOR SCHIZOPHRENIA 
 
One gene that has been associated with schizophrenia is Nrg1, which is widely 
expressed throughout the body and throughout life and has several roles in development. 
The human Nrg1 gene is roughly 1.4 megabases long, although less than 0.3% of this 
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encodes protein. The presence of multiple promoters and alternative splice sites allows 
for at least fifteen different Nrg1 isoforms to be produced from this gene (Falls, 2003). 
Nrg1 is classified into six types based on its extracellular N-terminal domain. Types I, II, 
IV, and V contain immunoglobulin-like domains and are collectively referred to as Ig-
Nrg1. Type III contains a cysteine-rich domain and is sometimes referred to as CRD-
Nrg1. The characteristic domain of Type VI is still unclear. All isoforms contain an 
epidermal growth factor (EGF)-like domain, which activates ErbB receptor tyrosine 
kinases. Alternative EGF-like spice variants produce α isoforms that are found in the 
mesenchyme β isoforms that are found in the nervous system. Downstream from these is 
a juxtamembrane region containing protease-cleavage sites, followed by a 
transmembrane domain and a cytoplasmic tail. Isoforms are further categorized based on 
the presence of a stalk before the transmembrane domain. Isoforms are labeled “1” if they 
have a stalk and trnasmembrane domain, “2” if they do not have a stalk but have a 
transmembrane domain, and “3” if they are truncated after the stalk and are synthesized 
as soluble isoforms without a transmembrane domain. This last form is directly released 
into the extracellular space. The carboxy tail is labeled either “a” or “b” form, depending 
on the exon. In Type III, the CRD also contains another transmembrane domain, so that 
this isoform remains attached to the membrane after cleavage (Buonanno & Fischbach, 
2001; P. J. Harrison & Law, 2006; Mei & Xiong, 2008). Most Nrg1 isoforms are 
synthesized as pro-Nrg1s, which are anchored to the membrane with an extracellular 
EGF domain. Variants are generated by cleavage on the extracellular side of the 
transmembrane domain by such enzymes as tumor necrosis factor-α converting enzyme 
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(TACE, also called ADAM17), β-site of amyloid precursor protein cleaving enzyme 1 
(BACE1), and meltrin beta (also called ADAM19) (Hu et al., 2006; Loeb, Susanto, & 
Fischbach, 1998; Montero et al., 2007; Willem et al., 2006; Yokozeki et al., 2007). The 
C-terminal fragment can also be cleaved on the internal side of the membrane by gamma 
secretase. This forms the intracellular domain (ICD), which can engage in back signaling 
to modify gene expression (Bao et al., 2004; Bao, Wolpowitz, Role, & Talmage, 2003). 
All of these possible combinations of types, EGF domains, stalks, and tails provide a 
great deal of diversity. These isoforms show differential regional and temporal 
expression, and likely have distinct functions. 
Nrg1 signaling involves the stimulation of ErbB receptor tyrosine kinases, which 
are homologous to the EGF receptor (EGFR, also called ErbB1). Nrg1 induces ErbB to 
dimerize, leading to kinase activation and phosphorylation of the intracellular domain 
(Bublil & Yarden, 2007). Adaptor proteins or enzymes can then dock on the 
phosphorylated tyrosine residues, allowing for the activation of downstream signaling 
pathways. Nrg1 activity can be mediated by the heterodimers ErbB2-ErbB3, ErbB2-
ErbB4, ErbB3-ErbB4, or ErbB4-EGFR, as well as the homodimer ErbB4-ErbB4. 
However, ErbB4 is the only ErbB protein that can interact with Nrg1 and display 
resultant tyrosine kinase activity (Bjarnadottir et al., 2007; Fu et al., 2001; Si, Wang, & 
Mei, 1999; Yarden & Sliwkowski, 2001). ErbB2 does not bind Nrg1, but instead 
functions as a co-receptor with an active kinase domain (Tzahar et al., 1996). ErbB3 can 
bind Nrg1, but has an impaired kinase domain and is catalytically inactive (Guy, Platko, 
Cantley, Cerione, & Carraway, 1994). The EGFR does not bind to Nrg1, but when 
forming a heterodimer with ErbB4 it can also activate signaling pathways more 
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commonly associated with the EGFR. Like Nrg1, ErbB4 has multiple isoforms that show 
variable temporal and regional expression (Mei & Xiong, 2008). 
 Several genetic linkage and association studies have pointed to Nrg1 as a probable 
candidate gene for schizophrenia. It was first implicated in an Icelandic linkage study in 
which a high-risk haplotype containing five SNPs and two microsatellite regions, named 
HAPICE, was significantly overrepresented among schizophrenic patients versus controls 
(Stefansson et al., 2002). Since then, many other studies have found an association 
between schizophrenia and HAPICE, or other haplotypes located in the Nrg1 gene. This 
finding has also been confirmed by meta-analysis (Badner & Gershon, 2002; Corvin et 
al., 2004; Hall, Gogos, & Karayiorgou, 2004; Hong et al., 2004; J. W. Kim et al., 2006; 
C. M. Lewis et al., 2003; Li et al., 2004; C. M. Liu et al., 2005; Munafo, Thiselton, Clark, 
& Flint, 2006; Petryshen et al., 2005; Stefansson et al., 2003; Tang et al., 2004; Thiselton 
et al., 2004; Williams et al., 2003; Zhao et al., 2004). In fact, the Nrg1 receptor ErbB4 
has also been implicated, as studies have found associations between ErbB4 haplotypes 
and schizophrenia (Agim et al., 2013; Nicodemus et al., 2006; Norton et al., 2006; 
Silberberg, Darvasi, Pinkas-Kramarski, & Navon, 2006). There has even been an 
interaction between Nrg1 and ErbB4 variants identified that is also associated with 
schizophrenia (Norton et al., 2006). This suggests that the Nrg1 impact on schizophrenia 
pathology is likely mediated through ErbB4 signaling. 
Genomic analysis can identify loci of interest, but the impact of relevant SNPs or 
CNVs is not always obvious. Some SNPs have functional relevance, as they can alter 
mRNA transcript stability, cause amino acid changes, or modify transcription factor 
binding affinity (Genomes Project et al., 2010). Even SNPs in non-coding regions can 
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affect gene splicing (Pagani & Baralle, 2004). However, others have simply been used as 
markers of specific loci and their functional consequences are not clear (Bush & Moore, 
2012). CNVs can span several genes, so the gene of importance is also not always 
obvious. Studies of gene expression may therefore illuminate the biological consequences 
of identified genetic, epigenetic or environmental risk factors. 
The theory that Nrg1 is involved in the pathogenesis of schizophrenia is bolstered 
by evidence that expression of both Nrg1 and ErbB4 are altered in schizophrenia. 
Schizophrenia is associated with an increase in specific mRNA transcripts of Nrg1 and 
ErbB4 in the frontal cortex and hippocampus (R. Hashimoto et al., 2004; Law, Kleinman, 
Weinberger, & Weickert, 2007; Law et al., 2006; Nicodemus et al., 2009; Nicodemus et 
al., 2006; Parlapani et al., 2010; Silberberg et al., 2006; Weickert, Tiwari, Schofield, 
Mowry, & Fullerton, 2012). In terms of protein expression, most studies have also 
reported an overexpression of specific splice variants of Nrg1 or ErbB4, and a shift in the 
ratios of various isoforms (V. Z. Chong et al., 2008; Hahn et al., 2006; R. Hashimoto et 
al., 2004; Law et al., 2007; Law et al., 2006; Parlapani et al., 2010; Silberberg et al., 
2006; Weickert et al., 2012). Changes in levels of the enzymes that cleave Nrg1 are also 
associated with schizophrenia, as there is a positive correlation between ADAM17 and 
psychosis. The increase in ADAM17 is correlated with a decrease in full length Nrg1, 
and the ratio of Nrg1 N-terminal fragments to full length was increased in Brodmann’s 
are 9 of the prefrontal cortex of schizophrenics (Marballi, Cruz, Thompson, & Walss-
Bass, 2012). This overexpression of Nrg1 and region-specific imbalance of Nrg1 
isoforms can be linked to phenotypic differences. For example, the high-risk HAPICE 
haplotype of Nrg1 is associated with increased Type III Nrg1 mRNA in postmortem 
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DLPFC of schizophrenics compared with controls, and this increase is also associated 
with an earlier age of onset of the disorder (Weickert et al., 2012). While there is strong 
evidence that Nrg1 is playing some role in the pathology of schizophrenia, it is difficult 
to pinpoint the relevant changes and effects. There is heterogeneity of Nrg1 expression 
throughout the brain, and studies have reported different effects of various isoform ratios. 
Also, this tissue is collected postmortem, so some changes could be due to antipsychotic 
treatment.  
Examining the roles of Nrg1 in the brain may therefore illuminate its significance 
to schizophrenia. Although it does have actions in several organ systems, its roles in the 
central nervous system are most relevant. These include numerous developmental 
functions, beginning during embryogenesis. During prenatal and perinatal brain 
development, Nrg1 is involved in neuronal progenitor cell proliferation, neuronal 
migration in the cortex and cerebellum, and axon migration. It also controls the timing of 
astrogenesis. During the postnatal period of brain maturation, Nrg1 activity influences 
dendritic spine formation and pruning, as well as synaptogenesis. It also controls 
myelination in both the central and peripheral nervous system. Throughout adulthood, 
Nrg1 signaling is involved in modulation of neurotransmission, neuronal plasticity, and 
long-term potentiation (Buonanno, 2010; Corfas, Roy, & Buxbaum, 2004; Falls, 2003; P. 
J. Harrison & Law, 2006; Jaaro-Peled et al., 2009; Mei & Xiong, 2008; Rico & Marin, 
2011; Schmitt, Parlapani, Gruber, Wobrock, & Falkai, 2008; Scolnick, Petryshen, & 
Sklar, 2006; Talmage, 2008). 
Mutant mouse models have been very helpful in defining the functions of Nrg1 in 
development. Yet, due to the widespread expression and importance of Nrg1 during 
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development, Nrg1 knockout (KO) mice do not survive past birth. In complete Nrg1 KO 
mice, the EGF-like domain is disrupted, thereby preventing all Nrg1 isoforms from 
binding to ErbB receptors. These KO mice develop cardiac malformations and died in 
utero at E10.5. This point coincides with the time when embryos normally switch from 
relying on maternal circulation to their own circulation (Falls, 2003; D. Meyer & 
Birchmeier, 1995). These complete KO mice also show a dramatic reduction in cranial 
and sensory neurons, as well as a loss of peripheral myelination (Britsch et al., 1998; D. 
Meyer et al., 1997). However, due to the early demise of these mice, the effects of a total 
loss of Nrg1 in the central nervous system are not clear. Ig-Nrg1 KOs display a similar 
phenotype to complete Nrg1 KOs, and also do not survive past E10.5 due to cardiac 
defects. These mice have normal peripheral myelination, although they do show the 
reduction in cranial and sensory nerves seen in complete Nrg1 KOs (Britsch et al., 1998; 
Kramer et al., 1996; D. Meyer et al., 1997). On the other hand, mice with CRD-Nrg1 
KOs do not have heart defects and survive until birth. Yet these mice die at birth because 
they lack functional neuromuscular synapses and are unable to breathe. The also have a 
reduction in myelination and cranial and sensory nerves (Wolpowitz et al., 2000). As 
homozygous Nrg1 KO mice are not viable, heterozygous mice that only have a 50% 
reduction in Nrg1 are used to further explore the phenotype (Duffy, Cappas, Scimone, 
Schofield, & Karl, 2008). 
As Nrg1 has been linked to schizophrenia susceptibility, the effects of a change in 
Nrg1 expression have been viewed with an eye towards schizophrenia-related 
endophenotypes. While it is implausible to claim to reproduce such a complex cognitive 
disorder in mice, we can elicit behaviors that may reflect specific symptoms of 
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schizophrenia (Corbett et al., 1995; Duncan, Zorn, & Lieberman, 1999; Lipska & 
Weinberger, 2000; Smithies, 1993; Tarantino & Bucan, 2000). Pharmacological models 
of schizophrenia have been developed based on the discovery that certain drugs, such as 
amphetamine and ketamine, reproduce symptoms of schizophrenia in humans (Corbett et 
al., 1995; Duncan et al., 1999; Gainetdinov, Mohn, & Caron, 2001). When mice are 
treated with these drugs, they display distinct phenotypes that can be ameliorated by 
treatment with antipsychotics. The relevant behaviors include hyperactivity, decreased 
social interaction, reduced prepulse inhibition (PPI) indicating sensorimotor deficits, and 
cognitive or learning deficits. Treatment with antipsychotics may also attenuate the 
hyperactivity and improve PPI (Corbett et al., 1995; Coyle, 1996; Duncan et al., 1999; 
Sams-Dodd, 1998; Swerdlow & Geyer, 1998; Tamminga, 1998). Genetic animal models 
can be used to study certain features of schizophrenia, and might therefore replicate some 
but not all of these symptoms. 
Several of these endophenotypes are detectable in Nrg1 EGF/- mice. These mice 
had a reduction in all known Nrg1 isoforms, as all need an EGF-like domain to activate 
ErbB receptors. Behavioral testing reveals that heterozygotes are hyperactive and show 
subtle deficits in PPI. The PPI deficit was not seen a baseline and was only apparent 
when mice were treated with MK-801, a noncompetitive NMDA receptor antagonist and 
a psychotomimetic(Duffy et al., 2008; Gerlai, Pisacane, & Erickson, 2000). Most Nrg1 
proteins are synthesized with a transmembrane (TM)-domain, and Nrg1 TM/- mice 
display a similar phenotype. They also show PPI deficits and hyperactivity that is 
reversed by antipsychotic treatment, as well as increased aggression and a lack of the 
typical preference to investigate a novel conspecific over a familiar one (Boucher et al., 
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2007; Karl, Duffy, Scimone, Harvey, & Schofield, 2007; O'Tuathaigh et al., 2007; 
O'Tuathaigh et al., 2008; O'Tuathaigh et al., 2006; Stefansson et al., 2002). Although the 
changes in Nrg1 expression in schizophrenia are more complex and subtle, the presence 
of these endophenotypes indicates that the heterozygous model is relevant for 
schizophrenia.  
There is also evidence that cognitive deficits are linked to Nrg1 signaling in 
patients with schizophrenia. The n-back task is a test of working memory in which 
subjects must encode a series of stimuli while recalling previous stimuli in that series. For 
example, in a 1-back task, subjects respond to each stimulus by recalling the one 
presented just prior (Callicott et al., 1999). The DLPFC is involved in holding and 
manipulating information over a delay (J. D. Cohen et al., 1997; Courtney, Ungerleider, 
Keil, & Haxby, 1997; E. E. Smith, Jonides, Marshuetz, & Koeppe, 1998), and increased 
working memory load leads to increased brain activation in this region (Braver et al., 
1997; J. D. Cohen et al., 1997; Kammer et al., 1997). In patients with schizophrenia, 
those who were homozygous for risk SNPs in both Nrg1 and ErbB4 showed significantly 
higher levels of fMRI activation in the DLPFC during the n-back test, suggesting that 
changes in Nrg1 signaling may be associated with an increased cortical activation 
requirement to perform the task (Nicodemus et al., 2010). 
INTERNEURON PRODUCTION DURING DEVELOPMENT AND 
ADULTHOOD 
 
While Nrg1 also influences neurotransmission and myelination, one role that is of 
particular interest given its role in cognition is its functions in cortical circuitry 
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development and interneuron migration (Rico & Marin, 2011). Most cortical GABAergic 
interneurons are produced in the telencephalon during embryogenesis from around E12.5 
until birth. This neurogenesis occurs in contiguous regions of the subpallial telencephalon 
called the lateral, medial, and caudal ganglionic eminences (or LGE, MGE, and CGE, 
respectively) (Flames & Marin, 2005). These areas are defined by their patterns of 
expression of various transcription factors. During early corticogenesis, the majority of 
neocortical interneurons originate in the MGE (Anderson, Marin, Horn, Jennings, & 
Rubenstein, 2001; Lavdas, Grigoriou, Pachnis, & Parnavelas, 1999; Marin, Anderson, & 
Rubenstein, 2000; Sussel, Marin, Kimura, & Rubenstein, 1999; Wichterle, Garcia-
Verdugo, Herrera, & Alvarez-Buylla, 1999; Wichterle, Turnbull, Nery, Fishell, & 
Alvarez-Buylla, 2001). However, a smaller population appears to come from the LGE, 
which also produces olfactory interneurons. There is also a later wave of neurogenesis 
that begins around E15.5. During this stage of cortical development, interneurons mostly 
originate in the LGE, although some still arrive from the MGE (Anderson et al., 2001; 
Corbin, Gaiano, Machold, Langston, & Fishell, 2000; Pleasure et al., 2000; Toresson, 
Potter, & Campbell, 2000; Wichterle et al., 1999; Yun, Potter, & Rubenstein, 2001). The 
CGE also contributes interneurons to the cortex, most of which are produced during the 
later stages of corticogenesis (T. Ma et al., 2012). Interneurons predominantly arrive at 
their destinations in the cortex through tangential migration (Parnavelas, 2000; 
Parnavelas, Barfield, Franke, & Luskin, 1991; Polleux, Whitford, Dijkhuizen, Vitalis, & 
Ghosh, 2002). The diversity in embryonic origins of cortical interneurons yields a 
diversity in their ultimate fates, as different regions give rise to distinct subtypes 
(Valcanis & Tan, 2003; Wichterle et al., 2001; Q. Xu, Cobos, De La Cruz, Rubenstein, & 
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Anderson, 2004). The timing of an interneuron’s birth also influences its fate. 
Interneurons derived from the MGE follows an inside-out layering pattern when they are 
incorporated into the cortex, in which interneurons born at earlier stages preferentially 
occupy the deeper layers of the cortex (Miyoshi, Butt, Takebayashi, & Fishell, 2007). 
Those derived from the LGE and CGE follow the opposite pattern, and the earlier-born 
interneurons are incorporated into the superficial layers (Lee, Hjerling-Leffler, Zagha, 
Fishell, & Rudy, 2010; T. Ma et al., 2012; Miyoshi et al., 2010; Vucurovic et al., 2010). 
ErbB4 is highly expressed in the interneuron precursors of the MGE and LGE, 
and Nrg1 signaling through ErbB4 is critical for interneuron migration and differentiation 
(Neddens, Vullhorst, Paredes, & Buonanno, 2009; Yau, Wang, Lai, & Liu, 2003). As 
shown in Figure 1, taken from Huang 2009, CRD-Nrg1 forms a permissive corridor 
through the LGE toward the cortex for the tangentially migrating interneurons. This 
corridor is bordered by the developing striatal mantle, where expression of 
Semaphorin3A and Semaphorin3F create an inhibitory territory that these migrating 
interneurons avoid (Flames et al., 2004; Marin, Yaron, Bagri, Tessier-Lavigne, & 
Rubenstein, 2001). There is also heterogeneous expression of Ig-Nrg1 in the cortex, and 
this seems to act as a diffusible chemoattractive gradient (Flames et al., 2004; Marin et 
al., 2003; Wichterle, Alvarez-Dolado, Erskine, & Alvarez-Buylla, 2003).  
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Extracellular signals control the migration of newborn interneurons from the medial and 
lateral ganglionic eminences  (LGE, MGE) to the neocortex during development. CRD-
Nrg1 forms a permissive corridor through which they migrate, bordered by 
chemorepellant signals from the striatum. Ig-Nrg1 forms a chemoattractive gradient in 
the neocortex.  
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After contributing to corticogenesis, all other regions of the telencephalic 
neuroepithelium contribute to the formation of the subventricular zone (SVZ) (Young, 
Fogarty, Kessaris, & Richardson, 2007). While the germinal zone regresses, neural stem 
cells do persist in the adult SVZ to form a neurogenic niche that provides new neurons to 
the olfactory bulb throughout life. The MGE, LGE, and embryonic cortex (also called the 
pallium) give rise to discrete areas of the SVZ. These regions express patterns of 
transcription factors that reflect their embryonic origins (Kohwi, Osumi, Rubenstein, & 
Alvarez-Buylla, 2005; Merkle, Tramontin, Garcia-Verdugo, & Alvarez-Buylla, 2004; 
Parmar, Sjoberg, Bjorklund, & Kokaia, 2003; Stenman, Toresson, & Campbell, 2003; 
Tamamaki, 2005; Ventura & Goldman, 2007; Willaime-Morawek et al., 2006; Young et 
al., 2007). This is shown in Figure 2, taken from Alvarez-Buylla 2008. The medial wall, 
dorsal wall, lateral wall, and ventral tip of the adult SVZ are homologous to the 
embryonic septum, pallium, LGE, and MGE, respectively (Alvarez-Buylla, Kohwi, 
Nguyen, & Merkle, 2008; Kohwi et al., 2007; Merkle, Mirzadeh, & Alvarez-Buylla, 
2007; Stenman et al., 2003; Ventura & Goldman, 2007; Waclaw et al., 2006; Young et 
al., 2007). The region of origin of SVZ progenitors biases them to a specific interneuron 
fate upon differentiation, once the new neurons are integrated into the olfactory bulb 
(Brill et al., 2009; Brill et al., 2008; De Marchis et al., 2007; Kelsch, Mosley, Lin, & 
Lois, 2007; Kohwi et al., 2007; Merkle et al., 2007; Young et al., 2007). The diversity 
that was seen in the generation of cortical interneurons is once again seen when neurons 
from these regions populate the olfactory bulb. 
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(A) Various regions of the SVZ derive from different embryonic germinal regions. 
Homologous structures are color-coded. This diversity is reflected in the expressed 
transcription factors (B). Olfactory interneuron subtypes also express different 
transcription factors. 
Different types of GCs are also derived from different
SVZ domains. Targeting of NSCs in the pallial and dor-
sal subpallial SVZ leads to primarily superficial GC pro-
duction, whereas ventral SVZ targeting leads to mostly
deep GC production (Merkle et al. 2007). However,
CalR+ GCs are not produced when NSCs in the dorsal
subpallium were targeted; rather, they are derived in
small numbers from the pallium, and in larger numbers
from the medial wall and RMS (Fig. 2). Similarly, a sub-
population of CalR+ PGCs is also derived from this
medial germinal zone. Although the ventral portion of
this medial region faces the nucleus accumbens (an LGE
derivative), more anterior and dorsal regions appear to
face the septum, which is not derived from the LGE, but
expresses the transcription factors Gsh2 and Dlx1/2.
Interestingly the RMS generates nearly all OB interneu-
ron subtypes, including a large percentage of CalR+ GCs
and PGCs (Merkle et al. 2007). The RMS forms along
what earlier in development correspond to the olfactory
ventricle. This ventricular wall is patterned and contains
both pallial and subpallial components (Fig. 2) (Long et
al. 2007).
The dendritic arbors of newborn OB interneurons also
appear to be specified within different domains of the SVZ.
A recent study used retroviruses to label proliferative cells
in the anterior or posterior SVZ of neonatal rats (Kelsch et
al. 2007). GCs with dendrites that branch into the superfi-
cial EPL are derived from cells labeled in the anterior SVZ
of the neonatal rat, whereas GCs that branch deep within
the EPL are derived from retroviral injections into the pos-
terior SVZ. Because retroviruses can label all dividing cells
in the SVZ, it is not clear whether this specification occurs
in primary or secondary progenitors. Nonetheless, the work
does suggest that differences in the rostrocaudal position of
dividing SVZ progenitors affect the branching pattern of
dendrites in young neurons that migrate to the OB.
To determine whether adult SVZ type B cells share the
same regional specification as radial glial cells labeled in
362 ALVAREZ-BUYLLA ET AL.
Figure 3. Transcription factor expression in the developing and adult forebrain germinal zones. Embryo: Different germinal zones are
labeled with different colors. The pallial–septal and pallial–LGE bord rs express transcriptio factors a sociated with both neighbor-
ing progenitor zones and are shown by hatch marks in A and two-colored boxes in B, below the corresponding schematic. Transcription
factors expressed in each region are indicated within each colored box. Some subtypes of OB interneurons have been associated with
specific transcription factors; these are indicated in bold text (for references, see text). (MGE) Medial ganglionic eminence; (LGE) lat-
eral ganglionic eminence. Adult: Adult germinal zones homologous to those in the embryo (based on anatomy and transcription fac-
tor expression) are shown in the same colors as those for the embryo. Note the increase in the number of transcription factors with
overlapping expression at the dorsolateral boundary in the adult ventricle compared to the embryo. (C) Certain subtypes of OB
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An overview of SVZ neurogenesis, taken from Sui 2012, is shown in Figure 3. In 
SVZ proliferation, neural stem cells are the primary precursors, also called B cells, which 
have the capacity for self-renewal and are multipotent. These are astroglia cells that are 
derived from the radial glial cells that are the neural stem cells of the embryonic and early 
postnatal brain (Anthony, Klein, Fishell, & Heintz, 2004; Doetsch, Caille, Lim, Garcia-
Verdugo, & Alvarez-Buylla, 1999; Imura, Kornblum, & Sofroniew, 2003; Laywell, 
Rakic, Kukekov, Holland, & Steindler, 2000; Merkle & Alvarez-Buylla, 2006; Miyata et 
al., 2004; Noctor, Martinez-Cerdeno, Ivic, & Kriegstein, 2004). B cells are generally in 
contact with the ventricle through small apical processes that are surrounded by 
ependymal cells (Mirzadeh, Merkle, Soriano-Navarro, Garcia-Verdugo, & Alvarez-
Buylla, 2008). They divide slowly to give rise to transit-amplifying cells, also called C 
cells. C cells then divide quickly to produce neuroblasts, or A cells, which will travel to 
the olfactory bulb to be integrated into existing circuitry (Lledo, Merkle, & Alvarez-
Buylla, 2008).  
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FIGURE 3: SVZ Neurogenesis 
 
 
Stem cells and transit amplifying cells proliferate in the SVZ (1) and give rise to 
neuroblasts (2). These neuroblasts migrate tangentially through the RMS (3) to arrive at 
the olfactory bulb. They then migrate radially (4) into the GCL or GL, where they 
differentiate into olfactory interneurons and are incorporated into the existing circuitry. 
(Sui, Horne, & Stanic, 2012) 
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Neuroblasts form a complex network of chains that span the length of the SVZ as 
they migrate anteriorly (Doetsch & Alvarez-Buylla, 1996; Lois, Garcia-Verdugo, & 
Alvarez-Buylla, 1996; Rousselot, Lois, & Alvarez-Buylla, 1995). These migrating 
neuroblasts join to form the rostral migratory stream (RMS) as they travel to the olfactory 
bulb (Doetsch & Alvarez-Buylla, 1996; Lois & Alvarez-Buylla, 1994). They assemble 
themselves into chains that cover the distance from the SVZ to the olfactory bulb, and 
crawl along each other in a process called chain migration (Lois et al., 1996; Wichterle, 
Garcia-Verdugo, & Alvarez-Buylla, 1997). These chains are formed exclusively from 
neuroblasts, although they are surrounded by tubes of specialized astrocytes (Doetsch & 
Alvarez-Buylla, 1996; Eom, Li, & Anton, 2010; Lois et al., 1996). It takes new neurons 
2-5 days from their birth in the SVZ to reach the olfactory bulb, and another 5-10 days to 
complete their radial migration out of the RMS to reach their target destination. During 
this process, they differentiate into specific interneuronal subtypes, develop dendritic 
trees and synaptic spines, and become incorporated into the existing olfactory bulb 
circuitry (Carleton, Petreanu, Lansford, Alvarez-Buylla, & Lledo, 2003; Petreanu & 
Alvarez-Buylla, 2002).  
The olfactory bulb is a layered structure containing the glomerular layer (GL), 
external plexiform layer (EPL), mitral cell layer (ML), internal plexiform layer (IPL), and 
granule cell layer (GCL), from most to least superficial. Olfactory sensory neurons 
(OSNs) are located in the olfactory epithelium in the posterior area of the nasal cavity. 
OSN axons form the olfactory nerve, which travels through the cribiform plate to reach 
the GL. In this region, OSNs synapse with projection neurons in structures called 
glomeruli, which are tangles of neuropil where OSN axons form synaptic connections 
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with projection neuron dendrites. Signaling from heterogeneous populations of inhibitory 
interneurons modulates this interaction. Projection neurons then send their axonal output 
to higher areas of the brain for processing (Whitman & Greer, 2009). 
Signaling in the olfactory bulb starts with the OSN. Along with OSNs, the 
olfactory epithelium also contains supporting cells and basal cells, which are stem cells 
that regenerate OSNs throughout life. As OSNs only live for 30 to 60 days, these are 
continually being replaced. OSNs extend a dendritic process to the surface of the 
olfactory mucosa, where it branches into specialized cilia that provide a receptive surface 
for odorant molecules that are inhaled and dissolve in the olfactory mucosa (L. Buck & 
Axel, 1991; Firestein, 2001; Graziadei & Graziadei, 1979; Moulton & Beidler, 1967). 
Each individual OSN only expresses a single G protein-coupled odorant receptor out of 
the extensive multigene family of over 1000 different receptors (L. Buck & Axel, 1991; 
Chess, Simon, Cedar, & Axel, 1994; Mombaerts, 2001; Serizawa et al., 2003). The 
olfactory epithelium can be divided into four broad zones along the dorsoventral axis. 
OSNs that express the same receptor are contained in the same zone, although they may 
be widespread within this region (Ressler, Sullivan, & Buck, 1993; Vassar et al., 1994). 
Glial cells called olfactory ensheathing cells surround axonal projections from OSNs as 
they traverse the cribiform plate (Au, Treloar, & Greer, 2002; Doucette, 1984). They then 
converge in the olfactory bulb to form glomeruli, with each OSN contributing a single 
axon. Several thousand OSNs express the same odorant receptor, and these project to a 
few specific glomeruli that are exclusive to one receptor (L. B. Buck, 2000; Mombaerts, 
2001; Mombaerts, Wang, Dulac, Chao, et al., 1996; Ressler, Sullivan, & Buck, 1994; 
Vassar et al., 1994; Wachowiak & Shipley, 2006). As receptors bind multiple odorants, 
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and odorants activate multiple receptors at varying degrees of efficiency, the pattern of 
glomerular activation acts as a signature for each odorant (Friedrich & Korsching, 1997; 
Koulakov, Gelperin, & Rinberg, 2007; Leveteau & MacLeod, 1966; Spors & Grinvald, 
2002; Spors, Wachowiak, Cohen, & Friedrich, 2006). 
In the glomerulus, OSN axons form glutamatergic synapses with the apical 
dendrites of mitral or tufted cells, two classes of excitatory projection neurons. The 
dendrites of these cells branch extensively, but each only receives input from a single 
glomerulus, maintaining the specificity of OSNs. Mitral cells have their cell bodies 
located in the ML and, in addition to their apical dendrites, extend several lateral 
dendrites into the deeper regions of the EPL to synapse with interneurons. The axons of 
mitral cells coalesce into the lateral olfactory tract and project to the piriform cortex, 
where higher olfactory processing occurs. Tufted cells can be located in the external, 
middle, or deep regions of the EPL. All but the external tufted cells also extend 
secondary lateral dendrites in the most superficial region of the EPL to synapse with 
interneurons. Tufted cells give rise to axons that give off collaterals in the IPL, which 
connect the glomeruli receiving input from OSNs that express the same odorant receptor. 
Tufted cell axons then join the lateral olfactory tract, and are thought to send projections 
to the anterior olfactory nucleus for processing (Belluscio, Lodovichi, Feinstein, 
Mombaerts, & Katz, 2002; Illig & Eudy, 2009; Lledo et al., 2008; Mombaerts, Wang, 
Dulac, Vassar, et al., 1996; Wachowiak & Shipley, 2006; Yan et al., 2008; Zou, Chesler, 
& Firestein, 2009). 
The olfactory circuitry also contains interneurons that provide inhibitory input to 
this signaling pathway through their interaction with mitral and tufted cells. The majority 
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of these interactions are dendrodendritic. In these reciprocal synapses, glutamate is 
released from projection neurons to excite interneurons, which in turn releases GABA 
back onto the projection neurons to inhibit their signaling (Lledo, Saghatelyan, & 
Lemasson, 2004). The olfactory bulb contains a very high proportion of inhibitory 
neurons, as they are one hundred times more prevalent than the projection neurons 
(Nissant & Pallotto, 2011). As the excitability of projection neurons modulates the 
sensory information sent back to the cortex, inhibitory interneurons play an important 
role in encoding olfactory information (Lledo et al., 2008). Most interneurons reside in 
the GL and GCL of the olfactory bulb. The EPL contains far fewer cell bodies than other 
olfactory layers, however it does also contain interneurons. These form dendrodendritic 
synapses with mitral and tufted cells, however they are less well characterized. 
Interneurons are a heterogeneous population not only in terms of location, but also in 
their connectivity, firing patterns, morphology, and immunomarker expression (Crespo, 
Blasco-Ibanez, Marques-Mari, & Martinez-Guijarro, 2001; Kosaka & Kosaka, 2005; 
McQuiston & Katz, 2001; Pinching & Powell, 1971a; Price & Powell, 1970; Shipley & 
Ennis, 1996). 
The periglomerular cells are interneurons of the GL. In the mouse, all of these are 
GABAergic, while some are also dopaminergic. They surround the glomeruli and project 
dendritic branches that interact with OSN axons and principle neuron dendrites (Kohwi et 
al., 2007; Kosaka & Kosaka, 2007). Most periglomerular cells are confined to one 
glomerulus, although a small number of them do have axonal projections to other nearby 
glomeruli (Pinching, 1970; Pinching & Powell, 1971a, 1971b). In glomeruli, OSN axons 
synapse with the dendrites of periglomerular cells, in addition to those of mitral cells. 
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These periglomerular cells then form dendrodendritic connections with the projection 
neuron of the same glomerulus. OSNs also activate external tufted cells, which form 
excitatory connections with a lateral network of superficial short axon cells. Short axon 
cells excite surrounding periglomerular cells, leading to more widespread inhibition of 
mitral cells through dendrodendritic synaptic connections. Thus, periglomerular cells 
provide local feedforward inhibition when activated by a local OSN, as well as broad 
inhibition of other mitral cells when activated by a network of excitatory connections 
(Aungst et al., 2003; Cleland, Johnson, Leon, & Linster, 2007; Linster & Cleland, 2009). 
This is a mechanism for intraglomerular feedback inhibition as these interneurons can 
quickly begin to gate the activity of projection neurons after they are activated. Local 
inhibitory input can serve to enhance to contrast of odors. As mitral cells are receiving 
both excitatory and inhibitory input, they only overcome the inhibition and show a net 
activation when they are stimulate by odor ligands with a high affinity for their odor 
receptors (Cleland & Sethupathy, 2006). Meanwhile, the broader inhibitory signaling is 
thought to be involved in normalizing the signal intensity. Global mitral cell inhibition is 
delivered in proportion to sensory activation. Therefore, while OSN activation can show 
a large degree of variation depending on the odor concentration, mitral cell activation is 
more stable. This allows the olfactory system to recognize the identity of the odor 
regardless of its intensity (Aungst et al., 2003; Chalansonnet & Chaput, 1998; Cleland et 
al., 2007; Cleland & Sethupathy, 2006; T. A. Harrison & Scott, 1986; Meredith, 1986). 
Granule cells make up approximately 95% of olfactory bulb interneurons. Their 
cell bodies are located in the GCL and they extend apical dendritic projections that 
branch extensively in the EPL (Nissant & Pallotto, 2011). There, they form 
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dendrodendritic synapses with mitral and tufted cells. Granule cells in the superficial 
GCL project to lateral dendrites of tufted cells in the superficial EPL, while those in the 
deep GCL synapse with lateral dendrites of mitral cells. There are also granule cells in 
the central zone of the GCL with dendrites that span the entire EPL. This segregation 
suggests that there may be parallel processing pathways for olfactory information through 
the mitral and tufted cell pathways (Greer, 1987; Imamura et al., 2006; Mori, 1987; Mori, 
Kishi, & Ojima, 1983; Orona, Scott, & Rainer, 1983). The lateral dendrites of mitral and 
tufted cells form reciprocal synapses with granule cells, as is seen with periglomerular 
cells. Upon depolarization, glutamate is released to activate granules cells, which then 
release GABA to inhibit mitral and tufted cells. The lateral dendrites of mitral cells can 
traverse great distances of up to 1 mm, and may contact granule cells along this entire 
length. It is possible for an action potential to spread along the length of the dendrite, and 
the spread may be blocked by focal stimulation of inhibitory granule cells along the way 
(Christie & Westbrook, 2003; Debarbieux, Audinat, & Charpak, 2003; J. Ma & Lowe, 
2004; Margrie, Sakmann, & Urban, 2001; Xiong & Chen, 2002). Mitral cells can 
therefore interact with distant granule cells, which can then modulate this activity. This is 
an effective mechanism for lateral inhibition. Odors are not topographically represented 
in the olfactory bulb, in that glomeruli that are stimulated by similar odors do not 
neighbor each other and are instead widely distributed, although there are also foci of 
activation in specific regions of the GL and a degree of chemotopy in the olfactory bulb 
(Johnson, Woo, & Leon, 1998; L. Ma et al., 2012; Stewart, Kauer, & Shepherd, 1979; F. 
Xu et al., 2003; X. Yang et al., 1998). Granule cells also show a distributed pattern of 
activation in response to a stimulus (Shepherd, Chen, Willhite, Migliore, & Greer, 2007). 
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The olfactory bulb has a columnar organization that is maintained from the glomeruli 
through the GCL. Yet, as seen in the GL, there are distributed clusters of columnar 
activation in the GCL in response to a stimulus (D. C. Willhite et al., 2006). The ability 
of a mitral cell dendrite to activate granule cells at varying distances allows for the 
formation of a pattern of activation to identify odors. The clusters of granule cell 
activation may be involved in enhancing the contrast to assist with odor identification, as 
multiple inhibitory inputs onto a mitral cell will be more effective at suppressing its 
activity. 
While periglomerular and granule cells both have reciprocal dendrodendritic 
interactions with projection neurons are involved in providing inhibitory input to both the 
activated projection neurons and those at variable distances, these interneurons have 
different effects on projection neuron firing. Periglomerular cells have stronger inhibitory 
effects on mitral cells and can reduce its firing frequency or even completely silence it 
independent of granule cell activity. The inhibitory effects of granule cells are activity-
dependent. A granule cell cannot silence the mitral cell that activates it and, at most, can 
only have minimal effects on its firing frequency if the periglomerular inhibition is weak. 
However, if a granule cell is strongly activated it might silence other mitral cells through 
lateral inhibition. Increased granule cell activation also results in slight delays in the first 
spike time of the mitral cell. Thus, granule cells may be involved in controlling the 
synchrony of mitral cells (Arevian, Kapoor, & Urban, 2008; Arruda, Publio, & Roque, 
2013; Davison, Feng, & Brown, 2003; Gire & Schoppa, 2009). 
In addition to being spatially and embryologically distinct, interneuron subtypes 
vary in their temporal production throughout life. Interneuron production begins as early 
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as E14 and peaks during the first postnatal week in the mouse (Alvarez-Buylla & Lim, 
2004; Wichterle et al., 2001). Interneurons that are born during this perinatal period are 
more likely to survive in the olfactory bulb long term, although it is not clear whether 
they are functionally different from those produced later in life (Lemasson, Saghatelyan, 
Olivo-Marin, & Lledo, 2005; Magavi, Mitchell, Szentirmai, Carter, & Macklis, 2005; 
Petreanu & Alvarez-Buylla, 2002; Winner, Cooper-Kuhn, Aigner, Winkler, & Kuhn, 
2002). Periglomerular cells are all GABAergic and can be subdivided into three discrete 
populations based on their immunoreactivity to tyrosine hydroxylase (TH), an enzyme 
involved in dopamine synthesis, or to calcium binding proteins calretinin (CR) or 
calbindin (CB) (Parrish-Aungst, Shipley, Erdelyi, Szabo, & Puche, 2007). During early 
embryogenesis, almost all new periglomerular neurons are TH+. This is followed by a 
perinatal period with high levels of TH+ and CB+ newborn periglomerular interneurons. 
Postnatally, the majority of new periglomerular interneurons are CR+. Low levels of 
TH+ and vanishingly low levels of CB+ adult-born periglomerular interneurons are seen. 
Parvalbumin-expressing interneurons of the EPL are only produced perinatally through 
the first few weeks of life. Granule cells, the vast majority of which are CR+, show a 
peak in production during the early postnatal period, but continue to be produced at high 
levels throughout adulthood (Batista-Brito, Close, Machold, & Fishell, 2008). 
Interneuron turnover is more common for adult-born neurons, although the exact 
rate of turnover is not well defined. On the low end, studies have estimated a turnover 
rate of roughly 15% of granule cells (Lagace et al., 2007; Ninkovic, Mori, & Gotz, 2007). 
Others have estimated that half of the superficial granule cells and the majority of deep 
granule cells are replaced continuously (Imayoshi et al., 2008; Valley, Mullen, Schultz, 
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Sagdullaev, & Firestein, 2009). In the GL, periglomerular cells seem to have a roughly 
10% per month turnover rate (Sawada et al., 2011). Decreased neurogenesis leads to 
increased survival of interneurons in the olfactory bulb, indicating that olfactory turnover 
is being impaired (Lazarini et al., 2009; Mouret, Lepousez, Gras, Gabellec, & Lledo, 
2009). This suggests that there are a certain number of interneurons necessary for the 
integrity of the olfactory circuitry to be maintained, and the increased survival may be a 
compensatory mechanism in response of the decreased supply of new interneurons. 
Manipulation of SVZ neurogenesis has been useful in defining the role of adult-
born neurons in olfaction. Deficits in SVZ neurogenesis during embryogenesis leads to 
impaired performance on olfactory discrimination tasks (Bath et al., 2008; Gheusi et al., 
2000; W. R. Kim et al., 2007). However, most studies have not seen this in mice with 
deficits in adult SVZ neurogenesis (Breton-Provencher, Lemasson, Peralta, & 
Saghatelyan, 2009; Imayoshi et al., 2008; Lazarini et al., 2009; Valley et al., 2009). It is 
possible that adult-born neurons are involved in olfactory discrimination, and this has 
simply been difficult to measure because these represent a relatively small proportion of 
neurons. In fact, while mice with blocked SVZ neurogenesis are still able to perform 
discrimination tasks, they show an increased reaction time in these tasks (Mouret et al., 
2009). Increased reaction time in a discrimination task is generally associated with 
greater difficulty (Abraham et al., 2004; Uchida & Mainen, 2003; Wise & Cain, 2000), so 
there does seem to be a subtle discrimination deficit associated with decreased adult 
neurogenesis. There is also evidence that these neurons are used in other learning and 
memory tasks. Adult SVZ neurogenesis is necessary for fear conditioning and long-term 
memory of olfactory reward association learning (Lazarini et al., 2009; Sultan et al., 
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2010; Valley et al., 2009). This indicates that there may be a critical role for new 
interneurons in providing circuit plasticity (Mouret et al., 2008; Nissant, Bardy, Katagiri, 
Murray, & Lledo, 2009). Decreased neurogenesis therefore has a negative effect on 
performance, as turnover is critical for optimization of olfaction. 
Nrg1 and ErbB4 play an important role in neural development, and may be 
involved in the neurogenesis that continues into adulthood in the olfactory system. In 
addition to being expressed in the cortex, amygdala, hippocampus, medial habenula, 
reticular thalamic nuclei, hypothalamic nuclei, subthalamic nucleus, SNc and VTA, it is 
also seen along the ventral and medial border of the striatum/nucleus accumbens and in 
the subependymal zone along the lateral and olfactory ventricles (Steiner, Blum, Kitai, & 
Fedi, 1999). This last area is the rostral migratory stream (RMS), where ErbB4 presence 
suggests a role in cell proliferation and migration. Given the common origins of cortical 
and olfactory interneurons, abnormalities in the olfactory system may also be expected. 
ErbB4 is expressed at high levels at P11 in the RMS and remains detectable as 
cells migrate into the olfactory bulb. Expression is maintained at reduced levels in the 
RMS and granule neurons into adulthood. Double-labeling in the adult RMS for ErbB4 
and PSA-NCAM, a marker for migrating cells, revealed a very high level of 
colocalization. There was also limited colocalization with LeX, a marker of neural 
progenitor cells. It therefore seems that ErbB4 is being expressed on migrating 
neuroblasts. Conditional ErbB4 knockout mice were used to confirm the role of ErbB4 in 
migration. ErbB4-deficient mice demonstrated abnormal neuroblast chain organization 
and migration and deficits in placement and differentiation of olfactory interneurons. The 
neuronal precursors of mutant mice migrated more slowly and many more cells moved 
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back toward the SVZ or perpendicular to the RMS, as well as changing direction more 
frequently (Anton et al., 2004). 
A study by Ghashghaei et al built on this work by clarifying the role of Nrg1, 
which is expressed by immature neuroblasts in the SVZ and at high levels in the region 
around the RMS. An exogenous Nrg1 infusion into the SVZ leads to rapid aggregation of 
proliferating precursor cells and affects the organization of migration. To examine the 
initial effect of Nrg1 on cells leaving the SVZ, the cell tracker dye CMFDA was used to 
label newborn SVZ cells. After 7 days of infusing Nrg1 into the ventricle, there was 
increased proliferation in the Nrg1-treated brains compared to controls. However, only a 
few CMFDA cells had progressed through the RMS to the olfactory bulb, as compared to 
the large numbers migrating out of control brains. This suggests that Nrg1, in addition to 
having an effect on proliferation, may also be acting as a chemoattractant, as the 
exogenous excess prevented new cells from leaving the SVZ (Ghashghaei et al., 2006). 
OLFACTION IS ABNORMAL IN SCHIZOPHRENIA, IS AFFECTED BY 
NEUREGULIN 1, AND PROVIDES INSIGHTS RELEVANT TO BRAIN 
DEVELOPMENT IN SCHIZOPHRENIA 
 
 For decades there has been growing interest in olfactory abnormalities in patients 
with schizophrenia. Several studies have confirmed deficits in odor 
identification(Brewer, Edwards, Anderson, Robinson, & Pantelis, 1996; Houlihan, 
Flaum, Arnold, Keshavan, & Alliger, 1994; Hurwitz, Kopala, Clark, & Jones, 1988; L. C. 
Kopala, Clark, & Hurwitz, 1993; L. C. Kopala, Good, & Honer, 1995; L. C. Kopala, 
Good, & Honer, 1994; L. Kopala, Clark, & Hurwitz, 1989; L. Kopala, Good, Martzke, & 
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Hurwitz, 1995; Malaspina et al., 1994; Moberg et al., 1997; Seidman et al., 1997; Serby, 
Larson, & Kalkstein, 1990; Wu et al., 1993) and odor memory (Dunn & Weller, 1989; 
Wu et al., 1993). Some have found   sensitivity (Geddes, Huws, & Pratt, 1991), while 
others have reported an increase(Bradley, 1984; L. C. Kopala et al., 1993; L. Kopala et 
al., 1989) or decrease in this measure (Isseroff, Stoler, Ophir, Lancet, & Sirota, 1987; 
Serby et al., 1990). There also appear to be abnormalities in judging the hedonic value of 
odors. Most studies found that schizophrenic patients have more difficulty identifying 
pleasant odors, and rate these odors as being less pleasant, while showing no difference 
from healthy controls in rating unpleasant odors (Kamath, Turetsky, & Moberg, 2011; 
Moberg et al., 2003; Plailly, d'Amato, Saoud, & Royet, 2006; Strauss, Allen, Ross, Duke, 
& Schwartz, 2010). However, one observed the opposite pattern, and described 
schizophrenics as giving pleasant odors more positive ratings (Doop & Park, 2006). 
 There is some evidence to suggest that first-degree relatives of schizophrenics 
may share these deficits (L. C. Kopala et al., 2001; Roalf et al., 2006; Ugur, Weisbrod, 
Franzek, Pfuller, & Sauer, 2005). In one study, 19 psychotic patients, 27 nonpsychotic 
relatives, and 43 healthy controls were given the University of Pennsylvania Smell 
Identification Test (UPSIT), a scratch-and-sniff multiple choice test (L. C. Kopala et al., 
2001). The performance of nonpsychotic subjects was intermediate to that of psychotic 
relatives and controls, as 58% of psychotic subjects, 34% of nonpsychotic subjects, and 
9% of controls had an olfactory deficit. This may indicate that a genetic predisposition 
for schizophrenia is also related to the observed olfactory deficits. 
  Schizophrenics can display both negative and positive symptoms, however the 
negative symptoms have been more closely linked to olfaction deficits (Corcoran et al., 
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2005; Geddes et al., 1991). In particular, blunted affect, apathy, and anhedonia show a 
correlation with poor performance on the UPSIT (Ishizuka et al., 2010). Social deficits in 
schizophrenia are often present long before the onset of psychosis, and are among the 
negative symptoms that are most resistant to treatment (Malaspina et al., 2000). As 
olfaction is closely related to social interaction in other mammals, Malaspina examined 
the relationship between olfactory deficits and social drive in schizophrenia (Malaspina 
& Coleman, 2003). Social drive was determined from medical records and patient and 
family interviews, and IQ was also measured. This study showed that, together, social 
drive and intelligence accounted for almost 50% of the variation in UPSIT scores. Poor 
self-care is also associated with both negative symptoms and poor olfactory 
discrimination (Brewer et al., 1996).  
 It has even been proposed that the olfactory deficit could be used as a diagnostic 
tool to predict development of schizophrenia. One study examined olfactory 
identification ability in people at ultra-high risk for schizophrenia, including those with 
attenuated or limited psychotic symptoms, or a genetic risk combined with a decrease in 
mental functioning. Patients who went on to develop schizophrenia or schizophreniform 
psychosis had significantly lower olfactory ability as compared to controls or patients 
who developed other psychotic disorders (Brewer et al., 2003). Similarly, adolescents 
with early onset psychosis also displayed smell identification deficits. These deficits were 
specifically associated with characteristics of schizophrenia, such as negative symptoms 
and cognitive deficits, and not typical features of bipolar disorder, such as grandiosity 
(Corcoran et al., 2005). 
 An olfactory deficit measured at the onset of a first psychotic episode may also 
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signify a poorer long-term prognosis. For example, results of the UPSIT test can predict 
symptom remission a year later. Patients without remission on negative or cognitive 
symptoms had shown an olfactory deficit. However, this was not the case for patients 
displaying positive or anxiety/depression symptoms a year later (Good, Whitehorn, Rui, 
Milliken, & Kopala, 2006). A 2010 study also used the UPSIT to test olfactory function 
in patients who met the criteria for a first episode of schizophrenia spectrum disorder and 
had less than 6 months lifetime exposure to antipsychotics. Subjects were then assessed 
an average of 41 months later, and patients who did not originally exhibit an olfactory 
deficit were better able to attend to their basic needs (Good et al., 2010). 
 Olfactory bulb abnormalities are also apparent. Schizophrenic patients show a 
23% decreased olfactory bulb volume bilaterally(Turetsky et al., 2000) while their 
relatives showed a volume decrease only in the right olfactory bulb, when compared to 
healthy controls (Turetsky, Moberg, Arnold, Doty, & Gur, 2003). Despite having a 
decreased right bulb volume, the unaffected relatives in this study did not demonstrate the 
impaired olfactory ability seen in the schizophrenic patients. 
 While not much research has been done on the structure of the olfactory bulb in 
schizophrenic patients, there is some evidence to suggest that neurogenesis in the SVZ 
may play a role in the pathology of schizophrenia. Irradiation of the SVZ and SGZ in 
adult male rats has been proposed as a model for schizophrenia (Iwata et al., 2008). Three 
months after irradiation, the authors confirmed depleted neurogenesis and elicited several 
schizophrenia-related endophenotypes. Irradiated rats exhibited hyperactivity after a 
methamphetamine dose, as well as auditory sensory gating deficits, social interaction 
deficits, and working memory deficits. These results imply that dysfunction in 
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neurogenesis and cell migration from the SVZ might be somewhat responsible for these 
deficits. 
 While antidepressants cause neurogenesis mainly in the hippocampus, chronic 
antipsychotic use may also increase neurogenesis in the SVZ (Newton & Duman, 2007). 
Atypical antipsychotics such as olanzapine and risperidone have been used to effectively 
treat schizophrenia, and cause a 2- to 3-fold increase in neurogenesis in the adult rat SVZ 
(Wakade, Mahadik, Waller, & Chiu, 2002). The increased appearance of BrdU-positive 
cells in the anterior SVZ suggests that these drugs cause increased migration of neurons 
through the rostral migratory stream to the olfactory bulb. In contrast, the typical 
antipsychotic haloperidol did not stimulate neurogenesis, confirming the results of 
previous research (Malberg, Eisch, Nestler, & Duman, 2000). The ability of 
olanzapine(W. Green, Patil, Marsden, Bennett, & Wigmore, 2006) to stimulate SVZ 
neurogenesis after 3 weeks of treatment has been confirmed in rats. However, one study 
of risperidone(W. Green et al., 2006) and one of olanzapine(Kodama, Fujioka, & Duman, 
2004) failed to show this effect on SVZ cell division. 
There is clear evidence that schizophrenia patients exhibit structural and 
functional olfactory abnormalities, though we do not yet know the extent of the structural 
differences or the significance of the functional deficits. The presence of olfactory 
deficits in unaffected relatives suggests that a genetic mechanism might be responsible. 
Given the schizophrenia-related phenotype seen in Nrg1-deficient mice, the correlation 
between olfactory deficits and negative and cognitive symptoms, and the clear 
abnormalities in cell proliferation and migration, the olfactory system is a useful model to 
elucidate the mechanism of action of Nrg1 and its role in development.  
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 Our lab has set out to measure behavioral and genetic/epigenetic effects in old 
father offspring (OFO) and young father offspring (YFO). These groups had fathers aged 
12 months or 3 months, respectively. Both old fathers and young fathers were bred to 3-
month-old females. In previous studies, performed by Maria Milekic, only the male 
offspring were tested. These studies found decreased open field activity and decreased 
prepulse inhibition in OFOs. However, as there is evidence that the paternal age effect 
may be even stronger in females, we began to test both the female and male offspring in 
parallel. Mice were run through a battery of behavioral tests to determine the behavioral 
phenotype and whether any sex differences were present. The estrous cycle of female 
offspring was determined after each behavioral test, in the method described by Caligioni 
(Caligioni, 2009). The ultimate goal of this study was to determine whether behavioral 
differences between OFOs and YFOs could be attributed to genetic or epigenetic 
inheritance. By comparing OFOs and YFOs that showed the most extreme behavioral 
differences, we could attempt to identify differentially methylated regions or mutations 









 The open field test is a widely-used measure of general activity and exploratory 
behavior, which assesses the response of a mouse to an unfamiliar environment. A 
decrease in the open field activity of OFOs is the most consistent finding seen in previous 
cohorts of male OFOs. In this study, the effect was replicated, but it was only significant 
for the male offspring (Figure 4). Male OFOs showed decreased total ambulatory 
distance (p=0.0379) and decreased ambulatory distance in the center (p=0.0224). There 
was also a near-significant trend toward decreased ambulatory distance in the periphery 
(p=0.0606).  
Prepulse Inhibition (PPI) 
 
 When a noise is presented to a mouse, it will exhibit an unconditioned, reflexive 
startle response. When a much weaker noise precedes a strong stimulus the startle is 
attenuated as the nervous system has a chance to adapt its response to the stimulus. In 
humans, deficits in PPI signify impaired sensorimotor gating. We were particularly 
interested in PPI since several psychiatric disorders are associated with a reduction in 
PPI, including schizophrenia (Geyer, Swerdlow, Mansbach, & Braff, 1990), bipolar 
disorder (Giakoumaki et al., 2007), and autism spectrum disorder (Perry, Minassian, 
Lopez, Maron, & Lincoln, 2007).  
Previous male OFO cohorts have shown a decrease in PPI, however this has been 
difficult to replicate. Figure 5 shows the measurements of %PPI for this cohort when the 
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prepulse is 2db (a), 6db (b), 8db (c), 12db (d), or 16db (e) above the background noise. 
None of the measures of %PPI for either male or female offspring showed a significant 
effect of paternal age (Figure 5).  
Fear Conditioning 
 
In humans, we have seen an effect of paternal age on general intelligence of the 
offspring. To determine whether this would translate into a difference in learning and 
memory between our cohorts of old and young father offspring, we used a paradigm that 
paired a neutral stimulus and context with an aversive stimulus. The fear conditioning test 
takes places over 3 days. On the first day, mice learn that a tone is paired with a foot 
shock. They receive three trial of this pairing and learn to react to the tone with a fear 
response that includes freezing. On the second day, we cover the walls and floor of the 
chambers with plastic and change the lighting and scent of the test chambers. The mice 
then receive 3 tones without any shock pairings. The amount of freezing to the tone 
measures the strength of the tone-shock association in the mice. On the third day, the 
original appearance and scent of the chambers is restored. Mice are placed in the 
chambers, but again do not receive any shocks. The amount of freezing in this session 
measures the strength of the association between the context of the chamber and the 
shock. Fear conditioning is useful because there is a distinction between the roles of the 
amygdala and hippocampus in the learned fear responses. The amygdala is critical in 
learning to freeze to both the tone and the context, but the hippocampus is only involved 
in learning to freeze to the context. 
 Figure 6 shows the results of the fear conditioning tests, after mice had learned to 
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associate a tone with delivery of a shock. To test conditioning to the tone, mice were 
placed in a novel box, after which the tone was played and freezing behavior was 
measured. Figure 6a shows background levels of freezing to the novel box before the 
tone test is delivered. There was no paternal age effect on this behavior, although there 
was a gender effect. Males showed higher background levels of freezing (p=0.0022). 
Freezing behavior to the tone (Figure 6b) or to the context of the shock delivery box 
(Figure 6c) did not show any gender or paternal age effects. 
Social Interaction 
 
 In the social interaction test, mice were introduced to a novel conspecific of the 
same gender in an open field. In one corner of the field, the novel mouse was contained 
in a box with a mesh screen to allow interaction. Another corner of the field contained an 
empty novel box. This allowed us to control for interest in novelty and specifically assess 
novel social interaction. Some paternal age-related psychiatric disorders, most notably 
autism spectrum disorders, are notable for deficits in social interaction. We were 
therefore interested in any patterns of abnormal social interaction our old father offspring 
might demonstrate. 
 Figure 7 shows the results of this test. There was no paternal age effect on time 
spent with the novel mouse (Figure 7a), time spent with the novel box (Figure 7b), or 
the ratio of time spent with the novel mouse divided by the total time spent with either 
the novel box or the novel mouse (Figure 7c). This last measure is an assessment of the 
percentage of time that included social interaction out of the time spent investigating 
novel objects. The only significant effect found in this test is one of gender, as male mice 
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 In the light-dark test, mice are allowed to explore an open area that contains one 
brightly lit side and one darkened side. The task makes use of the conflict between a 
mouse’s instinct to avoid the mildly threatening, bright, open area and the tendency to 
explore the novel environment (Bourin & Hascoet, 2003; Crawley & Goodwin, 1980). 
Therefore an increase in time spent in the light compartment is considered an indicator of 
decreased anxiety. In fact, this test has been used to determine whether drugs are 
anxiolytic or anxiogenic (Bourin & Hascoet, 2003). 
 In this test, there was a paternal age effect specific to the female offspring. Female 
OFOs spent significantly more time in the light, with p=0.0201 (Figure 8a). The light-
dark test was also the only test that showed an effect of estrous in the females. Females in 




Due to the finding that female OFO spent more time in the light compartment 
during the light-dark choice test, we were interested in testing whether female OFOs also 
displayed decreased neophobia. As female OFOs were less deterred by their aversion to 
light in their exploration of the compartment, this might indicate a reduced level of 
anxiety in response to novelty. To determine whether this effect could also be seen in 
relation to a novel food, we food-deprived mice for 24 hours after weighing them. They 
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then had access to both a novel food and a familiar food in their home cages. We 
measured latency to eat each food, and the amount of each consumed. Blueberry Nutri-
Grain bars were used for the novel food, as mice prefer this over a range of other 
palatable foods and will consume it even when they are not food-deprived (Swank & 
Sweatt, 2001). 
Mice were weighed before food deprivation. In addition to a gender effect that 
showed males weighing more than females (p<0.0001), there was also an effect of 
paternal age on weight for the male OFOs. Male OFO weighed less than YFO, with a p-
value of 0.0424 (Figure 9a). While there was no significant paternal age effect on latency 
to eat either food or in familiar food consumed, the female OFO consumed more of the 






 As changes in estrogen levels may effect such behavioral elements as activity and 
emotionality (M. A. Morgan & Pfaff, 2001), the estrous cycle must be taken into account 
when performing behavioral tests on female mice. However, the findings in this area 
have been very inconsistent. Various studies have reported either an anxiolytic or 
anxiogenic effect of estrogen, as measured by the open field or elevated plus maze (Mora, 
Dussaubat, & Diaz-Veliz, 1996; Nomikos & Spyraki, 1988; Palermo-Neto & Dorce, 
1990). It has also been shown to either facilitate or reduce learning in learned fear tasks 
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(Diaz-Veliz, Soto, Dussaubat, & Mora, 1989; Diaz-Veliz, Urresta, Dussaubat, & Mora, 
1991; Gibbs, Burke, & Johnson, 1998; Mora et al., 1996; Sfikakis, Spyraki, Sitaras, & 
Varonos, 1978; Shors, Lewczyk, Pacynski, Mathew, & Pickett, 1998; Singh, Meyer, 
Millard, & Simpkins, 1994). It has been more reliably associated with an increase in 
running wheel activity (M. A. Morgan & Pfaff, 2002; Ruiz de Elvira, Persaud, & Coen, 
1992; Thomas, Storlien, Bellingham, & Gillette, 1986; Wade & Zucker, 1970). In this 
study, the estrous cycle did not have a large effect on behavior. The only significant 
finding was that mice in estrus spent more time in the light compartment during the light-
dark test. Thus signifies some minor support for an anxiolytic effect of estrogen. 
Behavioral Phenotype 
 
 Previous cohorts have shown decreased open field activity, sometimes 
accompanied by decreased PPI, in male OFO. In this study, the decreased locomotor 
activity was replicated in male OFOs, although we did not reproduce the PPI deficit. In 
addition, we observed that there seems to be an effect of paternal age on weight for the 
male OFOs. Male OFOs weighed significantly less than the YFOs of this cohort. 
 However, the female OFOs displayed a different phenotype. Female OFOs did 
not show a significant difference in open field activity. Instead, female OFOs spent 
increased time in the light during the light-dark test, as well as consuming more of the 
novel food during the food neophobia test. Weight cannot account for the change in 
consumption, as this measure did not differ between the female OFOs and YFOs. There 
are therefore two measures that indicate reduced anxiety and less aversion to novelty in 
female OFOs. This appears to run counter to the reduced exploratory behavior in the 
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males, however the decreased locomotor activity in the males might also be interpreted as 
a state of decreased arousal. In sum, paternal age does seem to have disparate effects on 
male and female offspring in our study. 
 Still, we cannot draw that conclusion lightly. While it is true that the fathers were 
characterized by disparate ages, this is not the only difference between the groups. 
Notably, the old fathers were drawn from retired breeders while the young fathers were 
virgins at the start of the study. The difference in experience and hormonal status of the 
old and young fathers may also have heritable genetic or epigenetic effects. This 
highlights the difficulty in interpreting studies of environmental influences. Animal 
research has the advantage of allowing an impressive amount of control over 
experimental factors. However, certain variables, such as age, are harder to isolate. We 




 Further statistical analysis of the data has revealed the presence of individual 
effects of father on offspring behavior. These litter effects could not be explained by age 
of the father. This suggests that there may be other paternal variables that have an effect 
on the inheritance of the described behavioral phenotype. In future studies, behavioral 
testing should be run on the fathers to determine whether individual paternal effects on 
the offspring are linked to a specific paternal phenotype. 
 
	  64	  	  
Genetic and Epigenetic Inheritance 
 
 One possible explanation for the behavioral differences between OFOs and YFOs 
is the accumulation of copy error mutations in the germ cell lines of older fathers. 
Spermatogenesis involves the perpetuation of mitotic divisions throughout life. During 
each of these divisions, the entire genetic sequence must be replicated, carrying the 
possibility of de novo mutations. In fact, point mutations, microsatellite repeats, and copy 
number variations that result from mitotic copy errors have all been associated with 
advanced paternal age (Crow, 2000a; Goriely & Wilkie, 2012; Hehir-Kwa et al., 2011; 
Sun et al., 2012). 
 These were originally thought of as random mutations that would amass as the 
number of mitotic cycles increased. However, more recent studies have put forth a 
“selfish spermatogonial selection” hypothesis (Goriely, McGrath, Hultman, Wilkie, & 
Malaspina, 2013). This is based on the observation that mutations in germ cells that affect 
proliferation can lead to selective expansion of that clonal cell line. These mutations will 
then be preferentially enriched within the sperm cell population. Of note, several of the 
risk genes linked to schizophrenia and other neurodevelopmental disorders associated 
with advanced paternal age are involved in cellular proliferation pathways. In fact, some 
of these candidate genes are also linked to cancer, highlighting their proliferative 
advantage. Nrg1 is among these, as it has been implicated in breast cancer, multiple 
myeloma, and B cell leukemia/lymphoma (Britsch, 2007; Emamian, 2012). 
This could explain why paternal age seems to produce a consistent phenotype in 
the offspring. If the paternal age effect were simply due to random mutations, each 
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mutation would be responsible for a different phenotypic effect and we would not see a 
significant group-wide shift. However, if we consider that selfish selection could be 
behind the relevant mutations, genes that are involved in proliferative pathways would be 
expanded. We could then expect to see distinct phenotypes and disease risks emerge as a 
result of advanced paternal age. 
 Another plausible mechanism is the inheritance of epimutations from old fathers. 
Our studies, and others that examined paternal age effects (Auroux, 1983; Foldi, Eyles, 
McGrath, & Burne, 2010; Garcia-Palomares et al., 2009; R. G. Smith et al., 2009), 
observed a population-wide quantitative shift in behavior. If the advanced paternal age 
effects were due to an increase in rare mutations, as was originally proposed, we would 
expect to see the mouse model result in rare outliers instead of the generalized effects we 
have described. Thus, the buildup of epigenetic changes over time that can be passed 
down through the germ line, creating an accumulation of subtle changes, is more fitting 
with the evidence. 
 This is also consistent with recent studies identifying changes in DNA 
methylation that are linked to advanced paternal age. Epigenetic changes have been 
identified in the male germ line, and these sperm methylation patterns show both intra- 
and inter-individual variability (Flanagan et al., 2006). These changes appear to be passed 
on to the offspring, as human infants show CpG methylation levels in umbilical cord 
blood that are correlated with parental age (Adkins, Thomas, Tylavsky, & Krushkal, 
2011). Maria Milekic has also been analyzing the changes in methylation seen in the 
male OFO mice described here, and her findings also support these studies. She has 
identified a list of differentially methylated genes associated with paternal age in the male 
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offspring. 
 Methylation analysis has not been performed on the female offspring. Yet there is 
reason to believe that the female and male OFOs would show disparate epigenetic effects, 
in the same way that they display distinct behavioral phenotypes. In human newborns, 
parental-age related methylation changes do show gender differences. While most of 
these gender-specific methylation differences are located on the X chromosome, this is 
also the case for some autosomal CpGs (Adkins et al., 2011). However, as the behavioral 
phenotype seen in female OFOs is not as robust as that observed in males, the female 
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1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
p=0.0224	  
695747.308 695747.308 1.502 .222 1.502 .217
1 8150.04 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
28070.45 28070.45 . 61 .8 59 . 61 .057
175 81081695.184 46332 .972







itt r * Gender * Group
R sidual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
8595.9 1 8595.9 1 .764 .3832 .764 .134
1 17548.075 17 48.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
25366 233 25366 233 2 255 1349 2 255 304
175 1968187 291 11246 785







itt r * Gender * Group
R sidual
ANOVA Table for Ambulatory Distance CENTER TOTAL
549674 530 549674 530 .993 .3204 .993 .159
1 1780 128 1780 128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
68 4 9 68 4 9 1.237E-4 .9911 1.237E-4 .050
175 96894508 561 553682 906







itt r * Gender * Group
R sidual
ANOVA Table for Ambulatory Distance     TOTAL
9 7 170 9 7 170 1 73 3 18 1 73 168
1 2113 15 2113 15 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
113666 044 113666 044 3 1 3 07 3 1 3 40
175 6390186 139 36515 49







itt r * Gender * Group
R sidual
ANOVA Table for Latency to Light (s)
63575 482 63575 482 33 5666 33 86
1 34390 019 343 0 0 9 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
171882.979 171882.979 .891 . 465 .891 . 48
175 3375 377. 95 192 76.4 4







itt r * Gender * Group
R sidual
ANOVA Table for Latency to Dark
5737 99.06 5737 99.06 .411 . 366 .411 . 06
1 834.259 883 .259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
238164.88 238164.88 .05 .8091 .059 .057
175 7118747 7.560 4067855.586







itt r * Gender * Group
R sidual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: ender
Significance Level: 5 
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
ffect: roup
ignificance Level: 5 
-78.595 60.44 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
ff t: ender
i ifi  l:  
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
ff t: roup
i ifi  l:  
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.3 1 201.5 6 .9894
Mean Diff. Crit. Diff. P-Value
F, M
ff   l  i  PERIPHERY TOTAL
ff t: ender
i ifi  l   
238.942 204.905 .0225 S
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
ff   Ambulatory Dis ance PERIPHERY TOTAL
ff t: roup
i ifi  l   
-15.110 31.398 .3435
Mean Diff. Crit. D ff. P-Value
F, M
ff   Ambulatory Dis ance CENTER TOTAL
ff t: ender
i ifi  l   
2 .296 31.925 .1349
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
ff   Ambulatory Distance CENTER TOTAL
ff t: roup
i ifi  l   
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. rit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significa ce Level: 5 %
-.043 .079 .2830




Significa ce Level: 5 %
.002 .080 .9522




Significa ce Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significa ce Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significa ce Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significa ce Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significa ce Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significa ce Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significa ce Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significa ce Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significa ce Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significa ce Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Gr up
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Gr up
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Gr up
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Gr up
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Gr up
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
D nnett for Novel Food Consumed (g)
roup
15.775 19.140
Mean Diff. Crit. Diff.
F
D nnett for Latency to Eat
ender
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
D nnett for Latency to Eat
roup
-3.929 .595 S
Mean Diff. Crit. Diff.
F
D nnett for Weight
ender
.729 .605 S
Mean Diff. Crit. Diff.
Ctl
D nnett for Weight
 roup
i i i  l   
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kra er for A bulatory Distance PERIPHERY TOTAL
Effect: ender
Significance Level: 5 
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/ ra er for Ambulatory Distance PERIPHERY TOTAL
ffect: roup
ignificance Level: 5 
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
/ r r f r Ambulatory Distance CENTER TOTAL
ff t: ender
i ifi  l:  
2 .296 1.976
Mean Diff. Crit. Diff.
Ctl, OFO
/ r r f r Ambulatory Distance CENTER TOTAL
ff t: roup
i ifi  l:  
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
/  f  Ambulatory Distance     TOTAL
 ender
i i i  l   
2 3.238 224.358 S
Mean Diff. Cr t. Diff.
Ctl, OFO
Ambulatory Distance     TOTAL
roup
7.692 56. 67
Mean Diff. Crit. Diff
F, M
La ency to i t (s)
ender
3.124 7.617
Mean Diff. Cr t. Diff.
Ctl, OFO
Tukey/Kram r for Latency t  Ligh  (s)
roup
124.644 130. 35
Mean Diff. Crit. Diff
F, M
Tukey/Kram r for Latency t  Dark
ender
- 3 .857 132.419
Mean Diff. Cr t  Diff.
Ctl, OFO
Tukey/Kram r for Latency t  Dark
roup
479.56 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kram r for Total Time Ligh
 ender
i i i  l   
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: roup
Significance Level: 5 
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th 0 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Cri . Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
ignificance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
ignificance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
ignificance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
ignificance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
ignificance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
ignificance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
ignificance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
ignificance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
ignificance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
ignificance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
ignificance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.07 17548.07 1.560 .2133 1.560 .223
1 11220.7 11220.7 .998 .319 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 8 4.959 8 4.959 .428 .5138 .428 .097
1 33622.4 1 33622.45 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 54967 .5 0 54967 .5 0 .993 .3204 .993 .1 9
1 1780.128 1780.128 .003 .9548 . 0 .050
1 1142 14.799 1142 14.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2 2663 .518 2 2663 .518 4.021 .0465 4.021 .501
1 64.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .81 8 .054 .056
1 406 0.472 06 .472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349





Lit er * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .67 4 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .38 .5357 .38 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.2 1 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444





Lit er * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.4 1 .2366 1.4 1 .2
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .0 5 .9429 .0 5 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.2 9 .2731 1.2 9 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.3 1 1989360.3 1 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.3 8 .2 55 1.3 8 .20
1 1424809.9 2 1424809.9 2 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .1 7 .1 7 1.795 .1821 1.795 .250
1 .139 .139 1.959 .163 1.959 .269
1 .075 .075 1.060 .304 1.060 .167
175 2.400 .071







Litter * Gender * Group
Residual
ANOVA Table for S cial/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .29 .29 .001 .9749 .001 .050
1 5.625 5.625 .218 .64 5 .218 .074
1 17.789 17.789 .0 9 .808 .0 9 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .471 .520 .1 7
1 8 5.503 8 5.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .039 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.0 0 .3186 1.0 0 .160
1 389.593 389.593 .550 .4595 .550 .1 0
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 .233 .186
1 1833.19 1833.19 .048 .8270 .048 . 5
1 .0 7 .0 7 1.746E-7 .9997 1.746E-7 . 5
175 6693737.4 5 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2 22.654 2 22.654 .061 .8059 .061 .057
175 7293349.902 416 6.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .01 .01 .983 .3228 .983 .15
1 .009 .009 .757 .3855 .757 .1 3
1 .01 .01 .90 .3420 .90 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
75 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for N vel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57 903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58 874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60 441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Soci l/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19 107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Ge der
Significance Level: 5 %
9.282 19 427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 594 <.0001 S




Significance Level: 5 %
.729 604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Me  Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Me  Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Me  Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Me  Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Sig ificance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Sig ificance Level: 5 %
200.829 361.398
Me  Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Sig ificance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Sig ificance Level: 5 %
-.043 .079




Sig ificance Level: 5 %
.002 .080




Sig ificance Level: 5 %
-8.103 5.151 S
Me  Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Sig ificance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Sig ificance Level: 5 %
1.933 6.447
Me  Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Sig ificance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Sig ificance Level: 5 %
-4.023 7.897
Me  Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Me  Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Me  Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Me  Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Me  Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Me  Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201 852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238 942 205 236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31 449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24 296 31 976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263 238 224 358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3 124 57 617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130 857 132 419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level:  %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Lev l: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
 iff. rit. iff.
tl, 
Gam s/Howell for Familia Food Consumed (g)
ff t: 
i ifi  l:  
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
ignificance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Gam s/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Lev l: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




ignificance Level: 5 
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because th  cell counts are not equal, the h rmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, th  harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
C l, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because th  c ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
C l, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because th  cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
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FIGURE 4: Open Field Activity 
(A) Total ambulatory distance traveled during the open field test. Male OFOs showed 
decreased activity (p=0.0379), but there was no paternal age effect in females. 
(B) Ambulatory distance traveled in the center of the open field. Male OFOs showed 
decreased activity (p=0.0224), but there was no paternal age effect in females. 
(C) Ambulatory distance traveled in the periphery of the open field. Male OFOs showed 
a trend towards decreased activity (p=0.0606), while there was no paternal age effect in 
females.  
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FIGURE 5: Prepulse Inhibition 
 
Percent prepulse inhibition for prepulse 2db (A), 6db (B), 8db (C), 12db (D), or 16db (E) 




C	   D	  
E	  
A	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1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
A	  
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance L vel: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance L vel: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance L vel: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance L vel: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance L vel: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance L vel: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance L vel: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance L vel: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance L vel: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance L vel: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance L vel: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance L vel: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance L vel: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Lat ncy Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Lat ncy Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Lat ncy Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Lat ncy Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
che fe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
che fe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Lat ncy to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Lat ncy to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferro i/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett f r Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance L vel: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Weight
Effect: Group
Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kram  for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kram  for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kram  for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kram  for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kram r for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/How ll for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/H well for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency Novel F od (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Familiar Food C su d (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Familiar Food C su d (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for W ight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Weight
Effect: Group
Significance Level: 5 %
B	  
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .99 .3 04 .99 .159
1 1780.128 1780.128 . 03 .9 48 . 03 . 0
1 1142014.799 1142014.799 2. 3 .1527 2. 3 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .566 .330 .086
1 34390.019 34390.019 .178 .67 4 .178 .070
1 216371.334 216371.334 1.122 .2 10 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Ge d r
Significance L vel: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Ge d r
Significance L vel: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Ge d r
Significance L vel: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Ge der
Significance L vel: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance L vel: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance L vel:  %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance L vel:  %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance L vel: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level:  %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Ef ect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Ef ect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency t  Eat
Ef ect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Ef ect: Gender
Significance Level: 5 %
.729 .604 . 183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Ef ect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Ef ect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Ef ect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Ef ect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Schef e for Total Time ark
Ef ect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef e for Total Time Dark
Ef ect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level:  %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level:  %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level:  %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance L vel: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonf rroni/Dunn for Ambulatory Distance CENTER TOTAL
Ef ect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonf rroni/Dunn for Ambulatory Distance     TOTAL
Ef ect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonf rroni/Dunn for Ambulatory Distance     TOTAL
Ef ect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level:  %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level:  %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level:  %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Ge d r
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Ge d r
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Weight
Effect: Ge d r
Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dun ett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dun ett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dun ett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dun ett for Ambulatory Distance     TOTAL
Effect: Ge d r
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dun ett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Ge d r
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Ge d r
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Ge d r
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level:  %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Ge d r
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Ge d r
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Ge d r
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F
Dunnett for Social/Social+Novel
Effect: Ge d r
Significance Level:  %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Ge d r
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Ge der
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level:  %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kram r for Ambulatory Distance PERIPHERY TOTAL
Effect: Ge d r
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kram r for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tuk y/Kram r for Ambulatory Distance CENTER TOTAL
Effect: Ge d r
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kram r for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kram r for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Ef ect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Ef ect: Gender
Significance Level: 5 %
1 4.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Ef ect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Ef ect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %fre ze
Ef ect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Ef ect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total C ntext %Freeze
Ef ect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freez
Ef ect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %fre ze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level:  %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar ood Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level:  %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level:  %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level:  %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level:  %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the c ll c unts are not equal, the harmonic mean
is used to stimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the c ll c unts are not equal, the harmonic mean
is used to stimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Ge d r
Significance Level: 5 %
263.238 224.358 S
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significanc  Level: 5 %
7.692 56.667
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significanc  Level: 5 %
3.124 57.617
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significanc  Level: 5 %
124.644 130.235
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significanc  Level: 5 %
-130.857 132.419
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significanc  Level: 5 %
479.564 98.098
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significanc  Level: 5 %
-786.257 608.127 S
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significanc  Level: 5 %
-401.713 82.783
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significanc  Level: 5 %
463.514 592.555
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significanc  Level: 5 %
-387.052 340.067 S
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significanc  Level: 5 %
129.124 345.769
Me n Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significanc  Level: 5 %
200.829 361.347
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significanc  Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significanc  Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significanc  Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significanc  Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significanc  Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significanc  Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significanc  Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significanc  Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significanc  Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significanc  Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significanc  Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significanc  Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significanc  Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significanc  Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significanc  Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significanc  Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significanc  Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significanc  Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significanc  Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significanc  Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti ate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significanc  Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is s d to sti te n.
Student-Newman-Keuls for Weight
Effect: Group
ignificance Level: 5 %
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FIGURE 6: Fear Conditioning 
In the fear conditioning paradigm, mice were trained to associate a tone with the delivery 
of a shock. They were then tested on their association of either the tone or the shock-
delivery box with the shock by measuring the percent of time spent frozen. (A) shows 
levels of freezing to the novel box before the tone test was administered. (B) shows 
%freezing to the tone delivery. (C) shows the freezing to the context of the shock-
delivery box. None of these measures showed any effect of paternal age, although males 
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1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
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Ctl, OFO
Fisher's PLSD for Total Time Light
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F, M
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Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
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Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
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Mean Diff. Crit. Diff. P-Value
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Fisher's PLSD for Th10 Tone1 %freeze
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Fisher's PLSD for Latency Familiar Food (s)
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F, M
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Effect: Gender
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Ctl, OFO
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Effect: Group
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Effect: Gender
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Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
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Scheffe for Total Time Dark
Effect: Gender
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463.514 591.599 .1238
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Ctl, OFO
Scheffe for Total Time Dark
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200.829 360.764 .2734
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Ctl, OFO
Scheffe for Total Novel Time
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-.043 .079 .2830
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Effect: Group
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1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
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Effect: Gender
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-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
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Mean Diff. Crit. Diff. P-Value
F, M
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.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
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Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
A	  
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .62 .4312 .62 .118
515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .64 7 .215 .074
1 585.12 585.12 .82 .36 9 .82 .140
1 232.904 232.904 .329 .56 .329 .086
157.864 115 .864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 145 6.591 145 6.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .883 .022 .052
64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .42 5 .644 .12
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 59 .134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Lev l: 5 %
-401.713 81.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Lev l: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Lev l: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit  Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Lev l: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Lev l: 5 %
200.829 360.764 .2734
Mean Diff. Crit  Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Lev l: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Lev l: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Lev l: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Lat ncy to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Valu
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Valu
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Me n Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Me n Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonf rroni/D nn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Lev l: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonf rroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 6.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Signifi ance L vel: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Me n Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance L vel: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance L vel: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Signifi ance L vel: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.4 6 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Lev l: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freez
Effect: Gender
Significance Lev l: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Lev l: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Lev l: 5 %
-54.62 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar  (s)
Effect: Group
Significance Lev l: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Lev l: 5 %
36.219 61.56
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food ( )
Effect: Group
Significance Lev l: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Lev l: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar  s e  ( )
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th1  Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
M an Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Me n Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
M an Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Me n Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
M an Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Gam s/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Lev l: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Gam s/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Gam s/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Lev l: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
M an Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
M an Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance L vel: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance L vel: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance L vel: 5 %
-54.629 56.402
M an Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance L vel: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance L vel: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance L vel: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance L vel: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance L vel: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance L vel: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the ll counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the ll counts are not equal, the harmonic mean
is used to estimate n
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the ll counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the c ll counts are not equal, the harmonic mean
is used to estimate n
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Di f.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 7.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts a e not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts a e not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
M an Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significa ce Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .4 8 .5139 .4 8 .097
1 4814.959 4814.959 .4 8 .5138 .4 8 .097
1 33622.451 33622. 51 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966. 71 1966. 71 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917. 0 20917. 0 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.3 8 61898.3 8 .0 6 .8994 .0 6 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.3 8 127808.3 8 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.0 6 .3101 1.0 6 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.5 7 .0613 3.5 7 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552. 52 859552. 52 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 .467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 . 39 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * ender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * ender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * ender * Group
Resi ual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * ender * Group
Resi ual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * ender * Group
Resi ual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * ender * Group
Resi ual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Me n Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean iff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
ignificance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
ignificance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
ignificance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
ignificance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
ignificance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
ignificance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
ignificance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
ignificance Level: 5 %
-.043 .079 .2830




ignificance Level: 5 %
.002 .080 .9522




ignificance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
ignificance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
ignificance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
ignificance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
ignificance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
ignificance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
ignificance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
ignificance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
ignificance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
ignificance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
ignificance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean iff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn or Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mea  Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to ark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Th10 ToneBox %fre ze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effec : Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dun  for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effec : Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effec : Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effec : Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Valu
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. iff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Famil ar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effec : Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effec : Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effec : Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effec : Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Me  Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-N w an-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New an-Keuls for Weight
Effect: Group
Significance Level: 5 %
B	  
	  73	  	  
FIGURE 7: Social Interaction 
In the social interaction test, mice were placed in an open field that contained a novel 
mouse in a box with a mesh screen, allowing for interaction, in one corner. Another 
corner just contained a novel box. There was no paternal age effect on (A) time spent in 
social interaction, (B) time spent investigating the novel box, or (C) the ratio of social 
session time to social plus novel session time. However, there was a gender effect on 
total social time, as males spent more time engaging in social interaction. 
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 (A) In this task, an open field chamber was split in two, with one side brightly lit and the 
other side darkened. This graph shows the total time spent in the light portion of the 
chamber for both male and female OFOs and YFOs. The female OFOs spent significantly 
more time in the light half of the chamber (p=0.0201). Male offspring did not show an 
effect of paternal age.  
(B) This graph shows the latency to enter the light portion of the chamber when mice 






1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
B	  
p=0.0201	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1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
A	   B	  
C	   D	  
E	  
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .89 6 .018 .052
1 1379636.05 1379636.056 2.9 8 .0862 2.9 8 .386
1 2 08. 78 2 08. 78 .006 .9391 .006 .051
1 2438533.387 243 533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.94 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.53 549674.530 .9 3 .3204 .9 3 .15
1 1780.1 8 1780.128 .0 3 .9548 .0 3 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .0 1 .9 15 .0 1 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113. 1 2113. 15 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.3 7 8070.337 .221 .6389 .221 .074
1 19 6.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 6357 .4 2 63575.482 .330 .5666 .330 .086
1 3439 .019 34390.019 . 78 .6734 . 78 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.9 7 74275.977 .385 .5357 .385 .092
1 24161 .7 2 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .23 6 1.411 .206
1 8834.259 8834.259 .002 .96 9 .00 .050
1 20917. 80 20917. 80 .005 .9429 .005 .051
1 228711.9 3 228711.903 .056 .8128 .056 .056
1 4916738.30 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160. 90 5244160. 90 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084. 80 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .0 6 .8730 .0 6 .053
1 1187151.370 1187151.370 .8 0 .3725 .8 0 .138
1 548708.529 548708.529 .370 .54 0 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .469 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .11 .111 1.572 .211 1.572 .225
1 .3 7 .317 4.470 .0359 4.47 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.1 7 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Famili  Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027




Litt r * Gender
Litter * Group
Gender * Group
Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLS  for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .896
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLS  for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
4 .73 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLS  for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-. 06 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheff  f r Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheff  f r Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheff  f r Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41. 31 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheff  f r Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheff  f r Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheff  f r Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheff  f r Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheff  f r Familiar Fo d Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef  f r Familiar Fo d Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Schef  f r Novel F od Consu d (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef  f r Novel F od Consu d (g)
Effect: Group
Significance Level: 5 %
15. 75 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Schef  f r Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef  f r Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Schef  f r Weight
Effect: Gender
Significance Level: 5 %
.729 . 04 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef  f r Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 To l Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
- 8.595 0.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .0 7 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
5.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.9 9 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunn tt for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunn tt for Latency Fami iar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Latency Fami iar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunn tt for Latency Nove  F od (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Latency Novel Fo d (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunn tt for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunn tt for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunn tt for Novel Fo d Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunn tt for Latency t  Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F
Dunnett for W ight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for W ight
Effect: Group
Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/H well for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1 49 2.25 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for tency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5 57 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for tency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16.926 16.926 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 520 .107
1 865.503 865.503 1.83 .1776 1.832 .255
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 . 74
1 585.125 585.125 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
1 82.739 82.739 .117 .7330 .117 .063
175 124064.865 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .51 5 .435 .0 8
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2 66 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
287923.6 4 287923.6 4 .194 .6602 .194 .072
175 259840850.908 1484804.862







itt r * Gender * Group
R sidual
ANOVA Table for Total Novel Time
.037 .037 .525 .4697 .525 .108
1 .21 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
.075 .075 1.060 .3 47 1.060 . 67
175 2.400 .071







i  * Gender * Group
R sidual
ANOVA Table for Social/Social+Novel
388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







i  * Gender * Group
R sidual
ANOVA Table for Th10 ToneBox %freeze
326.643 326.643 .691 .4068 .691 .126
1 16.926 16. 26 .036 .8501 .036 .054
1 294.132 294.132 .623 .4312 .623 .118
1 515.095 515.095 1.090 .2978 1.090 .170
1 245.755 245.755 .520 .4717 .520 .107
1 865.503 865.503 1.832 .1776 1.832 .255
203 .354 203 .354 4 10 0 93 4. 10 .530
175 82 77.020 472. 40







i  * Gender * Group
R sidual
ANOVA Table for Th10 Total Context %Freeze
152.210 152.210 .215 643 .215 . 74
1 585.12 585.1 5 .825 .3649 .825 .140
1 232.904 232.904 .329 .5673 .329 .086
1 1157.864 1157.864 1.633 .2029 1.633 .232
1 709.241 709.241 1.000 .3186 1.000 .160
1 389.593 389.593 .550 .4595 .550 .110
82.73 82.73 .117 .7330 .117 . 6
175 124064.865 708.942







i  * Gender * Group
R sidual
ANOVA Table for Th10 Tone1 %freeze
14 76.591 14 76.591 .381 .5378 .381 .092
1 1662 .493 16 29.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
. 7 . 7 1.746E-7 .9997 1.746E-7 .050
175 6693737.4 5 38249.928







itt r * Gender * Group
R sidual
ANOVA Table for Latency Familiar Food (s)
996.689 996.689 .024 .8773 .024 .0 3
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
2522.65 2522.65 .061 .80 9 .061 .057
175 7293349.902 41676.285







itt r * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .003 .222 .6382 .222 .075
1 .003 .003 .184 .6681 .184 .070
1 .006 .006 .373 .5421 .373 .091
1 .004 .004 .236 .6277 .236 .076
1 3.817E-4 3.817E-4 .024 .8764 .024 .053
1 .006 .006 .375 .5413 .375 .091
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.902 .063 .8023 .063 .057
1 .016 .016 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.253 1.384 .2410 1.384 .203
1 719.916 719.916 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Inte action Bar Plot for Total Time Light
Effect: Gender * Group



















Inte action Bar Plot for Total Time Dark
Effect: Gender * Group




















Inte action Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: roup
Significance Level: 5 
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLS  for Total Social Time
Effect: ender
ignificance Level: 5 
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
is er's  f r T tal Social Time
ffect: roup
i ifica ce evel: 5 
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
i r'   f r T tal Novel Time
ff t: ender
i ifi  l:  
4.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
i r'   f r otal Novel Time
ff t: roup
i ifi  l:  
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
i '    Social/Social+Novel
 ender
i i i  l   
.002 .080 .9522




l   
-8.103 5.142 .0022 S
Mean Diff. Crit. D ff. P-Value
F, M
'   neBox %freeze
ender
l   
-1.054 5.229 .6913
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
'   Box %freeze
roup
l   
1.933 6.435 .5541
Mean Diff. Crit. D ff. P-Value
F, M
'   tal Context %Freeze
ender
l   
-.406 6.543 .9027
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
'  Th10 Total Context %Freeze
roup
l   
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
'  Th10 Tone1 %freeze
ender
l   
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
i '    Th10 Tone1 %freeze
 roup
i ifi  l:  
41.7 1 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
i r'   f r t  Familiar Food (s)
ff t: ender
i ifi  l:  
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency F miliar Food (s)
ff t: roup
i ifi  l:  
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
ffect: ender
i ifica ce evel: 5 
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: roup
Significance Level: 5 
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for A bulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for A bulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.0 4 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
ignificance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
ignificance L vel: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
ignificance L vel: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
igni icance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
igni icance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
igni icance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
igni icance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
igni icance L vel: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
igni icance L vel: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
igni icance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
igni icance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: roup
Significance Level: 5 
41.731 58.005
Mean Diff. Crit. Diff.
F
unnett for Latency Familiar Food (s)
Effect: ender
ignificance Level: 5 
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
ett f r Latency amiliar Food (s)
ffect: roup
i ifica ce evel: 5 
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
tt f r L tency N vel F od (s)
ff t: ender
i ifi  l:  
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
tt f r Lat ncy Novel Food (s)
ff t: roup
i ifi  l:  
-.027 .032
Mean Diff. Crit. Diff.
F
tt f r Familiar Food Consumed (g)
ff t: ender
i ifi  l:  
.022 .032
Mean Diff. Crit. Diff.
Ctl
tt f r F miliar Food Consumed (g)
ff t: roup
i ifi  l:  
-.013 .037
Mean Diff. Crit. Diff.
F
tt f  Novel Fo d Consumed (g)
ff t: ender
i ifi  l:  
-.034 .038
Mean Diff. Crit. Diff.
Ctl
tt f r Novel Food Consumed (g)
ff t: roup
i ifi  l:  
15.7 5 19.14
Mean Diff. Crit. Diff.
F
tt f  Latency to Eat
ff t: ender
i ifi  l:  
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
/ r r f r l t r  i t  P RIPHERY TOTAL
ff t: ender
i ifi  l:  
238.94 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
/ r r f r l t r  i t  PERIPHERY TOTAL
ff t: roup
i ifi  l:  
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
key/ ra er f r lat ry ista ce CENTER TOTAL
ffect: ender
i ifica ce evel: 5 
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/ ra er for Ambulatory Distance CENTER TOTAL
Effect: roup
Significance Level: 5 
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kra er for Ambulatory Distance     TOTAL
Effect: ender
Significance Level: 5 
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kra er for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20.961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
tudent-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 1780.128 1780.128 .003 .9548 .003 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.035 300.035 .001 .9815 .001 .050
1 2226632.518 2226632.518 4.021 .0465 4.021 .501
1 3864.306 3864.306 .007 .9335 .007 .051
1 68.469 68.469 1.237E-4 .9911 1.237E-4 .050
175 96894508.561 553682.906







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.170 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .058 .057
1 1120.432 1120.432 .031 .8612 .031 .053
1 8070.337 8070.337 .221 .6389 .221 .074
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .183
1 1536827.783 1536827.783 .378 .5 96 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 1.358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
1 40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.014 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 . 120 1.569 .22
1 4665047.363 4665047.363 3.547 .0613 3.547 .450
1 4041129.363 4041129.363 3.073 .0814 3.073 .397
1 6100084.180 6100084.180 4.639 .0326 4.639 .563
1 1875257.898 1875257.898 1.426 .2340 1.426 .208
1 2011926.910 2011926.910 1.530 .2178 1.530 .220
175 230138061.585 1315074.638







Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923. 74 287923.67 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
.037 .037 .525 .4 97 .525 .108
.211 .211 2.984 .085 2.984 .387
.111 .111 1.572 .2 16 1 572 .225
. 17 . 17 4.470 .0359 4.470 .546
.127 .127 1.795 .1821 1.795 .250
.139 .139 1.9 .1634 1.9 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071




itt r * end r
Litter * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
88.778 88.778 1.289 .2578 1.289 . 92
226.113 226.113 .7 0 .3878 .7 0 .132
32.399 32.399 .107 .7 35 .107 . 62
1192.107 1192.107 .952 . 484 .952 . 93
.299 .299 . 01 .974 . 01 . 0
65.625 65.625 .2 8 .6415 .2 8 . 74
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683




itt r  end r
Litter * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
326. 3 326. 3 .691 .4068 .691 .1 6
16.926 16.926 .036 .8501 .036 .0 4
294.132 294.132 .62 .43 2 .62 .118
515 095 515 095 1 090 2978 1 090 170
45 755 45 755 5 0 4717 5 0 1 7
865 503 865 503 8 2 17 6 8 2 55
1 2 36 354 2 36 354 4.310 .0 93 4.310 .530
175 82677.020 472.440







Litter * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
15 210 5 2 0 .215 .64 7 .215 . 74
585 125 585 125 . 25 . 649 . 25 . 40
232 904 232 904 . 29 . 673 . 29 . 86
1157 8 4 1157 8 4 1.633 .2029 1.633 .232
709 241 709 241 1.000 .31 6 1.000 .16
389 593 389 593 .550 .4595 .550 . 10
8 739 8 739 .117 .733 .117 .063
175 124 64.8 5 708.942







Litter * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
14576 9 45 6 59 .381 .5378 .381 .092
16629 493 16629 493 .435 .5105 .435 .098
19644 581 19644 581 .514 .4745 .514 .106
10401 353 10401 353 .272 .6027 .272 .080
47157 613 47157 613 1.233 .2684 1.233 .186
1833 190 1833 190 .048 .82 0 .048 .055
0 7 07 1.746E-7 .9997 1.746E-7 . 0
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency amiliar Food (s)
99 689 99 689 024 87 3 024 053
9689 203 9689 203 232 6303 232 76
904 8 904 8 02 8830 02 052
64 773 64 773 2 686 2
789 769 789 769 189 639 189 1
2 6 5 3 2 6 5 3 0 9426 0 1
522 654 2522 54 .061 .80 .061 .05
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Fo d (s)
0 1 0 47 290 47 5
007 007 44 235 44 21
03 03 233 6296 233 0 6
01 01 1 282 2590 1 282 92
011 011 983 3228 983 1 8
009 009 757 3855 757 3
0 .908 . 420 .908 . 50
175 1.9 8 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar ood Consumed (g)
0 4 0 4 1 547 2152 1 547 222
0 3 0 3 2 2 6382 2 2 75
003 003 184 6681 184 070
006 006 373 5421 373 091
004 004 236 6277 236 076
3. 17E-4 3. 17E-4 024 87 4 024 5
00 00 375 5413 375 91
175 2 751 016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
261 902 261 902 .063 .8 23 . 63 . 57
.016 .016 3.795E-6 .9984 3.795E-6 .050
5764.2 5764.2 1.384 .2410 1.384 .203
719.9 6 719.9 6 .17 .67 1 .17 .069
5681.508 5681.508 1.364 .2444 1.364 .201
6 6 8 6 6 8 .002 . 682 .002 .
48 31 8 31 .012 .91 5 .012 .051
175 728827 49 4164 731




itt r  end r
Litter * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 412 1 41 .351 .5545 .351 . 89
11.910 11.910 2.958 .0 72 2.958 .384
6.801 6.801 1.689 .1954 1.689 .238
3.051 3.051 .758 .3853 .758 .133
7.964 7.964 1.978 .1614 1.978 .27
017 017 . 04 .9485 . 04 . 0
037 037 .009 .9239 .009 .051
175 70 736 027




itt r * end r
Litter * Group
Gender * Group
Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Amb latory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance L vel: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance L vel: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe f r Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe f r Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe f r Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
M an Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
cheffe for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
cheffe for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance L vel: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance L vel: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance L vel: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance L vel: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance L vel: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 
-.043 .079 .2830




Significance Level: 5 
.002 .080 .9522




Significance Level: 5 
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
onferroni/ unn for Th10 ToneBox %freeze
Effect: ender
Significance Level: 5 
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
onferroni/ unn for Th10 ToneBox %freeze
ffect: roup
ignificance Level: 5 
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
ferr i/  f r h10 T tal Context %Freeze
ffect: ender
i ifica ce evel: 5 
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
f rr i/  f r h10 T tal Cont xt %Freeze
ff t: roup
i ifi  l:  
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
f rr i/  f r h10 T n 1 %fr eze
ff t: ender
i ifi  l:  
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
f rr i/  f r Th10 Tone1 %freeze
ff t: roup
i ifi  l:  
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
f i/  f  Latency Familiar Food (s)
ff t: ender
i ifi  l:  
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
i/  f  Latency Familiar Food (s)
 roup
i i i  l:  
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
i/  f  Latency Novel Food (s)
 ender
i i i  l:  
6.219 61.455 .2463
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
i/   Latency Novel Food (s)
 roup
i i i  l   
-.027 .032 .0894
Mean Diff. Crit. D ff. P-Value
F, M
i/  f  Familiar Food Consum d (g)
 ender
i i i  l:  
.022 .032 .1886
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
i/   Familiar Food Consumed (g)
 roup
i i i  l:  
-.013 .037 .5057
Mean Diff. Crit. D ff. P-Value
F, M
i/  f  Novel Food Consumed (g)
 ender
i i i  l:  
-.034 .038 .0767
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
i/   Novel Food Consume  (g)
 roup
i i i  l   
15.775 19.107 .105
Mean Diff. Crit. D ff. P-Value
F, M
i/   t  to Eat
 ender
i i i  l:  
9.282 19.427 .3470
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
i/    to Eat
 roup
i i  l   
-3.929 .594 <.0001 S
Mean Diff. Crit. D ff. P-Value
F, M
i/  f  Weight
 ender
i i i  l:  
.729 .604 .0183 S
Mean Diff. Crit  Diff. P-Value
Ctl, OFO
i/   Weight
 roup
i i i  l   
1.361 201.880
Mean Diff. Crit. Diff.
Dunnett P RIPHERY TOTAL
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett f r Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 
263.238 224.390 S
Mean Diff. Crit. Diff.
tl
Dunnett for Ambulatory Distance     TOTAL
Effect: roup
Significance Level: 5 
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: ender
Significance Level: 5 
3.124 57.625
Mean Diff. Crit. Diff.
tl
Dunnett for Latency to Light (s)
ffect: roup
ignificance Level: 5 
124.644 130.254
Mean Diff. Crit. Diff.
F
unnett for Latency to Dark
Effect: ender
Significance Level: 5 
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency to Dark
Effect: roup
Significance Level: 5 
479.564 598.183
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Light
Effect: Gender
Significance Level: 5 
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Total Time Light
Effect: Group
Significance Level: 5 
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dunnett for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl
Dunnett f r Weight
Effect: Group
Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kram r for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kram r for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significa ce Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significa ce Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significa ce Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significa ce Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effect: Group
Significa ce Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204.956
Mean Diff. Crit. Diff.
F, M
Games/H well for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/How ll for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/H well for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/How ll for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Ga es/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 
-.027 .032
Mean Diff. Crit. Diff.
F, M
Ga es/Howell for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
a es/Ho ell for Familiar Food Consumed (g)
Effect: roup
Significance Level: 5 
-.013 .036
Mean Diff. Crit. Diff.
F, M
a es/ o ell for Novel Food Consumed (g)
Effect: ender
Significance Level: 5 
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
a es/ o ell for Novel Food Consumed (g)
ffect: roup
ignificance Level: 5 
15.775 20.961
Mean Diff. Crit. Diff.
F, M
a es/ ell f r Latency to Eat
ffect: ender
i ifica ce evel: 5 
9.282 20.924
Mean Diff. Crit. Diff.
Ctl, OFO
a es/ ell f r Latency t  Eat
ffect: roup
i ifica ce evel: 5 
-3.929 .571 S
Mean Diff. Crit. Diff.
F, M
a es/ o ell for Weight
ffect: ender
ignificance Level: 5 
.729 .875
Mean Diff. Crit. Diff.
Ctl, OFO
a es/ ell f r Weight
ffect: roup
i ifica ce evel: 5 
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.94 205.2 6 S
 iff. rit. iff.
tl, 
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stud nt-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
ff t: r
i ifi  l:  
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
tudent-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
ean iff. rit. iff.
, 
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Ne man-Keuls for Ambulatory Distance     TOTAL
ffect: e er
i ifica ce evel: 5 
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gr up
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti at  n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance L vel: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti at  n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to esti at  n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to esti at  n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimat  n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newma -Keuls for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newma -Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newma -Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newma -Keuls for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newma -Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N wman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New a -Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-N w an-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-New a -Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
St dent-N w an-Keuls for Weight
Effect: Gender
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newm -Keuls for Weight
Effect: Group
Significance Level: 5 %
1 695747.308 695747.308 1.502 .2221 1.502 .217
1 8150.041 8150.041 .018 .8946 .018 .052
1 1379636.056 1379636.056 2.978 .0862 2.978 .386
1 2708.378 2708.378 .006 .9391 .006 .051
1 2438533.387 2438533.387 5.263 .0230 5.263 .622
1 14689.614 14689.614 .032 .8589 .032 .054
1 28070.450 28070.450 .061 .8059 .061 .057
175 81081695.184 463323.972







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance PERIPHERY TOTAL
1 8595.941 8595.941 .764 .3832 .764 .134
1 17548.075 17548.075 1.560 .2133 1.560 .223
1 11220.778 11220.778 .998 .3192 .998 .160
1 4811.310 4811.310 .428 .5139 .428 .097
1 4814.959 4814.959 .428 .5138 .428 .097
1 33622.451 33622.451 2.990 .0856 2.990 .388
1 25366.233 25366.233 2.255 .1349 2.255 .304
175 1968187.291 11246.785







Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance CENTER TOTAL
1 549674.530 549674.530 .993 .3204 .993 .159
1 17 .128 1780.128 .003 .9548 .0 3 .050
1 1142014.799 1142014.799 2.063 .1527 2.063 .281
1 300.03 300.035 .0 1 .9815 .001 .050
1 2226632.518 2226632.518 4. 21 .0 65 4.021 . 0
1 3864. 0 3864. 0 .007 .9335 .007 .051
1 68.469 6 .469 1.237E-4 . 911 1.237E-4 .050
175 968 45 .561 553682.906





Litt r * Group
Gender * Group
Litter * Gender * Group
Residual
ANOVA Table for Ambulatory Distance     TOTAL
1 39167.17 39167.170 1.073 .3018 1.073 .168
1 2113.515 2113.515 .058 .8102 .05 .057
1 1120.432 1120.432 .031 .86 2 .031 .053
1 8070.337 070.337 .221 .6389 .221 .07
1 1966.671 1966.671 .054 .8168 .054 .056
1 40680.472 40680.472 1.114 .2927 1.114 .173
1 113666.044 113666.044 3.113 .0794 3.113 .402
175 6390186.139 36515.349







Litter * Gender * Group
Residual
ANOVA Table for Latency to Light (s)
1 63575.482 63575.482 .330 .5666 .330 .086
1 34390.019 34390.019 .178 .6734 .178 .070
1 216371.334 216371.334 1.122 .2910 1.122 .174
1 74275.977 74275.977 .385 .5357 .385 .092
1 241616.782 241616.782 1.253 .2646 1.253 .188
1 127368.201 127368.201 .660 .4175 .660 .122
1 171882.979 171882.979 .891 .3465 .891 .148
175 33753377.695 192876.444







Litter * Gender * Group
Residual
ANOVA Table for Latency to Dark
1 5737999.060 5737999.060 1.411 .2366 1.411 .206
1 8834.259 8834.259 .002 .9629 .002 .050
1 20917.380 20917.380 .005 .9429 .005 .051
1 228711.903 228711.903 .056 .8128 .056 .056
1 4916738.300 4916738.300 1.209 .2731 1.209 .18
1 1536827.783 1536827.783 .378 .5396 .378 .092
1 238164.882 238164.882 .059 .8091 .059 .057
175 711874727.560 4067855.586







Litter * Gender * Group
Residual
ANOVA Table for Total Time Light
1 61898.308 61898.308 .016 .8994 .016 .052
1 1989360.301 1989360.301 .515 .4739 .515 .106
1 5244160.690 5244160.690 1.358 .2455 .358 .200
1 1424809.952 1424809.952 .369 .5444 .369 .091
1 13593718.788 13593718.788 3.520 .0623 3.520 .447
1 127808.328 127808.328 .033 .8559 .033 .054
40103.054 40103.054 .010 .9190 .010 .051
175 675883672.567 3862192.415







Litter * Gender * Group
Residual
ANOVA Table for Total Time Dark
1 1362555.01 1362555.014 1.036 .3101 1.036 .164
1 2063802.646 2063802.646 1.569 .2120 1.569 .224
1 4665047.36 4665047.3 3 3 547 0613 3.547 .450
1 4041129.363 4041129.363 3 73 0814 3. 73 .397
1 6100084.180 610 084.1 4 639 03 6 4.639 .563
1 1875257.898 1875257.898 1 2 2340 1. 2 .208
2011 26.910 20 1926. 1 530 178 .530 .220
175 230138061.585 315074.638




Litt r * Gender
Litter * G oup
Gend r * roup
Litter * Gender * Group
Residual
ANOVA Table for Total Social Time
1 859552.552 859552.552 .579 .4478 .579 .113
1 38029.739 38029.739 .026 .8730 .026 .053
1 1187151.370 1187151.370 .800 .3725 .800 .138
1 548708.529 548708.529 .370 .5440 .370 .091
1 855674.660 855674.660 .576 .4488 .576 .113
1 3.663 3.663 2.467E-6 .9987 2.467E-6 .050
1 287923.674 287923.674 .194 .6602 .194 .072
175 259840850.908 1484804.862







Litter * Gender * Group
Residual
ANOVA Table for Total Novel Time
1 .037 .037 .525 .4697 .525 .108
1 .211 .211 2.984 .0859 2.984 .387
1 .111 .111 1.572 .2116 1.572 .225
1 .317 .317 4.470 .0359 4.470 .546
1 .127 .127 1.795 .1821 1.795 .250
1 .139 .139 1.959 .1634 1.959 .269
1 .075 .075 1.060 .3047 1.060 .167
175 12.400 .071







Litter * Gender * Group
Residual
ANOVA Table for Social/Social+Novel
1 388.778 388.778 1.289 .2578 1.289 .192
1 226.113 226.113 .750 .3878 .750 .132
1 32.399 32.399 .107 .7435 .107 .062
1 1192.107 1192.107 3.952 .0484 3.952 .493
1 .299 .299 .001 .9749 .001 .050
1 65.625 65.625 .218 .6415 .218 .074
1 17.789 17.789 .059 .8084 .059 .057
175 52794.571 301.683







Litter * Gender * Group
Residual
ANOVA Table for Th10 ToneBox %freeze
1 326.643 326.643 .691 .4068 .691 .126
1 16. 26 16. 26 .036 .8501 .036 .054
1 294. 32 294. 32 .62 .4312 .623 .118
1 515.095 515.095 1.09 .2978 1.090 .170
1 245.755 245.755 .52 .4717 .520 .107
865.503 865.503 .832 . 776 .832 . 5
1 2036.354 2036.354 4.310 .0393 4.310 .530
175 82677.020 472.440







Litt r * Gender * Group
Residual
ANOVA Table for Th10 Total Context %Freeze
1 152.210 152.210 .215 .6437 .215 .074
1 585.125 5 5.125 825 3649 .82 . 40
1 232.904 32.904 329 56 3 .329 .086
1 1157.864 1157.864 1 633 2029 1.633 .23
1 709.241 709.241 1.000 .31 6 1.0 .160
1 389.593 389.5 3 .550 .4595 .550 .11
1 82.739 82.739 .1 7 .7330 .1 7 . 63
175 124064.865 708.942







Litt r * Gender * Group
Residual
ANOVA Table for Th10 Tone1 %freeze
1 14576.591 14576.591 .381 .5378 .381 .092
1 16629.493 16629.493 .435 .5105 .435 .098
1 19644.581 19644.581 .514 .4745 .514 .106
1 10401.353 10401.353 .272 .6027 .272 .080
1 47157.613 47157.613 1.233 .2684 1.233 .186
1 1833.190 1833.190 .048 .8270 .048 .055
1 .007 .007 1.746E-7 .9997 1.746E-7 .050
175 6693737.405 38249.928







Litter * Gender * Group
Residual
ANOVA Table for Latency Familiar Food (s)
1 996.689 996.689 .024 .8773 .024 .053
1 9689.203 9689.203 .232 .6303 .232 .076
1 904.807 904.807 .022 .8830 .022 .052
1 64.773 64.773 .002 .9686 .002 .050
1 7895.769 7895.769 .189 .6639 .189 .071
1 216.533 216.533 .005 .9426 .005 .051
1 2522.654 2522.654 .061 .8059 .061 .057
175 7293349.902 41676.285







Litter * Gender * Group
Residual
ANOVA Table for Latency Novel Food (s)
1 .001 .001 .047 .8290 .047 .055
1 .007 .007 .644 .4235 .644 .121
1 .003 .003 .233 .6296 .233 .076
1 .015 .015 1.282 .2590 1.282 .192
1 .011 .011 .983 .3228 .983 .158
1 .009 .009 .757 .3855 .757 .133
1 .010 .010 .908 .3420 .908 .150
175 1.998 .011







Litter * Gender * Group
Residual
ANOVA Table for Familiar Food Consumed (g)
1 .024 .024 1.547 .2152 1.547 .222
1 .003 .0 . 2 . 82 . 2 . 5
1 .003 .0 3 .184 .6681 .184 . 70
1 .006 .006 .373 .5421 .373 . 91
1 .004 .004 236 277 .236 . 6
1 3.8 7E-4 3.817E-4 24 8764 . 24 . 3
1 .006 .006 375 5413 .375 . 91
175 2.751 .016







Litter * Gender * Group
Residual
ANOVA Table for Novel Food Consumed (g)
1 261.902 261.9 2 . 63 . 023 .063 .0 7
1 .016 . 16 3.795E-6 .9984 3.795E-6 .050
1 5764.253 5764.25 1.384 .2410 1.384 .203
1 719.916 719.9 6 .173 .6781 .173 .069
1 5681.508 5681.508 1.364 .2444 1.364 .201
1 6.618 6.618 .002 .9682 .002 .050
1 48.131 48.131 .012 .9145 .012 .051
175 728827.949 4164.731







Litter * Gender * Group
Residual
ANOVA Table for Latency to Eat
1 1.412 1.412 .351 .5545 .351 .089
1 11.910 11.910 2.958 .0872 2.958 .384
1 6.801 6.801 1.689 .1954 1.689 .238
1 3.051 3.051 .758 .3853 .758 .133
1 7.964 7.964 1.978 .1614 1.978 .271
1 .017 .017 .004 .9485 .004 .050
1 .037 .037 .009 .9239 .009 .051
175 704.736 4.027







Litter * Gender * Group
Residual
















Interaction Bar Plot for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender * Group



















Interaction Bar Plot for Ambulatory Distance CENTER TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Ambulatory Distance     TOTAL
Effect: Gender * Group
















Interaction Bar Plot for Latency to Light (s)
Effect: Gender * Group

















Interaction Bar Plot for Latency to Dark
Effect: Gender * Group
















Interaction Bar Plot for Total Time Light
Effect: Gender * Group



















Interaction Bar Plot for Total Time Dark
Effect: Gender * Group




















Interaction Bar Plot for Total Social Time
Effect: Gender * Group

















Interaction Bar Plot for Total Novel Time
Effect: Gender * Group

















Interaction Bar Plot for Social/Social+Novel
Effect: Gender * Group
















Interaction Bar Plot for Th10 ToneBox %freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Total Context %Freeze
Effect: Gender * Group
















Interaction Bar Plot for Th10 Tone1 %freeze
Effect: Gender * Group




















Interaction Bar Plot for Latency Familiar Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Latency Novel Food (s)
Effect: Gender * Group




















Interaction Bar Plot for Familiar Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Novel Food Consumed (g)
Effect: Gender * Group



















Interaction Bar Plot for Latency to Eat
Effect: Gender * Group
















Interaction Bar Plot for Weight
Effect: Gender * Group
Error Bars: ± 1 Standard Error(s)
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Ge d r
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Ambulatory Distanc      TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
, M
Fisher's PLSD for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
, M
Fisher's PLSD for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. -Value
Ctl, OFO
Fisher's PLSD for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Social/Social+Novel
Effect: Gender
Significance Level: 5 %
.002 .080 .9522
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Social/Social+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Th10 Tone1 %freeze
Effect: Group
Significance Lev l: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61 455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 . 767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Novel Food Consumed (g)
Effect: Group
Significance Level:  %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Valu
F, M
Fisher's PLSD for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Latency to Eat
Effect: Gr up
Significance Level: 5 %
-3.929 .594 <.0001 S
Mean Diff. Crit. Diff. P-Value
F, M
Fisher's PLSD for Weight
Effect: Gender
Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Fisher's PLSD for Weight
Effect: Group
Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.1 4 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency t  Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 3 .206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Dark
Effect: Group
Significance Level: 5 %
479.56 597. 34 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Light
E fect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Time Dark
Effect: Gender
Significance Level: 5 
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Schef e for Total im  Dark
Ef ect: Group
Significance Level: 5 
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Schef e for Total S cial Time
Ef ect: Gender
Significance Level: 5 
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Social Time
Effect: Group
Significance Level: 5 
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Total Novel Time
Effect: Gender
Significance Level: 5 %
10 .019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Significance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 ToneBox %freeze
Effect: Ge d r
Significance Level: 5 %
-1.054 .229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Total Context %Freeze
Effect: Gender
Significance L vel: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
. 1 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency Novel Food (s)
Effect: Group
Significance Leve : 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032 .1886
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Scheffe for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Scheffe for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S




Significance Level: 5 %
1.361 201.526 .9894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 204.905 .0225 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonf rroni/Dunn for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.398 .3435
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.925 .1349
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.302 .9021
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 223.996 .0215 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.575 .7888
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.524 .9148
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.025 .0602
Mean Di f. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.206 .0524
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 597.134 .1148
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 607.146 .0114 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 581.843 .1748
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 591.599 .1238
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 339.519 .0257 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.212 .4614
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 360.764 .2734
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 366.813 .5764
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079 .2830




Significance Level: 5 %
.002 .080 .9522




Sig ificance Level: 5 %
-8.103 5.142 .0022 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Gender
Sig ificance Level: 5 %
-1.054 5.229 .6913
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.435 .5541
M an Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.543 .9027
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Th10 Total Context %Freeze
Effect: Group
Significa c  Level: 5 %
-4.023 7.883 .3153
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.015 .8962
Mean Diff. Crit. Diff. P-Value
Ctl, FO
Bonferroni/Dunn for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.903 .1567
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.874 .0688
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.441 .0111 S
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.455 .2463
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032 .0894
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Du n for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 
.022 .032 .1886
Mean Diff Crit. Diff. P-Value
Ctl, OFO
Bonfe roni/Du n for Familiar Food C nsumed (g)
E ect: Group
Significance Level: 5 
-.013 .037 .5057
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Du n for Novel Fo d Consumed (g)
Effect: Gender
Significance Level: 5 
-.034 .038 .0767
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.107 .1050
Mean Diff. Crit. Diff. P-Value
F, M
Bonferroni/Dunn for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.427 .3470
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferroni/Dunn for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .594 <.0001 S




Significance Level: 5 %
.729 .604 .0183 S
Mean Diff. Crit. Diff. P-Value
Ctl, OFO
Bonferro i/Dunn for Weight
Effect: Group
Significance Level: 5 %
1.361 201.880
Mean Diff. Crit. Diff.
F
Dun ett for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.265 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 31.453
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.981
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.689
Mean Diff. Crit. Diff.
F
Dunnett for Ambulatory Distance     TOTAL
Effect: Ge d r
Significance Level: 5 %
263.238 224.390 S
Mean Diff. Crit. Diff.
Ctl
Dunnett for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.675
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.625
Mean Diff. Crit. Diff.
Ctl
Du nett for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.254
Mean Diff. Crit. Diff.
F
Du nett for Latency to Dark
Effect: Ge der
Significance Level: 5 %
-130.857 132.438
Mean Diff. Crit. Diff.
Ctl
Du nett for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.183
Mean Diff. Crit. Diff.
F
Dun ett for Total Time Light
Effect: Ge der
Significance Level: 5 %
-786.257 608.213 S
Mean Diff. Crit. Diff.
Ctl
Dun ett for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.865
Mean Diff. Crit. Diff.
F
Dun ett for Total Time Dark
Effect: Ge der
Significance Level: 5 %
463.514 592.638
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.115 S
Mean Diff. Crit. Diff.
F
Dunnett for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.818
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.398
Mean Diff. Crit. Diff.
F
Dunnett for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.458
Mean Diff. Crit. Diff.
Ctl
Dunnett for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F
Dunnett for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.238
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.447
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.555
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.897
Mean Diff. Crit. Diff.
F
Dunnett for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.029
Mean Diff. Crit. Diff.
Ctl
Dunnett for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.005
Mean Diff. Crit. Diff.
F
Dunnett for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.978
Me n Diff. Crit. Diff.
Ctl
Dunnett for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.547 S
Mean Diff. Crit. Diff.
F
Dunnett for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.563
Mean Diff. Crit. Diff.
Ctl
Dunnett for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F
Dunnett for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl
Dunnett for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F
Dunnett for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mea  Diff. Crit. Diff.
Ctl
Dunnett for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.140
Mean Diff. Crit. Diff.
F
Dunnett for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.461
Mea  Diff. Crit. Diff.
Ctl
Dunnett for Latency to Eat
Effect: Group
Sig ificance L vel: 5 %
-3.929 .595 S




Sig ificance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Sig ificance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Sig ificance Level: 5 %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
M an Diff. Crit. Diff.
F, M
Tukey/Kramer for Ambulatory Distance     TOTAL
Eff ct: Gender
Significa c  Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Ambulatory Distance     TOTAL
Eff ct: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Light (s)
Eff ct: Gender
Significa ce Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608. 27 S
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
M an Diff. Crit. Diff.
F, M
Tukey/Kramer for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Total Novel Time
Eff ct: Group
Significa c  Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .080




Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Gender
Significanc  Level: 5 %
- .054 5.237
Mean Diff. Crit. Diff.
Ctl, FO
Tukey/Kramer for Th10 ToneBox %freeze
Effect: Group
Significanc  Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tot l C ntext %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.8 6
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Familiar Food (s)
Effe t: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency Novel Food (s)
Effe t: G nder
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency Novel Food (s)
Effe t: Group
Significanc  Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Tukey/Kramer for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Tukey/Kramer for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S




Significance Level: 5 %
.729 .605 S




Significance Level: 5 %
1.361 204. 56
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
E fect: Gender
Significance Level: 5 %
238.942 213.901 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level: 5 %
-15.110 30.857
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 34.182
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 223.235
Mean Diff. Crit. Diff.
F, M
Games/Howell for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 231.603 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.941
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 58.553
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 147.428
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 115.390 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 651.255
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 533.463 S
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 617.400
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Time Dark
Effect: Gender
Significance Level: 5 %
463.514 557.941
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell or Total Time Dark
Effect: Group
Significance Level: 5 %
-387.052 326.513 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 376.077
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 362.320
Mean Diff. Crit. Diff.
F, M
Games/Howell for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 373.201
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Total Novel Time
Effect: Group
Significance Level: 5 %
-.043 .079




Significance Level: 5 %
.002 .081




Significance Level: 5 %
-8.103 4.923 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.499
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.575
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.556
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Total Context %Freeze
Effect: Group
Significance Level: 5 %
-4.023 7.834
Mean Diff. Crit. Diff.
F, M
Games/Howell for Th10 Tone1 %freeze
Effect: Gender
Significance Level: 5 %
.531 8.087
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 58.387
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 56.402
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 56.098 S
Mean Diff. Crit. Diff.
F, M
Games/Howell for La ency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 62.216
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency Novel Food (s)
Effect: Group
Significance Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Games/Howell for Familiar Food Consumed (g)
Effect: G nder
Significance Level: 5 %
.022 .033
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .036
Mean Diff. Crit. Diff.
F, M
Games/Howell for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .037
Mean Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 20 961
Mean Diff. Crit. Diff.
F, M
Games/Howell for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 20.924
M an Diff. Crit. Diff.
Ctl, OFO
Games/Howell for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .571 S




Significance Level: 5 %
.729 .875




Significance Level: 5 %
1.361 201.852
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Gender
Significance Level: 5 %
238.942 205.236 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance PERIPHERY TOTAL
Effect: Group
Significance Level:  %
-15.110 31.449
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Gender
Significance Level: 5 %
24.296 31.976
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance CENTER TOTAL
Effect: Group
Significance Level: 5 %
-13.749 220.658
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Gender
Significance Level: 5 %
263.238 224.358 S
Mean Diff. Crit. Diff.
C l, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Ambulatory Distance     TOTAL
Effect: Group
Significance Level: 5 %
7.692 56.667
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Gender
Significance Level: 5 %
3.124 57.617
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Light (s)
Effect: Group
Significance Level: 5 %
124.644 130.235
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Gender
Significance Level: 5 %
-130.857 132.419
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency to Dark
Effect: Group
Significance Level: 5 %
479.564 598.098
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Gender
Significance Level: 5 %
-786.257 608.127 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Time Light
Effect: Group
Significance Level: 5 %
-401.713 582.783
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
S udent-Newman-Keuls for Total Time Dark
Effect: Gend r
Sig ificance Lev l: 5 %
463.514 592.555
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell count  are not equal, the harmonic m an
is used t  estimate n.
Student-Newman-Keuls for Total Time Dark
Effect: Group
Sig ificance Lev l: 5 %
-387.052 340.067 S
Mean Diff. Crit. Diff.
F, M
Because the cell count are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Gender
Significance Level: 5 %
129.124 345.769
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Social Time
Effect: Group
Significance Level: 5 %
200.829 361.347
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Total Novel Time
Effect: Gender
Significance Level: 5 %
104.019 367.406
M an Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is d to estimate n.
Student-Newman-Keuls for Total Novel Ti e
Effect: Group
Significance Level: 5 %
-.043 .079
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is d to estimate n.
Student-Newman-Keuls for Soci l/Soci l+Novel
Effect: G nder
Significance Level: 5 %
.002 .080
Mean Diff. Crit. Diff.
Ctl, OFO
B ause the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Soci l/Soci l+Novel
Effect: Group
Significance Level: 5 %
-8.103 5.151 S
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Gender
Significance Level: 5 %
-1.054 5.237
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 ToneBox %freeze
Effect: Group
Significance Level: 5 %
1.933 6.446
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Total Context %Freeze
Effect: Gender
Significance Level: 5 %
-.406 6.554
Mean Diff. Crit. Diff.
Ctl, FO
Because th  cell counts are not equal, t e harmonic mean
i  used to estimate n.
Student-Newman-Keuls for Th10 Total Cont xt %Freeze
Effect: Group
Significanc  Level: 5 %
-4.023 7.896
Mean Diff. Crit. Diff.
F, M
Because th  c ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Gender
Significanc  Level: 5 %
.531 8.028
Mean Diff. Crit. Diff.
Ctl, OFO
Because th  c ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Th10 Tone1 %freeze
Effect: Group
Significance Level: 5 %
41.731 57.997
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Gender
Significance Level: 5 %
-54.629 58.969
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Familiar Food (s)
Effect: Group
Significance Level: 5 %
-78.595 60.539 S
Mean Diff. Crit. Diff.
F, M
B caus  the c ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effect: Gender
Significance Level: 5 %
36.219 61.554
Mean Diff. Crit. Diff.
Ctl, OFO
B caus  the c ll counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Latency Novel Food (s)
Effe t: Group
Significanc  Level: 5 %
-.027 .032
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Gender
Significance Level: 5 %
.022 .032
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Familiar Food Consumed (g)
Effect: Group
Significance Level: 5 %
-.013 .037
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Gender
Significance Level: 5 %
-.034 .038
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Novel Food Consumed (g)
Effect: Group
Significance Level: 5 %
15.775 19.137
Mean Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stude t-Newman-Keuls for Latency to Eat
Effect: Gender
Significance Level: 5 %
9.282 19.458
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Stude t-Newman-Keuls for Latency to Eat
Effect: Group
Significance Level: 5 %
-3.929 .595 S
M an Diff. Crit. Diff.
F, M
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Ge der
Significance Level: 5 %
.729 .605 S
Mean Diff. Crit. Diff.
Ctl, OFO
Because the cell counts are not equal, the harmonic mean
is used to estimate n.
Student-Newman-Keuls for Weight
Effect: Group
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FIGURE 9: Food Neophobia 
(A) Measurements of weight before food deprivation showed an effect of gender, as 
males weighed more than females (p<0.0001). There was also a significant paternal age 
effect only for the male offspring. Male OFOs weigh less than YFOs (p=0.0424) 
(B) The latency to eat either food was not dependent on group. 
(C) The latency to eat the familiar pellet was not significantly changed in any group. 
(D) The latency to consume novel food was not different between the groups for males or 
females. 
(E) Grams of familiar food consumed did not differ among the groups for males or 
females. 
(F) Female OFOs consumed significantly more of the novel food than YFOs (p=0.0480). 



















Migration is one of the neurodevelopmental roles associated with Nrg1, and it has 
been implicated in tangential migration of cortical interneurons during embryogenesis. 
The Nrg1 receptor ErbB4 is also highly expressed in the migrating neuroblasts of the 
SVZ and RMS, as well as in the olfactory bulb, and is found in all periglomerular, mitral, 
and tufted cells, as well as a subset of granule cells. Nrg1 is also expressed in the SVZ, 
around the RMS, and throughout the olfactory bulb (Anton et al., 2004; Bovetti et al., 
2006; Lindholm, Cullheim, Deckner, Carlstedt, & Risling, 2002; Oberto et al., 2001; 
Perroteau, Oberto, Ieraci, Bovolin, & Fasolo, 1998; Perroteau et al., 1999). It is possible 
that the Nrg1-ErbB4 interaction is playing a similar role in the integration of adult-born 
interneurons into the olfactory bulb as is seen in the developing cortex. This theory is 
especially attractive given that the SVZ is derived from areas that give rise to cortical 
interneurons during development. 
All six types of Nrg1 are found in the brain, and show different patterns of 
expression at different ages reflecting their distinct roles in neurodevelopment. Of these, 
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types I, II, and III are the best characterized and show the highest levels of expression. In 
both humans and rodents, types III and II are the most prevalent, while types IV and VI 
combined make up less than 1% of the total Nrg1 (X. Liu et al., 2011). These isoforms 
are thought to have distinct functions, including playing differing roles in cortical 
migration. CRD-Nrg1 forms a permissive corridor allowing the passage of ErbB4-
expressing interneurons from the ganglionic eminences to the cortex. Meanwhile, Ig-
Nrg1 is secreted to form a chemoattractive gradient (Anton et al., 2004; Flames et al., 
2004). In this way, Nrg1 can have both short-range and long-range actions.  
 The SVZ yields newborn interneurons that migrate to the olfactory bulb through 
adulthood. As there is reason to suspect that this process may show similarities to cortical 
interneuron neurogenesis, it provides a useful model to examine circuitry dysfunctions 
that may be relevant to the broader clinical phenotype of schizophrenia. We have been 
using hypomorphic Nrg1 mice to investigate the functions of this gene in neurogenesis, 
shedding light on its roles in neuronal proliferation, migration, and differentiation, in 
addition to exploring its behavioral phenotype. Some endophenotypes seen in Nrg1 
heterozygotes are seen in all mutants, while others are associated with certain isoforms. 
By examining mice that are heterozygous for the Ig-domain, we can separate out the 




Behavioral Phenotype of Nrg1Ig/- Mice 
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 Previous studies from the Gingrich lab have also used Nrg1Ig/- mice to explore 
the role of Ig-Nrg1 in SVZ neurogenesis and behavior. Hyperactivity is one of the most 
common schizophrenia-related endophenotypes used to assess mutant mouse models, and 
it has also been seen in Nrg1 mutants (Gerlai et al., 2000; Stefansson et al., 2002). The 
results of this test are shown in Figure 10a. During an open field session lasting 60 
minues, Nrg1Ig/- mice displayed higher levels of activity than Nrg1+/+ mice. 
Hyperactivity is thought to be associated with the positive symptoms of schizophrenia, as 
it is sensitive to treatment with clozapine (Stefansson et al., 2002). 
 In addition to locomotor activity, mutant animals had altered social interaction, 
which is an endophenotype associated with the negative symptoms of schizophrenia. 
Mice were introduced to an intruder in their home cages for six minutes, during which 
they were allowed to interact. This interaction mainly consists of anogenital 
investigations (AGI), in which the resident mouse follows and olfactorily explores the 
intruder. Figure 10b shows the latency to first AGI as well as the time spent in AGI, 
broken down into 2-minute intervals. This test showed a significant effect of genotype. 
While Nrg1+/+ mice showed high levels of AGI during the first 2 minutes before 
habituating, Nrg1Ig/- mice had low levels of AGI throughout the session.  
 As social interaction in mice is closely linked to olfaction, performance was 
assessed in the olfactory discrimination task illustrated in Figure 11a. Mice were trained 
to distinguish between two odor-infused dishes of digging material to locate a food 
reward. In the first task, they were trained to discriminate between cinnamon and paprika. 
Although both groups of mice needed the same number of trials to reach the criterion of 
six correct choices in a row (Figure 11c), Nrg1Ig/- mice took longer to make their choice 
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(Figure 11b). As this subtle difference was apparent in a high contrast test of two spices, 
a more difficult test was used to tease out any deficits in the mutant mice. Mice were 
therefore trained to distinguish between carvone stereoisomers. While mice are able to 
distinguish between these two odors (Slotnick & Bisulco, 2003), the task is thought to be 
more difficult because the patterns of glomeruli activated by each stereoisomer have a 
high degree of overlap (Linster et al., 2001; B. D. Rubin & Katz, 1999, 2001). As shown 





 As the incorporation of newborn neurons into the olfactory bulb is necessary for 
optimal olfactory performance (Mouret et al., 2009), Merker and Gingrich wanted to 
determine whether impaired SVZ neurogenesis could explain the olfactory deficits seen 
in Nrg1Ig/- mice. The first group of mice was sacrificed 24 hours after receiving 
injections of BrdU. Slices were taken from the SVZ, and were stained for BrdU. This 
would yield a snapshot of levels of proliferation occurring in the germinal region of the 
SVZ for both Nrg1+/+ and Nrg1Ig/- mice. As shown in Figure 12a, there was no effect 
of genotype on total SVZ BrdU counts per mm^2. When he then looked at BrdU+ cells 
that had been integrated into the GCL of the olfactory bulb, there was a significant 
decrease in BrdU staining in the Nrg1IG/- mice at both 21 days and 60 days after BrdU 
injections (Figure 12b, 12c). However, while it was clear that changing levels of Ig-Nrg1 
caused a decrease in adult-born olfactory neurons, it was not clear whether this was due 
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to changes in survival, migration, or differentiation, or whether there was any 
heterogeneity in the SVZ proliferative zones or in the layers or regions of the olfactory 






 This experiment is an expansion of our lab’s previous experiments on Nrg1Ig/- 
mice bred on a C57Bl/6 background. As described, these mice show a subtle olfactory 
deficit in addition to decreased BrdU staining in the GCL of the olfactory bulb. However, 
the significance of this result is not clear. Examining BrdU staining from the SVZ 
through the RMS and into the olfactory bulb at three different time points, as well as 
staining for various olfactory interneuron markers in different layers of the olfactory 
bulb, would reveal the effects of altered Ig-Nrg1 expression on neuronal proliferation, 
survival, migration, and differentiation in adult neurogenesis. Additionally, mice were 
treated with either clozapine or vehicle as described in the methods section at a dosage of 
10mg/kg. As there is evidence that antipsychotic treatment can enhance neurogenesis and 
may change Nrg1 expression, we wanted to determine whether this would ameliorate any 
of the phenotypic or anatomical effects of the mutation.  
 The experimental design of this study is illustrated in Figure 13. Male mice were 
treated with either clozapine or vehicle in their drinking water for 21 days.  Mice then 
received a behavioral assessment, which included tests of locomotor activity in an open 
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field as well as social interaction.  After behavioral testing, they received four injections 
of BrdU over six hours. They were divided into three groups that were sacrificed 24 
hours, 21 days, or 60 days after the BrdU injection, and continued to receive either 




Open Field Activity 
 
 Locomotor activity in an open field is a common schizophrenia-related 
endophenotype, which was altered in our lab’s previous cohort of Nrg1Ig/- mice. We 
therefore assessed this measure in our cohort, as shown in Figure 14. The test was run 
over 60 minutes, and Figure 14a shows the average distance traveled by each of the four 
groups, broken down into 10-minute bins. Figures 14b, 14c, and 14d show the total 
distance traveled over the 60-minute session throughout the entire open field, in the 
center, and in the periphery, respectively. We were able to replicate the previously 
described finding of hyperactivity in Nrg1Ig/- mice (Figure 9a). The heterozygotes 
showed an increase relative to controls in total distance traveled (p=0.0004), as well as 
higher activity in the periphery (p=0.0083). However, we did not see any significant 
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 The resident-intruder task was used to measure social interaction. In this test, 
mice were housed individually and had a male intruder mouse introduced into their home 
cages for six minutes. Mice were scored on time spent in AGI with the novel mouse. 
Time spent sniffing the intruder as well as time spent chasing the intruder and attempting 
to sniff were both included in the measure of social interaction. The results are shown in 
Figure 15. Figure 15a shows the latency to the first AGI. Figures 15b and 15c show the 
total time in which the mice engaged in AGI with the intruder, with this information 
broken down into 2-minute bins in 15c. Although the previously described cohort did 
show a decrease in social interaction in the heterozygotes during the first 2 minutes of a 
resident-intruder task (Figure 9b), we did not replicate that finding in this cohort. There 
was no significant effect of either genotype or treatment on latency to AGI or total time 




 We then went on to examine olfactory neurogenesis, beginning in the SVZ. We 
compared total BrdU staining in Nrg1+/+ and Nrg1Ig/- mice treated with either vehicle or 
clozapine. Figure 16a shows an example of BrdU staining around the entire SVZ. This 
entire germinal region was outlined and the area was calculated using the ImageJ 
program. This value was used to calculate the BrdU counts per mm^2 24 hours after 
BrdU injections, shown in Figure 16b. This shows the baseline rates of proliferation for 
each of the four groups. The previous study did not show any change in BrdU staining in 
the SVZ after 24 hours (Figure 12). This finding was confirmed in the current cohort. 
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There was no effect of either genotype or treatment on overall BrdU staining in the SVZ 
after 24 hours. 
 However, the SVZ is diverse composition including regions derived from 
different embryonic structures and expressing different transcription factors (Lledo et al., 
2008). Taking advantage of these naturally occurring divisions, the SVZ can be divided 
into five distinct regions defined in Figure 17. These include the dorsal wall, medial 
wall, lateral wall, dorsal tip, and ventral tip. Dividing the SVZ into regions revealed that 
this diversity is also apparent in the rates of proliferation in each subregion. As shown in 
Figure 18, at 24 hours after BrdU injections, the highest levels of BrdU staining were 
seen in the lateral wall and dorsal and ventral tips of the SVZ, while the dorsal and 
medial walls showed lower levels of staining. There was also a significant decrease in 
BrdU staining in the Nrg1Ig/- mice specifically in the lateral wall of the SVZ (Figure 
18d). This was not seen in any of the other regions. This indicates that Ig-Nrg1 may have 
a more dramatic influence on proliferation in this region of the SVZ. Clozapine did not 
show an effect on any of the SVZ subdivisions. 
 Figure 19 shows SVZ staining in mice sacrificed 21 days after BrdU injections. 
At this time point, the majority of the BrdU+ cells had migrated out of the SVZ. 
Therefore, all measures of BrdU per mm^2 were lower relative to those seen after only 
24 hours. Once again, no significant effect of either genotype or treatment was seen in 
total SVZ BrdU staining (Figure 19a). The subdivisions also showed no effect of 
clozapine. However, the decrease in BrdU staining in the lateral wall of the SVZ in 
Nrg1Ig/- mice was maintained at 21 days post-BrdU, with p=0.002 (Figure 19d). 
Additionally, there was a decrease in the medial wall of the Nrg1Ig/- mice at 21 days 
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post-BrdU (Figure 19e), which was not seen at the earlier time point. This suggests that 
there is also a decrease in survival associated with the genotype, or there may be an 




 In following the migratory path from the SVZ to the olfactory bulb, we then 
looked to the RMS. An example of BrdU staining in this region can be seen in Figure 
20a. As shown in Figure 20b, there was a significant effect of genotype on BrdU counts 
per mm^2 measured in the RMS at 21 days post-BrdU. Nrg1Ig/- mice showed lower 
levels of BrdU staining, with a p-value of 0.0003. Given this finding, it may be more 
likely that the emergence of a decrease in BrdU staining in the medial wall of the SVZ at 




 Adult-born neurons produced in the SVZ migrate into the olfactory bulb and are 
incorporated into either the GL or GCL. Most adult-born neurons in the GCL express CR. 
In the GL, distinct populations of interneurons express tyrosine hydroxylase (TH), 
calretinin (CR), or calbindin (CB). CB+ interneurons are mainly produced perinatally, 
while CR+ and low levels TH+ GL interneurons are produced during adulthood (Batista-
Brito et al., 2008; Parrish-Aungst et al., 2007). We therefore stained the olfactory bulb 
with TH, CR, and BrdU. An example of this staining can be  seen in Figure 21. In the 
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GL, we counted cells in that were double-stained with BrdU and either TH or CR, while 
in the GCL we counted cells double-labeled with CR and BrdU. 
 
 
Glomerular Layer and Granule Cell Layer BrdU Staining 
 
 Figure 22 shows BrdU staining in the GL of the olfactory bulb at 21 days and 60 
days post-BrdU. Total BrdU measurements are shown in Figures 22a and 22b. Cells per 
mm^2 that were double-stained with BrdU and CR (Figure 22c, 22d) or BrdU and TH 
(Figure 22e, 22f). The majority of the BrdU+ cells were stained with CR, while less than 
25% were TH+. The number of BrdU+ cells in the GL also decreased from 21 days to 60 
days, indicating that adult-born neurons continue to experience turnover after they are 
added to the olfactory circuitry. However, there was no effect of either genotype or 
treatment on numbers of BrdU+ cells or the numbers of newborn TH+ and CR+ 
interneurons. 
 BrdU staining in the GCL of the olfactory bulb at 21 days and 60 days post-BrdU 
can be seen in Figure 23. Total BrdU staining is shown in Figure 23a and 23b, while 
double-staining of BrdU and CR in the GCL is shown in Figure 23c and 23d. These sets 
of graphs are almost equivalent as the vast majority of new GCL neurons were CR+. As 
was seen in the GL, there was a decrease in BrdU staining from 21 days to 60 days, 
indicating that turnover was also occurring in the GCL. In contrast to the BrdU staining 
in the GL, the GCL did show an effect of genotype, although there was still no effect of 
clozapine. Nrg1Ig/- had fewer newborn neurons in the GCL at both 21 days and 60 days 
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post-BrdU. This confirms the previous finding of decreased BrdU staining at both of 
these time points (Figure 11b, 11c). However, as the previous study did not look at the 
GL, we can now say that changes in Ig-Nrg1 expression preferentially alter levels of 
newborn neurons entering the GCL. 
 
Glomerular Layer and Granule Cell Layer Interneuron Distribution 
 
 In addition to measuring the number of BrdU+ cells in the GL and GCL, we also 
looked at total numbers of interneurons, both newborn and existing, at both 21 days and 
60 days post-BrdU. These measurements are displayed in Figure 24 for GL CR+ neurons 
(Figure 24a, 24b) and TH+ neurons (Figure 24c, 24d), and GCL CR+ neurons (Figure 
24e, 24f). There was no significant effect of either genotype or treatment on levels of any 
of these interneurons. Since there was a reduction in BrdU+CR+ granule cells with no 
reduction in total CR+ granule cells, this indicates that there is decreased turnover in the 
GCL of Nrg1Ig/- mice. The GCL appears to adapt to decreased proliferation by 
increasing the survival length of existing interneurons. 
 
Olfactory Bulb Heterogeneity 
 
 An interesting fact was also revealed when olfactory bulb staining was broken 
down by Bregma level from Bregma 2.8 at the caudal end and Bregma 3.6 at the rostral 
end. In the GL, there was still no apparent different between the groups at either 21 days 
or 60 days post-BrdU in BrdU staining (Figure 25a, 25b), or double-staining with BrdU 
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and TH (Figure 25c, 25d), or BrdU and CR (Figure 25e, 25f). Total TH+ (Figure 26a, 
26b) or CR+ (Figure 26c, 26d) interneurons did not show significant variance along the 
rostral-caudal axis. However, this was not the case in the GCL. We reported a decrease in 
BrdU+ cells in this region at both 21 days and 60 days post-BrdU. This decrease appears 
to be specific to new neurons in the region of the GCL contained from Bregma 3.2 to 





 In this study, we did not see a significant effect of clozapine treatment on either 
the behavioral phenotype or SVZ neurogenesis. Given the lack of any effect, we must 
consider the possibility that the clozapine treatment was ineffective. However, this seems 
unlikely, as we were able to measure clozapine in the blood of sample animals that 
experienced this protocol. By dissolving clozapine into the drinking water and measuring 
the amount consumed each week compared to the average weight of the animals, we 
could calculate the clozapine dosage at10mg/kg per day for each animal. Two animals 
were sacrificed to assess the efficacy of the treatment by measuring whole blood 
clozapine levels. One animal had a norclozapine level of 59ng/ml after three weeks, 
while another had a level of 237ng/ml after two weeks. This is lower than the clinical 
dosage in humans of around 300ng/ml.  
 A more likely explanation is that, even though this dosage is below the clinically 
effective range, it is too high to see the effects previously reported. Other studies have 
seen a decrease in locomotor activity in Nrg1 mutant mice treated with clozapine at a 
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dosage of only 1mg/kg (Rimer, Barrett, Maldonado, Vock, & Gonzalez-Lima, 2005; 
Stefansson et al., 2002). As we did not see the reduction in activity that has previously 
been reported with clozapine in Nrg1 mutants, it would be worth repeating the clozapine 
at a lower dose to determine whether we can replicate this finding. At least in the dentate 
gyrus, it also seems a lower dose is more effective at stimulating neurogenesis. Chronic 
clozapine treatment with 5mg/kg or 20mg/kg did not alter rates of neurogenesis in the 
dentate gyrus, although a very low dose of 0.5mg/kg was responsible for a temporary 
increase in proliferation in this region (Halim, Weickert, McClintock, Weinberger, & 
Lipska, 2004; U. Meyer, Knuesel, Nyffeler, & Feldon, 2010). Perhaps the SVZ 
neurogenesis that has been reported with the use of similar antipsychotics (W. Green et 




 While several studies have examined the phenotype of Nrg1 heterozygous mice 
with a mutation in the TM-domain or EGF-domain, in which levels of both Ig-Nrg1 and 
CRD-Nrg1 are altered, the Nrg1Ig/- phenotype has yet to be fully characterized. 
Hyperactivity is a schizophrenia-related endophenotype that has been measured in other 
Nrg1 mutants (Gerlai et al., 2000; Stefansson et al., 2002). Although one previous study 
did not see hyperactivity in Nrg1Ig/- mice (Rimer et al., 2005), hyperactivity was 
apparent in the previous cohort and the current study confirms his finding. Given the 
normal locomotor activity seen in Type III Nrg1 heterozygotes (Y. J. Chen et al., 2008), 
these results indicate that changes in Ig-Nrg1 expression are responsible for the observed 
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hyperactivity. On the other hand, we did not replicate the previous finding of decreased 
social interaction in Nrg1Ig/- mice. Further investigation is necessary to determine 
whether Ig-Nrg1 plays any role in this behavior. 
 Nrg1Ig/- also showed mild olfactory deficits. Heterozygotes showed an increased 
latency to choose between cinnamon and paprika in an olfactory discrimination reward 
paradigm, yet were able to learn the task in the same number of trials as Nrg1+/+ mice. 
They also needed a higher number of trials to reach criterion on the more difficult 
discrimination task in which they had to distinguish between the two enantiomers of 
carvone. This mild impairment in olfactory acuity points to a deficit in the function of 
interneurons, which enact lateral inhibition to boost the contrast between similar odors 
and enhance the capacity for olfactory discrimination (Luo & Katz, 2001; Schoppa & 
Urban, 2003; Yokoi, Mori, & Nakanishi, 1995). This hypothesis is backed up by the 
neuroanatomical findings discussed below. 
SVZ Neurogenesis 
 
 BrdU is a thymidine analog that is incorporated into a dividing cell’s DNA, 
thereby marking proliferating cells. At 24 hours after BrdU staining, the SVZ showed no 
difference in proliferating cells between Nrg1+/+ and Nrg1Ig/- mice. This finding 
confirmed what was seen in the previous cohort. Although there is an extensive 
neurogenic region surrounding the lateral ventricles that can generate neuroblasts and 
contribute new interneurons to the olfactory bulb, the majority of these are derived from 
the anterior SVZ (Alvarez-Buylla et al., 2008; Menezes, Smith, Nelson, & Luskin, 1995).  
 However, the SVZ is a heterogeneous structure with various regions deriving 
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from different embryological origins and expressing different transcription factors. This 
variability is maintained as the fate of a neuroblast appears to be set by its region of 
origin (Lledo et al., 2008). Subtle regional aberrations may be missed if this diversity is 
not taken into account. I therefore divided the SVZ into five regions based on their 
embryological origins. These were the dorsal, medial, and lateral walls, and the dorsal 
and ventral tips. When comparing BrdU staining between Nrg1+/+ and Nrg1Ig/- mice in 
each of these areas, a decrease in BrdU staining was apparent in the lateral wall of the 
heterozygous mice.  
This suggests that a decrease in Ig-Nrg1 expression is responsible for a baseline 
region-specific decrease in proliferation. Interestingly, the lateral wall is also the region 
of the SVZ that shows the highest levels of Nrg1 expression, particularly in the anterior 
SVZ. Thus it is not unexpected that the lateral wall was most impacted by changes in 
Nrg1 levels. Nrg1 expression in this region for the most part colocalizes with the 
expression of polysialylated neural cell adhesion molecule (PSA-NCAM), which is a 
transient marker of newly generated cells (Anton et al., 2004; Ghashghaei et al., 2006; 
Sato et al., 2001). After cleavage, Ig-Nrg1 is released extracellularly. The receptor ErbB4 
is also expressed in PSA-NCAM migrating neuroblasts (Ghashghaei et al., 2006), so the 
relevant Nrg1-ErbB4 interactions may be autocrine, juxtacrine, or paracrine in nature. 
Evidence of a decrease in proliferation is in line with previous research that has 
identified Nrg1 as a mitogen. In cultures of neural stem cells isolated from embryonic 
mouse telencephalon, treatment with the EGF domain of Nrg1 induced a four-fold 
increased in BrdU-labeled cells (Y. Liu, Ford, Mann, & Fischbach, 2005). This indicates 
that the proliferative effects of Nrg1 are likely due to an interaction with ErbB4, instead 
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of through back signaling of the ICD, as these effects were present after external 
application of Nrg1. One possible mechanism for this effect is the activation of 
phospholipase C (PLC). PLC has an interaction with ErbB4, and Nrg1 stimulation leads 
to a signaling cascade that is critical for stem cell proliferation (Gallicano, Yousef, & 
Capco, 1997; Lai & Feng, 2004; Montcouquiol & Corwin, 2001; Noh, Shin, & Rhee, 
1995; Quinlan, Faherty, & Kane, 2003). However, the mechanism for Nrg1-induced 
proliferation has yet to be confirmed. 
The results of this study also point to a role of Nrg1 signaling in survival of 
neuroblasts. After 21 days, BrdU staining in the SVZ shows a large overall reduction due 
to the migration of neuroblasts out of the SVZ through the RMS and into the olfactory 
bulb. Additionally, the reduction in BrdU+ cells seen in the lateral wall of Nrg1Ig/- mice 
at 1-day post-BrdU was even more dramatic at 21-days post-BrdU. This was 
accompanied by a reduction in BrdU staining in the medial wall, which had not been seen 
at the earlier time point. There are two possible explanations for this reduction. The Ig-
Nrg1 deficit could result in decreased survival of neuroblasts, or there could also be 
increased migration out of the SVZ. As there was also a decrease in BrdU+ cells in the 
RMS and olfactory bulb of the heterozygotes, impaired survival of neuroblasts seems 
more likely. 
  Other studies have also identified a role for Nrg1 signaling in survival. As 
previously described, Nrg1 signaling can include both the release of an extracellular 
domain, and the cleavage of an intracellular domain which can also engage in back 
signaling. Extracellular binding of ErbB receptors or depolarization can induce ICD 
cleavage. The ICD may then translocate to the nucleus to regulate gene expression. Its 
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functions include promoting cell survival and repressing regulators of apoptosis (Bao et 
al., 2004; Bao et al., 2003; Talmage, 2008). However, thus far ICD back signaling has 
only been associated with CRD-Nrg1. It is therefore possible the decreased survival 
described in Nrg1Ig/- mice is due to compensatory changes in expression of CRD-Nrg1. 
There might also be as yet unknown Ig-Nrg1 signaling mechanisms that influence 
survival, or previously undiscovered back signaling by these isoforms. However, this is 
speculative and needs further study. 
 The decrease in proliferation specifically in the lateral wall of the SVZ has 
implications for the composition of new olfactory bulb interneurons. In general, the 
lateral wall of the SVZ contribute periglomerular cells that express calbindin, which are 
produced perinatally, as well as deep granule cells. The dorsal SVZ produces TH+ 
periglomerular cells, while the medial SVZ produces CR+ periglomerular cells. Both of 
these regions also contribute superficial granule cells (Batista-Brito et al., 2008; Ihrie & 
Alvarez-Buylla, 2011; Lledo et al., 2008; Young et al., 2007). Since Nrg1Ig/- mice 
showed a decrease in proliferation in the lateral wall of the SVZ, a reduction in BrdU+ 
granule cells would also be expected.  
 As predicted, there was a decrease in new granule cells in the olfactory bulb at 
both 21-days and 60-days post-BrdU, most of which were CR+. NrgIg/- mice did not 
show a change in BrdU staining in the GL for either TH+ or CR+ periglomerular cells. 
This indicates that the regional specificity of Ig-Nrg1 on proliferation is reflected in a 
specific reduction in olfactory interneurons derived from that region. These findings 
suggest that the diversity of the olfactory bulb can be attributed to their origins in the 
SVZ, and can be traced back even further to the regional differences in SVZ embryologic 
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origins.  
 Interestingly, although there was a reduction in BrdU+ cells in the olfactory bulb 
of Nrg1Ig/- mice, there was no change in total counts of interneurons. This was true for 
both the GCL and all subtypes measured in the GL. Reduced proliferation and 
incorporation of new GCL interneurons into the olfactory bulb, combined with an equal 
number of overall cells, implies that the end result of this genetic manipulation is a 
decrease in GCL turnover. It seems there may be niche in the olfactory bulb that needs to 
be filled to maintain the circuitry, and the reduction in available migrating neuroblasts 
leads to fewer older GCL interneurons being replaced. 
 There is evidence that reduced SVZ proliferation increases the survival of 
olfactory bulb interneurons (Sui et al., 2012). Dopaminergic innervation modulates 
proliferation in the LGE during development, and continues to innervate this region as it 
is incorporated into the SVZ during adulthood (Abrous, Koehl, & Le Moal, 2005; 
Emsley, Mitchell, Kempermann, & Macklis, 2005; Freundlieb et al., 2006; Hoglinger et 
al., 2004; Lie, Song, Colamarino, Ming, & Gage, 2004; Ming & Song, 2005; Ohtani, 
Goto, Waeber, & Bhide, 2003). Dopamine induces proliferation of transit amplifying 
cells in this region, and depletion of dopaminergic fibers decreases proliferation (Baker, 
Baker, & Hagg, 2004; Freundlieb et al., 2006; Hoglinger et al., 2004; Kippin, Kapur, & 
van der Kooy, 2005; Winner et al., 2009). The relevant study used dopaminergic 
depletion to decrease SVZ proliferation and showed an increase in BrdU+ cells in the 
SVZ 15 days later and an increase in BrdU+ cells in the olfactory bulb 42 days later. 
They also saw equivalent numbers of total mature olfactory bulb interneurons (Sui et al., 
2012). This matches what was seen in the Nrg1Ig/- mice. The genetic manipulation 
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resulted in reduced proliferation with no change in the total number of olfactory 
interneurons. A compensatory increase in survival, and consequently decreased turnover, 
is therefore a plausible mechanism for these findings.  
 A recent study has pointed to a role for olfactory turnover in optimizing olfactory 
performance. For example, one study blocked turnover by infusing the caspase inhibitor 
zVAD into the olfactory bulb and administered a battery of olfactory tests to determine 
the effects. This did not affect turnover of OSN, but did increase the survival of olfactory 
interneurons. While these mice were still able to perform olfactory discrimination tests as 
well as control mice, they showed an increased discrimination time when performing the 
task. They also spent more time exploring new odors than the control mice (Mouret et al., 
2009). This provides evidence that the decrease in turnover leads to a longer processing 
time and less efficient functioning of the olfactory bulb circuitry. The decreased turnover 
seen in this study could therefore be responsible for the subtle olfactory deficits we have 
described. It seems reductions in turnover, whether by genetic or chemical means, can 
still result in this decreased efficiency of olfactory identification.  
 One novel finding of this study was that there also seems to be heterogeneity 
along the anterior-posterior axis of the olfactory bulb in terms of the rates of 
incorporation of new neurons. The decrease in BrdU+ cells in the GCL was specific to 
the area of the olfactory bulb from Bregma 3.2 to Bregma 3.4. This may have functional 
implications. While odorants activate a distributed pattern of glomeruli in the olfactory 
bulb, it has been thought that the glomeruli are arranged according to the chemical 
properties of the odorants that activate them (Johnson & Leon, 2007), although this 
theory has been recently disputed (L. Ma et al., 2012). If this is the case, a chemotopic 
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mapping of the olfactory bulb may elucidate the functions of glomeruli in that region, and 
Nrg1Ig/- mice should have greater difficulty discriminating between odors that activate 
the glomeruli in question. 
 Interestingly, in analyzing BrdU staining along the anterior-posterior axis of the 
olfactory bulb, it was apparent that the Nrg1+/+ mice showed increased BrdU+ cells in 
the region from Bregma 3.2 to Bregma 3.4, while the Nrg1Ig/- had somewhat even 
BrdU+ levels throughout. This suggests that the Nrg1+/+ had increased turnover 
specifically in that region. Since we were not training this cohort to discriminate between 
certain smells, it is likely that this area of the olfactory bulb is activated by relevant 
smells in the laboratory environment. Because Nrg1Ig/- mice did not show a similar 
increase, it is possible that they have an impaired ability to increase turnover in response 
to significant olfactory stimuli. Such a deficit would likely confer a disadvantage in 
adaptation to new stimuli.   
This becomes increasingly relevant when we recall that the regions of the brain 
that give rise to the SVZ are also responsible for contributing cortical interneurons during 
early development. These cortical circuits also undergo pruning and neuronal turnover. 
One can imagine that, if the same mechanisms are in place during neurodevelopment, 
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FIGURE 10: Nrg1Ig/- Behavioral Phenotype 
 
A. Locomotor Activity in Nrg1Ig/- Mice 
 










Behavioral testing of Nrg1Ig/- mutant mice:  For detailed methods please see corresponding sections in 
Experimental Design.  Rederived Nrg1Ig/- mice were backcrossed and maintained on a C57Bl/6 background as 
described previously [62, 95, 96].  As described for Nrg1 mutations affecting other type I and/or II isoforms (i.e., 
epidermal growth factor (EGF), transmembrane (TM) domains) [32, 65], but in contrast to another report [74], 
Nrg1Ig/- mice exhibited locomotor hyperactivity when compared to their wild-type (Nrg1+/+ mice) littermates (Fig. 
1).  Ongoing microdialysis experiments indicate that Nrg1Ig/- mice also have increased striatal release of 
dopamine in response to amphetamine (Merker, Gingrich, and Moore unpublished results), consistent with 
receptor imaging in patients [10].  As hyperactivity of Nrg1 mutant mice has been shown to be sensitive to 
treatment with the antipsychotic clozapine [32], this finding is consistent with the notion that NRG1 function 
exerts important effects on neural systems relevant to the positive symptoms of schizophrenia.  Experiments 
with animals treated chronicall with clozapine are ongoing in our group. 
 
Figure 1. Locomotor Activity in the Open Field 
 
The distance traveled in a darkened novel open field, recorded in 5 minute bins over 60 minutes. 
 n = 8-9 per genotype, p < 0.05 for genotype (ANOVA).  Points represent mean ± s.e.m. 
 
Less well understood are the neural substrates underlying the negative symptoms observed in patients 
with schizophrenia.  Most prominent among these symptoms is impaired social interaction.  As described 
above, evidence of negative symptom phenotypes has now been reported in Nrg1 mutant mouse models.  To  
 
     
The number of anogenital investigatory (AI) events (a) and total time spent in AI (b) from resident males during 
6 min when challenged with an unfamiliar mouse.  The 6 min test is broken into three 2-min bins. n = 8-9 per 
genotype. * p < 0.05,  ** p < 0.01 (ANOVA).  Data in a and b represent mean ± s.e.m. 
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FIGURE 10: Nrg1Ig/- Behavioral Phenotype 
 
(A) Locomotor Activity: Mice were run in a darkened novel open field for a period of 
60 minutes. The graph shows mean distance traveled for each group, broken down into 5-
minute intervals. 
(B) Social Interaction: Mice were introduced to a novel conspecific and allowed to 
interact with the unfamiliar mouse for 6 minutes. The graphs show number and duration 
of anogenital investigations, broken down into 2-minute intervals.  
	  99	  	  
FIGURE 11: Olfactory Discrimination 
 
 
(A) Discrimination Paradigm: This is a schematic of the odor discrimination test. Mice 
were trained to distinguish between two odor-infused dishes of digging material in order 
to locate a food reward. 
(B) Latency to Choose: Measure of the average time taken by mice in each group to 
make a choice in the odor discrimination task. 
(C) High Contrast Discrimination: Number of trials required for the mice to be able to 
perform a correct discrimination between cinnamon and paprika six times in a row. 
(D) Low Contrast Discrimination: Number of trials required for the mice to be able to 
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FIGURE 12: SVZ and Olfactory Bulb BrdU Staining 
(A) SVZ BrdU Staining: Mice were sacrificed 24 hours after BrdU injection. BrdU+ 
cells were counted in the SVZ. 
(B) GCL Olfactory Bulb BrdU Staining: Mice were sacrificed 21 days after BrdU 
injection. BrdU+ cells were counted in the GCL of the olfactory bulb.   
(C) GCL Olfactory Bulb BrdU Staining: Mice were sacrificed 60 days after BrdU 
injection. BrdU+ cells were counted in the GCL of the olfactory bulb. 
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FIGURE 13: Experimental Design 
 
At age 3 months, mice were treated with either clozapine or vehicle in their drinking 
water. Those in the clozapine group received a dosage of roughly 10 mg/kg. After 21 
days of treatment, mice were given an injection of BrdU every two hours for a total of 
four doses. Group 1 was sacrificed 24 hours after BrdU injections. Group 2 was 
sacrificed 21 days after BrdU injections. Group 3 was sacrificed 60 days after BrdU 
injections. Mice continued to receive clozapine treatment until they were sacrificed.  
  
Clozapine	  or	  	  	  	  	  	  	  	  Vehicle 
Age 3	  Months 4	  Months 5	  Months 
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FIGURE 14: Open Field Locomotor Activity  
 
Black bars indicate vehicle treatment, and white bars indicate clozapine treatment. 
(A) Distance traveled in a novel darkened open field over 30 minutes, broken down into 
5-minute intervals. 
(B) Total distance traveled in novel open field over 30 minutes. 
(C) Distance traveled in the center of the open field over 30 minutes. 
(D) Distance traveled in the periphery of the open field over 30 minutes. 
 * indicates p<0.05. 














































































































































Interaction Line Plot for TotDist
Effect: Category for TotDist * Geno * Drug
Error Bars: ± 1 Standard Error(s)

















Interaction Bar Plot for adistp
Effect: Geno * Drug
Error Bars: ± 1 Standard Error(s)



















Interaction Bar Plot for adistC
Effect: Geno * Drug
Error Bars: ± 1 Standard Error(s)
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Interaction Bar Plot for SVZ BrdU/um^2
Effect: Genotype * Treatment
Error Bars: ± 1 Standard Error(s)























Interaction Bar Plot for Region 4
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FIGURE 15: Social Interaction 
(A) Mice were introduced to a novel conspecific for a total of 6 minutes. The latency to 
initiate anogenital investigation of the unfamiliar mouse was recorded. 
(B) Total time spent in anogenital investigations with an unfamiliar mouse was recorded 
over 6 minutes. 
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into 2-minute intervals.  
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FIGURE 16: SVZ BrdU Staining after 24 hours 
  
A. Sample SVZ BrdU Staining 







(A) Sample staining of the SVZ 24 hours after BrdU injection. Images were captured 
using a confocal microscope at 20x magnification and combined to show an entire 
coronal slice of the SVZ. 
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(B) Total BrdU counts per mm^2 from the entire SVZ, 24 hours after BrdU injection.  
FIGURE 17: SVZ Subdivision 
 
SVZ subdivisions include the dorsal and lateral tips, and the dorsal, medial, and lateral 
walls. These divisions were based on the embryonic origins and expressed transcription 
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referenced in Figure 2.  
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FIGURE 18: SVZ Subdivision BrdU Staining after 24 hours 
  
The SVZ was subdivided into five previously described regions. Total BrdU+ cells per 
mm^2 were counted in the dorsal tip of the SVZ (A), the ventral tip of the SVZ (B), the 
dorsal wall of the SVZ (C), the lateral wall of the SVZ (D), and the medial wall of the 
SVZ (E). 
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FIGURE 19: SVZ BrdU Staining after 21 days 
 
(A) Total SVZ+ cells 
per mm^2 were counted for the entire SVZ 21 days after BrdU injections. SVZ was then 
divided into previously described subregions to calculate BrdU+ cells per mm^2 for the 
dorsal tip (B), ventral tip (C), lateral wall (D), medial wall (E), and dorsal wall (F). 
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(A) Sample BrdU staining of the RMS at 40x magnification. 
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This is a sample immunostain from the GL of the olfactory bulb. TH+ cells are colored 
blue, CR+ cells are colored yellow, and BrdU+ cells are colored red. White arrows 
indicate examples of double-labeled cells. 
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FIGURE 22:  Olfactory Bulb GL BrdU Staining at 21 days and 60 days after BrdU 
 
 
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). BrdU+ cells per mm^2 were counted in the GL of the olfactory bulb at 
21 days (A) and 60 days (B) after BrdU injection. Counts for cells double-labed for BrdU 
and CR (C, D) or BrdU and TH (E, F) were also obtained. 
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FIGURE 23: Olfactory Bulb GCL BrdU Staining at 21 days and 60 days after BrdU 
 
 
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). BrdU+ cells per mm^2 were counted in the GCL of the olfactory bulb 
at 21 days (A) and 60 days (B) after BrdU injection. Counts for cells double-labeled for 
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FIGURE 24: Olfactory Bulb Staining at 21 days and 60 days after BrdU 
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). In the GL of the olfactory bulb, counts per mm^2 of total interneurons 
expressing CR (A, B) or TH (C, D) were measured at 21 days (A, C) and 60 days (B, D) 
after BrdU injection. In the GCL of the olfactory bulb, counts per mm^2 of interneurons 
expressing CR at 21 days (E) and 60 days (F) were also measured.  
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FIGURE 25: Olfactory Bulb GL BrdU Staining by Bregma Level 
  
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). BrdU+ cells per mm^2 were counted in the GL of the olfactory bulb at 
21 days (A) and 60 days (B) after BrdU injection. Counts for cells double-labled for 
BrdU and CR (C, D) or BrdU and TH (E, F) were also obtained. These measurements are 
broken down along the rostral-caudal axis from Bregma level 2.8 at the caudal end to 
Bregma 3.6 at the rostral end. 
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FIGURE 26: Olfactory Bulb GL Staining by Bregma Level 
 
 
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). BrdU+ cells per mm^2 were counted in the GCL of the olfactory bulb 
at 21 days (A) and 60 days (B) after BrdU injection. Counts for cells double-labed for 
BrdU and CR (C, D) were also obtained. These measurements are broken down along the 
rostral-caudal axis from Bregma level 2.8 at the caudal end to Bregma 3.6 at the rostral 
end.  
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FIGURE 27: Olfactory Bulb GCL Staining Broken Down by Bregma Level 
 
The olfactory bulb was immunostained with BrdU, calretinin (CR) and tyrosine 
hydroxylase (TH). In the GL of the olfactory bulb, counts per mm^2 of total interneurons 
expressing CR (A, B) or TH (C, D) were measured at 21 days (A, C) and 60 days (B, D) 
after BrdU injection. In the GCL of the olfactory bulb, counts per mm^2 of interneurons 
expressing CR at 21 days (E) and 60 days (F) were also measured. These measurements 
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are broken down along the rostral-caudal axis from Bregma level 2.8 at the caudal end to 
Bregma 3.6 at the rostral end. 
 
 
CHAPTER 4: CONCLUSION 
 
 In this thesis, I have discussed two methods of adaptation that modulate the 
normal range of development and performance. Epigenetic factors regulate gene 
expression at the genetic level, while interneurons that modify neuronal activity at the 
neurocircuitry level. Both of these are influenced by environmental factors, allowing for a 
developmental response to external conditions. However, dysfunctions in either of these 
mechanisms can cause various vulnerabilities. While these effects may be subtle, they 
can also contribute to such devastating disorders as schizophrenia.  
 Interactions between genes and the environment can have wide-ranging effects 
throughout life, and epigenetic changes are thought to be a key mechanism through which 
the external influences achieve their effects. Early experiences during critical periods of 
development can have a lasting impact on an individual. The heritability of epigenetic 
effects may also be responsible for the transmission of traits across generations. One 
classic example involves the effect of maternal care on offspring methylation patterns. 
Rat dams can display high or low levels of licking and grooming (LG) behavior towards 
their offspring. Low LG leads to increased methylation of the estrogen receptor α 
promoter in the offspring hypothalamus, which results in female offspring displaying the 
same maternal care pattern as their mothers (Champagne, 2008). LG levels are also a 
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mechanism for the transmission of response to stress from mother to offspring in rats. 
High LG behavior causes a signaling cascade in the offspring that results in the 
hypomethylation of the glucocorticoid receptor promoter and this receptor’s increased 
expression in the hippocampus. This produces a less fearful phenotype (Weaver et al., 
2004; Weaver et al., 2007). Such changes may have adaptive value in the offspring. 
Dams living in a more threatening environment would have less time for LG behavior. 
The offspring born into such an environment might gain a survival advantage by being 
more fearful (Youngson & Whitelaw, 2008). Thus, the diversity and flexibility of a 
species may be maintained, transmitted, and expanded through the epigenome. 
  In addition to experience-dependent epigenetic inheritance, epigenetic states can 
also be transmitted to through the germ line. For example, imprinting occurs during 
gametogenesis in both the male and female germ line. Once the previous methylation 
patterns are, for the most part, erased, new methylation is added that is specific to the 
parent of origin. This allows either the maternal or paternal allele to be silenced, so that 
certain genes show only monoallelic expression (Verona, Mann, & Bartolomei, 2003). 
  While epigenetic regulation normally allows for adaptation, errors in this system 
can have disastrous consequences. Imprinting errors may be due to abnormal erasure, 
establishment, or maintenance of methylation. The epigenetic processes of 
spermatogenesis seem to break down with time, and epigenetic abnormalities have been 
observed. The spermatozoa of older rats show aberrations in chromatin packaging and 
integrity (Zubkova & Robaire, 2006), as well as ribosomal DNA hypermethylation 
(Oakes, Smiraglia, Plass, Trasler, & Robaire, 2003). Many imprinted genes are involved 
in brain development (Gregg et al., 2010), so abnormalities in methylation could result in 
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cognitive deficits. Malfunctions in the epigenetic regulation of the germ line in aging 
males may therefore contribute to the broad range of neurodevelopmental disorders that 
have been linked to advanced paternal age. 
 At the level of the brain, adaptations to the external environment are also 
occurring. This adaptation in response to experience can take several forms, including 
modulating synaptic strength, altering membrane excitability, or the formation of new 
synapses or dendritic branches. While these changes can occur quickly, the remodeling of 
circuitry by the integration of new neurons occurs over days or weeks and may indicate a 
more enduring type of adaptation (Sahay, Wilson, & Hen, 2011). Newborn granule cells 
seem to be selected for survival based on exposure to an activating odor. These adult-
born interneurons improve olfactory acuity by using lateral inhibition to enhance pattern 
separation between glomeruli that respond to similar stimuli. Because of this adaptive 
capacity of the brain, exposure to new odors is associated with increased ability to 
discriminate that odor as compared to other similar odors (Moreno et al., 2009; 
Rochefort, Gheusi, Vincent, & Lledo, 2002; Rochefort & Lledo, 2005). Conversely, odor 
deprivation impairs discrimination and reduces survival of adult-born granule cells 
(Mandairon & Linster, 2009; Wilson & Sullivan, 1995; Yamaguchi & Mori, 2005). Thus, 
individual organisms can respond to variable environments by adapting to external 
stimuli in ways that are of maximum benefit. 
 As Graziella Di Cristo said of interneurons: “We may compare GABAergic 
function of interneurons to that of the music director of a symphony orchestra, whose 
role is to structure and coordinate the overall musical performance and interpretation of 
the individual players. Without proper direction, the ensemble cannot produce the right 
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melody.”(Di Cristo, 2007) GABAergic interneurons play an important and multifaceted 
role in modulating brain activity of brain circuitry. They act to modulate excitatory 
transmission, generate temporal synchronicity, increase brain plasticity, and allow the 
brain to respond to experience (Di Cristo, Pizzorusso, Cancedda, & Sernagor, 2011). We 
are only beginning to understand their diverse functions in brain activity and 
development, as the purpose of the impressive heterogeneity of interneuron subtypes is 
still unclear. 
 Interspecies differences in the production of new interneurons may even expose a 
form evolutionary adaptation. In rodents, the SVZ continues to produce interneurons 
throughout the adult life, which are supplied to the olfactory bulb and have been shown to 
improve olfactory acuity. However, proliferation in the SVZ of humans drops to a 
negligible level after 18 months of age (Sanai et al., 2011). On the other hand, the human 
SVZ shows high rates of proliferation during early postnatal life. In addition to supplying 
new neurons to the olfactory bulb, humans develop a medial migratory stream (MMS) 
that splits off from the RMS to supply the ventromedial prefrontal cortex (VMPFC). This 
appears to be specific to humans and has not been detected in other vertebrates (Sanai et 
al., 2011). These differences reflect the differences in specialization between rodents and 
humans. Olfactory cues remain a critical aspect of rodent life and play a large role in 
social interaction. The richness of their olfactory world is enhanced by their superior 
ability in this area. In humans, however, olfactory discrimination does not have the same 
meaning or significance in daily life. While the function of the MMS has not yet been 
fully characterized, the VMPFC of the adult is thought to have functions in visual 
memory and contextualization and the emotional processing of visual cues (Longe, 
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Senior, & Rippon, 2009; Szatkowska, Szymanska, & Grabowska, 2004). This is in line 
with our increased reliance on visual information over olfactory cues and the greater 
cognitive complexity of human life. 
 The roles of epigenetic modulation and brain plasticity and adaptation are also 
linked, as epigenetic changes cause altered gene expression that can have complex 
repercussions in an organism’s neurobiology and behavior. In this thesis, we have 
explored the developmental implications of altered expression of a subset of isoforms of 
a single gene. While Nrg1 has several neurodevelopmental functions, including roles in 
neurotransmission and myelination, the scope of this study was to examine its effects on 
SVZ neurogenesis. We did this by tracking SVZ proliferation, the migration of immature 
neurons from this region, and their differentiation and integration into the olfactory bulb. 
Our findings revealed the Nrg1 has effects on proliferation in a subdivision of the SVZ as 
well as a possible impact on survival. This resulted in decreased turnover of interneurons 
in the GCL of the olfactory bulb, which had the functional consequence of impaired 
olfactory discrimination. This deficit in olfactory discrimination is similar to that seen in 
individuals with schizophrenia, a disorder that has also been linked to altered Nrg1 
expression. This may have wider functional relevance as the ganglionic eminences 
produce cortical interneurons during development and also give rise to the SVZ. It is 
therefore possible that this change in gene expression is linked to dysfunction of the 
ganglionic eminences, yielding impaired interneuron development in both the cortex and 
olfactory bulb. However, this is an oversimplification as several genes have been linked 
to schizophrenia susceptibility and interneuron development is only one function of Nrg1. 
Schizophrenia is likely to involve an accumulation of vulnerabilities, which may show as 
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much heterogeneity among affected individuals as is seen in the clinical phenotype. This 
would also explain the appearance of subclinical symptoms during the prodromal phase 
and the presence of schizophrenia-related endophenotypes in healthy individuals who 
have some genetic risk. Yet this study gives us a glimpse of the ways altered gene 
expression may have broad developmental impacts. 
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METHODS 
Open Field: Mice were placed in the center of a MedAssociates locomotor arena (17 x 
17 x 12 inches) for 60 minutes and activity was tracked photocell beam measurements 
and calculated with MedAssociates software. The testing room was brightly lit for the 
duration. 
 
Prepulse Inhibition: Mice were placed in sound-dampening chambers and allowed to 
acclimate for 10 minutes. Background noise was at 70db during the acclimation phase 
and the trials. A 120db startle stimulus lasting for 40ms was presented either by itself or 
preceded by a 15msec prepulse 100msec before the trial. The prepulse could be 2, 6, 8, 
12, or 16 db above background. The startle was measured by changes in the force on the 
floor and occurred between 30msec and 70msec after the startle stimulus. 
 
Social Interaction: Mice were placed in a MedAssociates arena for 60 minutes. This 
arena contained two novel boxes with mesh screens. An unfamiliar mouse of the same 
gender was placed in one of the boxes, while the other was left empty. Activity and time 
spend in each quadrant was measured with MedAssociates software. 
 
Fear Conditioning: The fear conditioning protocol took place over 3 days. During the 
first day, mice were trained to associate a tone with the delivery of an aversive, mild foot 
shock. The second day tests the conditioning of mice to the tone. The walls and floors of 
the fear conditioning boxes were covered with an unfamiliar material and a different 
odor, so the mice would not associate this environment with the shock delivery. Freezing 
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behavior was measured before the first tone, to provide a background value. Freezing 
after the delivery of the first tone was used to assess conditioning to the tone. On day 3, 
mice were placed back in the environment used on day 1. Freezing behavior was used as 
a measure of conditioning to the shock context. 
 
Light-Dark Test: In this task, MedAssociates arenas were divided into two 
compartments. One of these was dark and enclosed while the other side was open and lit. 
Mice were placed in the dark compartment at the start of the session. The latency to enter 
the light, and time and activity in each compartment was measured with MedAssociates 
software. 
 
Food Neophobia: Mice were food-deprived for 24 hours before the test, with free access 
to water. Mice were then individually placed in their home cages and allowed six minutes 
of simultaneous access to a familiar food pellet and a piece of Kellogg’s blueberry Nutri-
Grain bar. Both food options were weighed before and after the test to determine grams 
consumed. The latency to taste each food was also recorded. 
 
Social Investigation Paradigm. Male mice were housed individually in standard 
laboratory cages for one week prior to testing. A single group-housed male intruder was 
introduced in the home cage of the individually housed test subject and their behavior 
was recorded for 6 min. The test mouse was scored for behaviours related to AGI of the 
intruder (number of AGI events; total time spent in AGI). An AGI event was defined as 
any sniffing and grooming of the intruder near the tail, rump, or general anogenital area. 
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A trained observer (blind to genotype) scored the test mice for investigatory behaviors.  
 
Olfactory discrimination paradigm. Olfactory discrimination was measured using a 
three-chambered box. In one chamber, a food reward was buried in a dish of “digging 
media” infused with a distinct spice while another dish containing digging media with a 
different odor (without a reward) was placed in the other arm. Mice were placed in the 
starting chamber and allowed to find the food reward though exploratory digging. A 
correct choice was scored if the mouse began digging in the chamber where the food 
reward was buried. Trials were continued until the test subject recorded 6 correct choices 
in a row. Nrg1+/+ and Nrg1Ig/- mice were tested in this paradigm using the following odor 
pairs: cinnamon/paprika (“high-contrast”) and (+)/(-) carvone (“low contrast”). The 
“correct” odor was randomized between mice and between trials the reward was 
randomly assorted between each chamber. Each odor was tested at a 1:100 (w/v) dilution 
into digging material. 
 
Drug treatment was provided orally by dilution in drinking water.  Clozapine (Sigma) 
was prepared as follows:  200 mg of clozapine was dissolved in 6.5 ml of 1N HCl and 
subsequently diluted to a stock concentration of 5 mg/ml in .033 N HCl.  The pH of this 
solution was 5.9-6.6.  A vehicle control HCl stock solution was prepared and pH adjusted 
to 6.0 with NaOH.  Stock and vehicle were diluted to equivalent of .07 mg clozapine/ml 
in tap water and this was given to animals as sole source of water in darkened bottles.  
After confirmation of minimal degradation of clozapine in this aqueous solution solutions 
were changed weekly (all assays  performed by Thomas Cooper, Analytical 
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Psychopharmacology Laboratory, Nathan Kline Institute).  The amount of water 
consumed each week was measured and compared with the average weights of animals in 
each cage with an estimated dosage of 10 mg/kg per animal per day.  Two animals were 
sacrificed to determine whole blood clozapine levels (samples processed as above by 
APL at NKI).  After 3 weeks, a c57Bl/6 animal showed 59 ng/ml of norclozapine and 
after 2 weeks, a 129 strain animal showed a blood level of 237 ng/ml of norclozapine 
(therapeutic human levels are approximately 300 ng/ml). 
 
BrdU treatment: Mice were injected intraperitoneally with the thymidine analog 5-
bromo-2’-deoxyuridine (BrdU) (75 mg/kg, Sigma) once every two hours for a total of 
four doses each, and then sacrificed at either 24 hours or 21 days after the injections. 
Mice were anesthetized with xylazine/ketamine and intracardially perfused with ice-cold 
saline followed by 4% paraformaldehyde in phosphate buffer (PB). Brains were post 
fixed overnight at 4°C, and cut serially in 40um coronal sections cryostatically. 
 
Fluorescent Staining: Day 1: Wash 3X in PBS. Block 1hr in 10% Normal Donkey 
Serum (NDS). Free-float sections overnight at 4°C with all primary antibodies except 
BrdU (Rabbit Anti-Caltretinin Millipore 1:200, Chicken GFAP Abcam 1:1000, Mouse 
Anti-NeuN Millipore 1:100, Chicken Anti-TH Aves 1:1000). Day 2: Wash slices 3x in 
PBS-T. Mount slices on slides and dry in hood for 1hr. Treat with secondary antibodies 
(405 Donkey anti-Chicken, 647 Donkey anti-Rabbit, 488 Donkey anti-Mouse, Jackson 
Immuno 1:200). Fix in 4% PFA 15 min at room temperature. Wash 3x in PBS-T. Treat 
with 4N HCl for 30min. Wash 3x in PBS-T. Fix in 4% PFA 5 min. Block in 10% NDS 
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for 30 min. Stain with anti-BrdU overnight at 4°C (Rat anti-BrdU AbD Serotec 1:100). 
Day 3: Wash 3x in PBS-T. Stain with secondary antibody (Cy3 Donkey anti-Rat, Jackson 
Immuno 1:200). Wash 3x in PBS-T. Mount with ProLong Gold (Invitrogen) and store 
slides at -20°C. 
 
Image Collection:  Scan on Olympus confocal microscope using FluoView 1000 
software. Every sixth SVZ section was scanned and matched by Bregma level. ImageJ 
(NIH) was used for data collection. The area around the SVZ was selected and measured, 
and all BrdU+ cells were counted. 
 
Statistics: Data was analyzed using 2-way ANOVAs and t-tests, and graphs were 
produced with Statview and Prism.   
	  132	  	  
REFERENCES 
 
Abraham, N. M., Spors, H., Carleton, A., Margrie, T. W., Kuner, T., & Schaefer, A. T. 
(2004). Maintaining accuracy at the expense of speed: stimulus similarity defines 
odor discrimination time in mice. Neuron, 44(5), 865-876. doi: 
10.1016/j.neuron.2004.11.017 
 
Abrous, D. N., Koehl, M., & Le Moal, M. (2005). Adult neurogenesis: from precursors to 
network and physiology. Physiol Rev, 85(2), 523-569. doi: 
10.1152/physrev.00055.2003 
 
Adkins, R. M., Thomas, F., Tylavsky, F. A., & Krushkal, J. (2011). Parental ages and 
levels of DNA methylation in the newborn are correlated. BMC Med Genet, 12, 
47. doi: 10.1186/1471-2350-12-47 
 
Adler Nevo, G., Meged, S., Sela, B. A., Hanoch-Levi, A., Hershko, R., & Weizman, A. 
(2006). Homocysteine levels in adolescent schizophrenia patients. Eur 
Neuropsychopharmacol, 16(8), 588-591. doi: 10.1016/j.euroneuro.2006.03.006 
 
Agim, Z. S., Esendal, M., Briollais, L., Uyan, O., Meschian, M., Martinez, L. A., . . . 
Ozcelik, H. (2013). Discovery, validation and characterization of Erbb4 and Nrg1 
haplotypes using data from three genome-wide association studies of 
schizophrenia. PLoS One, 8(1), e53042. doi: 10.1371/journal.pone.0053042 
 
Akbarian, S., Kim, J. J., Potkin, S. G., Hagman, J. O., Tafazzoli, A., Bunney, W. E., Jr., 
& Jones, E. G. (1995). Gene expression for glutamic acid decarboxylase is 
reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen 
Psychiatry, 52(4), 258-266.  
 
Aleman, A., Kahn, R. S., & Selten, J. P. (2003). Sex differences in the risk of 
schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry, 60(6), 565-
571. doi: 10.1001/archpsyc.60.6.565 
 
Alkelai, A., Lupoli, S., Greenbaum, L., Giegling, I., Kohn, Y., Sarner-Kanyas, K., . . . 
Lerer, B. (2011). Identification of new schizophrenia susceptibility loci in an 
ethnically homogeneous, family-based, Arab-Israeli sample. FASEB J, 25(11), 
4011-4023. doi: 10.1096/fj.11-184937 
 
Alkelai, A., Lupoli, S., Greenbaum, L., Kohn, Y., Kanyas-Sarner, K., Ben-Asher, E., . . . 
Lerer, B. (2012). DOCK4 and CEACAM21 as novel schizophrenia candidate 
genes in the Jewish population. Int J Neuropsychopharmacol, 15(4), 459-469. doi: 
10.1017/S1461145711000903 
 
Alter, M. D., Gilani, A. I., Champagne, F. A., Curley, J. P., Turner, J. B., & Hen, R. 
(2009). Paternal transmission of complex phenotypes in inbred mice. Biol 
Psychiatry, 66(11), 1061-1066. doi: S0006-3223(09)00646-5 [pii] 
	  133	  	  
10.1016/j.biopsych.2009.05.026 
 
Alvarez-Buylla, A., Kohwi, M., Nguyen, T. M., & Merkle, F. T. (2008). The 
heterogeneity of adult neural stem cells and the emerging complexity of their 
niche. Cold Spring Harb Symp Quant Biol, 73, 357-365. doi: 
10.1101/sqb.2008.73.019 
 
Alvarez-Buylla, A., & Lim, D. A. (2004). For the long run: maintaining germinal niches 
in the adult brain. Neuron, 41(5), 683-686.  
 
Amador, X. F., Kirkpatrick, B., Buchanan, R. W., Carpenter, W. T., Marcinko, L., & 
Yale, S. A. (1999). Stability of the diagnosis of deficit syndrome in schizophrenia. 
Am J Psychiatry, 156(4), 637-639.  
 
Amminger, G. P., Leicester, S., Yung, A. R., Phillips, L. J., Berger, G. E., Francey, S. M., 
. . . McGorry, P. D. (2006). Early-onset of symptoms predicts conversion to non-
affective psychosis in ultra-high risk individuals. Schizophr Res, 84(1), 67-76. 
doi: 10.1016/j.schres.2006.02.018 
 
Anderson, S. A., Marin, O., Horn, C., Jennings, K., & Rubenstein, J. L. (2001). Distinct 
cortical migrations from the medial and lateral ganglionic eminences. 
Development, 128(3), 353-363.  
 
Andreasen, N. C., Ehrhardt, J. C., Swayze, V. W., 2nd, Alliger, R. J., Yuh, W. T., Cohen, 
G., & Ziebell, S. (1990). Magnetic resonance imaging of the brain in 
schizophrenia. The pathophysiologic significance of structural abnormalities. 
Arch Gen Psychiatry, 47(1), 35-44.  
 
Anello, A., Reichenberg, A., Luo, X., Schmeidler, J., Hollander, E., Smith, C. J., . . . 
Silverman, J. M. (2009). Brief report: parental age and the sex ratio in autism. J 
Autism Dev Disord, 39(10), 1487-1492. doi: 10.1007/s10803-009-0755-y 
 
Angermeyer, M. C., & Kuhn, L. (1988). Gender differences in age at onset of 
schizophrenia. An overview. Eur Arch Psychiatry Neurol Sci, 237(6), 351-364.  
 
Anthony, T. E., Klein, C., Fishell, G., & Heintz, N. (2004). Radial glia serve as neuronal 
progenitors in all regions of the central nervous system. Neuron, 41(6), 881-890.  
 
Anton, E. S., Ghashghaei, H. T., Weber, J. L., McCann, C., Fischer, T. M., Cheung, I. D., 
. . . Lai, C. (2004). Receptor tyrosine kinase ErbB4 modulates neuroblast 
migration and placement in the adult forebrain. Nat Neurosci, 7(12), 1319-1328. 
doi: 10.1038/nn1345 
 
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005). Epigenetic 
transgenerational actions of endocrine disruptors and male fertility. Science, 
308(5727), 1466-1469. doi: 10.1126/science.1108190 
	  134	  	  
 
Appels, M. C., Sitskoorn, M. M., Westers, P., Lems, E., & Kahn, R. S. (2003). Cognitive 
dysfunctions in parents of schizophrenic patients parallel the deficits found in 
patients. Schizophr Res, 63(3), 285-293.  
 
Applebaum, J., Shimon, H., Sela, B. A., Belmaker, R. H., & Levine, J. (2004). 
Homocysteine levels in newly admitted schizophrenic patients. J Psychiatr Res, 
38(4), 413-416. doi: 10.1016/j.jpsychires.2004.01.003 
 
Arevian, A. C., Kapoor, V., & Urban, N. N. (2008). Activity-dependent gating of lateral 
inhibition in the mouse olfactory bulb. Nat Neurosci, 11(1), 80-87. doi: 
10.1038/nn2030 
 
Arruda, D., Publio, R., & Roque, A. C. (2013). The periglomerular cell of the olfactory 
bulb and its role in controlling mitral cell spiking: a computational model. PLoS 
One, 8(2), e56148. doi: 10.1371/journal.pone.0056148 
 
Athanasiu, L., Mattingsdal, M., Kahler, A. K., Brown, A., Gustafsson, O., Agartz, I., . . . 
Andreassen, O. A. (2010). Gene variants associated with schizophrenia in a 
Norwegian genome-wide study are replicated in a large European cohort. J 
Psychiatr Res, 44(12), 748-753. doi: 10.1016/j.jpsychires.2010.02.002 
 
Au, W. W., Treloar, H. B., & Greer, C. A. (2002). Sublaminar organization of the mouse 
olfactory bulb nerve layer. J Comp Neurol, 446(1), 68-80.  
 
Aungst, J. L., Heyward, P. M., Puche, A. C., Karnup, S. V., Hayar, A., Szabo, G., & 
Shipley, M. T. (2003). Centre-surround inhibition among olfactory bulb 
glomeruli. Nature, 426(6967), 623-629. doi: 10.1038/nature02185 
 
Auroux, M. (1983). Decrease of learning capacity in offspring with increasing paternal 
age in the rat. Teratology, 27(2), 141-148. doi: 10.1002/tera.1420270202 
 
Badner, J. A., & Gershon, E. S. (2002). Meta-analysis of whole-genome linkage scans of 
bipolar disorder and schizophrenia. Mol Psychiatry, 7(4), 405-411. doi: 
10.1038/sj.mp.4001012 
 
Baker, S. A., Baker, K. A., & Hagg, T. (2004). Dopaminergic nigrostriatal projections 
regulate neural precursor proliferation in the adult mouse subventricular zone. Eur 
J Neurosci, 20(2), 575-579. doi: 10.1111/j.1460-9568.2004.03486.x 
 
Bao, J., Lin, H., Ouyang, Y., Lei, D., Osman, A., Kim, T. W., . . . Ambron, R. T. (2004). 
Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. 
Nat Neurosci, 7(11), 1250-1258. doi: 10.1038/nn1342 
 
Bao, J., Wolpowitz, D., Role, L. W., & Talmage, D. A. (2003). Back signaling by the 
Nrg-1 intracellular domain. J Cell Biol, 161(6), 1133-1141. doi: 
	  135	  	  
10.1083/jcb.200212085 
 
Barta, P. E., Pearlson, G. D., Powers, R. E., Richards, S. S., & Tune, L. E. (1990). 
Auditory hallucinations and smaller superior temporal gyral volume in 
schizophrenia. Am J Psychiatry, 147(11), 1457-1462.  
 
Bath, K. G., Mandairon, N., Jing, D., Rajagopal, R., Kapoor, R., Chen, Z. Y., . . . Lee, F. 
S. (2008). Variant brain-derived neurotrophic factor (Val66Met) alters adult 
olfactory bulb neurogenesis and spontaneous olfactory discrimination. J Neurosci, 
28(10), 2383-2393. doi: 10.1523/JNEUROSCI.4387-07.2008 
 
Batista-Brito, R., Close, J., Machold, R., & Fishell, G. (2008). The distinct temporal 
origins of olfactory bulb interneuron subtypes. J Neurosci, 28(15), 3966-3975. 
doi: 10.1523/JNEUROSCI.5625-07.2008 
 
Belluscio, L., Lodovichi, C., Feinstein, P., Mombaerts, P., & Katz, L. C. (2002). Odorant 
receptors instruct functional circuitry in the mouse olfactory bulb. Nature, 
419(6904), 296-300. doi: 10.1038/nature01001 
 
Bergemann, N., Parzer, P., Nagl, I., Salbach, B., Runnebaum, B., Mundt, Ch, & Resch, F. 
(2002). Acute psychiatric admission and menstrual cycle phase in women with 
schizophrenia. Arch Womens Ment Health, 5(3), 119-126. doi: 10.1007/s00737-
002-0004-2 
 
Bergemann, N., Parzer, P., Runnebaum, B., Resch, F., & Mundt, C. (2007). Estrogen, 
menstrual cycle phases, and psychopathology in women suffering from 
schizophrenia. Psychol Med, 37(10), 1427-1436. doi: 
10.1017/S0033291707000578 
 
Berger, T. K., Silberberg, G., Perin, R., & Markram, H. (2010). Brief bursts self-inhibit 
and correlate the pyramidal network. PLoS Biol, 8(9). doi: 
10.1371/journal.pbio.1000473 
 
Bertram, L., Busch, R., Spiegl, M., Lautenschlager, N. T., Muller, U., & Kurz, A. (1998). 
Paternal age is a risk factor for Alzheimer disease in the absence of a major gene. 
Neurogenetics, 1(4), 277-280.  
 
Bjarnadottir, M., Misner, D. L., Haverfield-Gross, S., Bruun, S., Helgason, V. G., 
Stefansson, H., . . . Andresson, T. (2007). Neuregulin1 (Nrg1) signaling through 
Fyn modulates NMDA receptor phosphorylation: differential synaptic function in 
Nrg1+/- knock-outs compared with wild-type mice. J Neurosci, 27(17), 4519-
4529. doi: 10.1523/JNEUROSCI.4314-06.2007 
 
Boucher, A. A., Arnold, J. C., Duffy, L., Schofield, P. R., Micheau, J., & Karl, T. (2007). 
Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of 
Delta9-tetrahydrocannabinol. Psychopharmacology (Berl), 192(3), 325-336. doi: 
	  136	  	  
10.1007/s00213-007-0721-3 
 
Bourin, M., & Hascoet, M. (2003). The mouse light/dark box test. Eur J Pharmacol, 
463(1-3), 55-65.  
 
Bovetti, S., De Marchis, S., Gambarotta, G., Fasolo, A., Perroteau, I., Puche, A. C., & 
Bovolin, P. (2006). Differential expression of neuregulins and their receptors in 
the olfactory bulb layers of the developing mouse. Brain Res, 1077(1), 37-47. doi: 
10.1016/j.brainres.2006.01.034 
 
Bradley, E. A. (1984). Olfactory acuity to a pheromonal substance and psychotic illness. 
Biol Psychiatry, 19(6), 899-905.  
 
Braver, T. S., Cohen, J. D., Nystrom, L. E., Jonides, J., Smith, E. E., & Noll, D. C. 
(1997). A parametric study of prefrontal cortex involvement in human working 
memory. Neuroimage, 5(1), 49-62. doi: 10.1006/nimg.1996.0247 
 
Bray, I., Gunnell, D., & Davey Smith, G. (2006). Advanced paternal age: how old is too 
old? J Epidemiol Community Health, 60(10), 851-853. doi: 
10.1136/jech.2005.045179 
 
Breton-Provencher, V., Lemasson, M., Peralta, M. R., 3rd, & Saghatelyan, A. (2009). 
Interneurons produced in adulthood are required for the normal functioning of the 
olfactory bulb network and for the execution of selected olfactory behaviors. J 
Neurosci, 29(48), 15245-15257. doi: 10.1523/JNEUROSCI.3606-09.2009 
 
Brewer, W. J., Edwards, J., Anderson, V., Robinson, T., & Pantelis, C. (1996). 
Neuropsychological, olfactory, and hygiene deficits in men with negative 




Brewer, W. J., Wood, S. J., McGorry, P. D., Francey, S. M., Phillips, L. J., Yung, A. R., . 
. . Pantelis, C. (2003). Impairment of olfactory identification ability in individuals 
at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry, 
160(10), 1790-1794.  
 
Brill, M. S., Ninkovic, J., Winpenny, E., Hodge, R. D., Ozen, I., Yang, R., . . . Gotz, M. 
(2009). Adult generation of glutamatergic olfactory bulb interneurons. Nat 
Neurosci, 12(12), 1524-1533. doi: 10.1038/nn.2416 
 
Brill, M. S., Snapyan, M., Wohlfrom, H., Ninkovic, J., Jawerka, M., Mastick, G. S., . . . 
Gotz, M. (2008). A dlx2- and pax6-dependent transcriptional code for 
periglomerular neuron specification in the adult olfactory bulb. J Neurosci, 
28(25), 6439-6452. doi: 10.1523/JNEUROSCI.0700-08.2008 
 
	  137	  	  
Britsch, S. (2007). The neuregulin-I/ErbB signaling system in development and disease. 
Adv Anat Embryol Cell Biol, 190, 1-65.  
 
Britsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C., & 
Riethmacher, D. (1998). The ErbB2 and ErbB3 receptors and their ligand, 
neuregulin-1, are essential for development of the sympathetic nervous system. 
Genes Dev, 12(12), 1825-1836.  
 
Broadbelt, K., Byne, W., & Jones, L. B. (2002). Evidence for a decrease in basilar 
dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr 
Res, 58(1), 75-81.  
 
Brown, A. S., Bottiglieri, T., Schaefer, C. A., Quesenberry, C. P., Jr., Liu, L., Bresnahan, 
M., & Susser, E. S. (2007). Elevated prenatal homocysteine levels as a risk factor 
for schizophrenia. Arch Gen Psychiatry, 64(1), 31-39. doi: 
10.1001/archpsyc.64.1.31 
 
Brown, A. S., & Susser, E. S. (2008). Prenatal nutritional deficiency and risk of adult 
schizophrenia. Schizophr Bull, 34(6), 1054-1063. doi: 10.1093/schbul/sbn096 
 
Brune, G. G., & Himwich, H. E. (1962). Effects of methionine loading on the behavior of 
schizophrenic patients. J Nerv Ment Dis, 134, 447-450.  
 
Bublil, E. M., & Yarden, Y. (2007). The EGF receptor family: spearheading a merger of 
signaling and therapeutics. Curr Opin Cell Biol, 19(2), 124-134. doi: 
10.1016/j.ceb.2007.02.008 
 
Buchanan, R. W., & Carpenter, W. T., Jr. (1997). The neuroanatomies of schizophrenia. 
Schizophr Bull, 23(3), 367-372.  
 
Buchanan, R. W., Kirkpatrick, B., Heinrichs, D. W., & Carpenter, W. T., Jr. (1990). 
Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry, 
147(3), 290-294.  
 
Buchanan, R. W., Strauss, M. E., Kirkpatrick, B., Holstein, C., Breier, A., & Carpenter, 
W. T., Jr. (1994). Neuropsychological impairments in deficit vs nondeficit forms 
of schizophrenia. Arch Gen Psychiatry, 51(10), 804-811.  
 
Buchanan, R. W., Vladar, K., Barta, P. E., & Pearlson, G. D. (1998). Structural 
evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry, 155(8), 
1049-1055.  
 
Buck, L., & Axel, R. (1991). A novel multigene family may encode odorant receptors: a 
molecular basis for odor recognition. Cell, 65(1), 175-187.  
 
Buck, L. B. (2000). The molecular architecture of odor and pheromone sensing in 
	  138	  	  
mammals. Cell, 100(6), 611-618.  
 
Buonanno, A. (2010). The neuregulin signaling pathway and schizophrenia: from genes 
to synapses and neural circuits. Brain Res Bull, 83(3-4), 122-131. doi: 
10.1016/j.brainresbull.2010.07.012 
 
Buonanno, A., & Fischbach, G. D. (2001). Neuregulin and ErbB receptor signaling 
pathways in the nervous system. Curr Opin Neurobiol, 11(3), 287-296.  
 
Bush, W. S., & Moore, J. H. (2012). Chapter 11: Genome-wide association studies. PLoS 
Comput Biol, 8(12), e1002822. doi: 10.1371/journal.pcbi.1002822 
 
Caligioni, C. S. (2009). Assessing reproductive status/stages in mice. Curr Protoc 
Neurosci, Appendix 4, Appendix 4I. doi: 10.1002/0471142301.nsa04is48 
 
Callicott, J. H., Mattay, V. S., Bertolino, A., Finn, K., Coppola, R., Frank, J. A., . . . 
Weinberger, D. R. (1999). Physiological characteristics of capacity constraints in 
working memory as revealed by functional MRI. Cereb Cortex, 9(1), 20-26.  
 
Cannon, M., & Clarke, M. C. (2005). Risk for schizophrenia--broadening the concepts, 
pushing back the boundaries. Schizophr Res, 79(1), 5-13. doi: 
10.1016/j.schres.2005.05.027 
 
Cannon, T. D. (1996). Abnormalities of brain structure and function in schizophrenia: 
implications for aetiology and pathophysiology. Ann Med, 28(6), 533-539.  
 
Cannon, T. D., & Keller, M. C. (2006). Endophenotypes in the genetic analyses of mental 
disorders. Annu Rev Clin Psychol, 2, 267-290. doi: 
10.1146/annurev.clinpsy.2.022305.095232 
 
Cannon, T. D., Mednick, S. A., & Parnas, J. (1990). Antecedents of predominantly 
negative- and predominantly positive-symptom schizophrenia in a high-risk 
population. Arch Gen Psychiatry, 47(7), 622-632.  
 
Cannon, T. D., van Erp, T. G., Huttunen, M., Lonnqvist, J., Salonen, O., Valanne, L., . . . 
Yan, M. (1998). Regional gray matter, white matter, and cerebrospinal fluid 
distributions in schizophrenic patients, their siblings, and controls. Arch Gen 
Psychiatry, 55(12), 1084-1091.  
 
Cantor-Graae, E., & Selten, J. P. (2005). Schizophrenia and migration: a meta-analysis 
and review. Am J Psychiatry, 162(1), 12-24. doi: 10.1176/appi.ajp.162.1.12 
 
Carleton, A., Petreanu, L. T., Lansford, R., Alvarez-Buylla, A., & Lledo, P. M. (2003). 
Becoming a new neuron in the adult olfactory bulb. Nat Neurosci, 6(5), 507-518. 
doi: 10.1038/nn1048 
 
	  139	  	  
Caspi, A., & Moffitt, T. E. (2006). Gene-environment interactions in psychiatry: joining 
forces with neuroscience. Nat Rev Neurosci, 7(7), 583-590. doi: 10.1038/nrn1925 
 
Ceschin, D. G., Walia, M., Wenk, S. S., Duboe, C., Gaudon, C., Xiao, Y., . . . 
Gronemeyer, H. (2011). Methylation specifies distinct estrogen-induced binding 
site repertoires of CBP to chromatin. Genes Dev, 25(11), 1132-1146. doi: 
10.1101/gad.619211 
 
Chalansonnet, M., & Chaput, M. A. (1998). Olfactory bulb output cell temporal response 
patterns to increasing odor concentrations in freely breathing rats. Chem Senses, 
23(1), 1-9.  
 
Champagne, F. A. (2008). Epigenetic mechanisms and the transgenerational effects of 
maternal care. Front Neuroendocrinol, 29(3), 386-397. doi: 
10.1016/j.yfrne.2008.03.003 
 
Chaves, A. C., Seeman, M. V., Mari, J. J., & Maluf, A. (1993). Schizophrenia: impact of 
positive symptoms on gender social role. Schizophr Res, 11(1), 41-45.  
 
Chen, J., Lee, G., Fanous, A. H., Zhao, Z., Jia, P., O'Neill, A., . . . International 
Schizophrenia, Consortium. (2011). Two non-synonymous markers in PTPN21, 
identified by genome-wide association study data-mining and replication, are 
associated with schizophrenia. Schizophr Res, 131(1-3), 43-51. doi: 
10.1016/j.schres.2011.06.023 
 
Chen, Y. J., Johnson, M. A., Lieberman, M. D., Goodchild, R. E., Schobel, S., 
Lewandowski, N., . . . Role, L. W. (2008). Type III neuregulin-1 is required for 
normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit 
components. J Neurosci, 28(27), 6872-6883. doi: 28/27/6872 [pii] 
10.1523/JNEUROSCI.1815-08.2008 
 
Chess, A., Simon, I., Cedar, H., & Axel, R. (1994). Allelic inactivation regulates 
olfactory receptor gene expression. Cell, 78(5), 823-834.  
 
Childers, S. E., & Harding, C. M. (1990). Gender, premorbid social functioning, and 
long-term outcome in DSM-III schizophrenia. Schizophr Bull, 16(2), 309-318. 
  
Chong, S., Vickaryous, N., Ashe, A., Zamudio, N., Youngson, N., Hemley, S., . . . 
Whitelaw, E. (2007). Modifiers of epigenetic reprogramming show paternal 
effects in the mouse. Nat Genet, 39(5), 614-622. doi: ng2031 [pii] 
10.1038/ng2031 
 
Chong, V. Z., Thompson, M., Beltaifa, S., Webster, M. J., Law, A. J., & Weickert, C. S. 
(2008). Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of 
schizophrenic patients. Schizophr Res, 100(1-3), 270-280. doi: 
10.1016/j.schres.2007.12.474 
	  140	  	  
 
Christie, J. M., & Westbrook, G. L. (2003). Regulation of backpropagating action 
potentials in mitral cell lateral dendrites by A-type potassium currents. J 
Neurophysiol, 89(5), 2466-2472. doi: 10.1152/jn.00997.2002 
 
Cleland, T. A., Johnson, B. A., Leon, M., & Linster, C. (2007). Relational representation 
in the olfactory system. Proc Natl Acad Sci U S A, 104(6), 1953-1958. doi: 
10.1073/pnas.0608564104 
 
Cleland, T. A., & Sethupathy, P. (2006). Non-topographical contrast enhancement in the 
olfactory bulb. BMC Neurosci, 7, 7. doi: 10.1186/1471-2202-7-7 
 
Cohen, J. D., Perlstein, W. M., Braver, T. S., Nystrom, L. E., Noll, D. C., Jonides, J., & 
Smith, E. E. (1997). Temporal dynamics of brain activation during a working 
memory task. Nature, 386(6625), 604-608. doi: 10.1038/386604a0 
 
Cohen, R. Z., Seeman, M. V., Gotowiec, A., & Kopala, L. (1999). Earlier puberty as a 
predictor of later onset of schizophrenia in women. Am J Psychiatry, 156(7), 
1059-1064.  
 
Corbett, R., Camacho, F., Woods, A. T., Kerman, L. L., Fishkin, R. J., Brooks, K., & 
Dunn, R. W. (1995). Antipsychotic agents antagonize non-competitive N-methyl-
D-aspartate antagonist-induced behaviors. Psychopharmacology (Berl), 120(1), 
67-74.  
 
Corbin, J. G., Gaiano, N., Machold, R. P., Langston, A., & Fishell, G. (2000). The Gsh2 
homeodomain gene controls multiple aspects of telencephalic development. 
Development, 127(23), 5007-5020.  
 
Corcoran, C., Whitaker, A., Coleman, E., Fried, J., Feldman, J., Goudsmit, N., & 
Malaspina, D. (2005). Olfactory deficits, cognition and negative symptoms in 




Corfas, G., Roy, K., & Buxbaum, J. D. (2004). Neuregulin 1-erbB signaling and the 
molecular/cellular basis of schizophrenia. Nat Neurosci, 7(6), 575-580. doi: 
10.1038/nn1258 
 
Corvin, A. P., Morris, D. W., McGhee, K., Schwaiger, S., Scully, P., Quinn, J., . . . Gill, 
M. (2004). Confirmation and refinement of an 'at-risk' haplotype for 
schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility 




	  141	  	  
Cosway, R., Byrne, M., Clafferty, R., Hodges, A., Grant, E., Abukmeil, S. S., . . . 
Johnstone, E. C. (2000). Neuropsychological change in young people at high risk 
for schizophrenia: results from the first two neuropsychological assessments of 
the Edinburgh High Risk Study. Psychol Med, 30(5), 1111-1121.  
 
Courtney, S. M., Ungerleider, L. G., Keil, K., & Haxby, J. V. (1997). Transient and 
sustained activity in a distributed neural system for human working memory. 
Nature, 386(6625), 608-611. doi: 10.1038/386608a0 
 
Coyle, J. T. (1996). The glutamatergic dysfunction hypothesis for schizophrenia. Harv 
Rev Psychiatry, 3(5), 241-253.  
 
Crawley, J., & Goodwin, F. K. (1980). Preliminary report of a simple animal behavior 
model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav, 
13(2), 167-170.  
 
Crespo, C., Blasco-Ibanez, J. M., Marques-Mari, A. I., & Martinez-Guijarro, F. J. (2001). 
Parvalbumin-containing interneurons do not innervate granule cells in the 
olfactory bulb. Neuroreport, 12(11), 2553-2556.  
 
Croen, L. A., Najjar, D. V., Fireman, B., & Grether, J. K. (2007). Maternal and paternal 
age and risk of autism spectrum disorders. Arch Pediatr Adolesc Med, 161(4), 
334-340. doi: 161/4/334 [pii] 
10.1001/archpedi.161.4.334 
 
Crow, J. F. (1997). The high spontaneous mutation rate: is it a health risk? Proc Natl 
Acad Sci U S A, 94(16), 8380-8386.  
 
Crow, J. F. (2000a). A new study challenges the current belief of a high human 
male:female mutation ratio. Trends Genet, 16(12), 525-526.  
 
Crow, J. F. (2000b). The origins, patterns and implications of human spontaneous 
mutation. Nat Rev Genet, 1(1), 40-47. doi: 10.1038/35049558 
 
Dalman, C. (2009). Advanced paternal age increases risk of bipolar disorder in offspring. 
Evid Based Ment Health, 12(2), 59. doi: 12/2/59 [pii] 
10.1136/ebmh.12.2.59 
 
Davison, A. P., Feng, J., & Brown, D. (2003). Dendrodendritic inhibition and simulated 
odor responses in a detailed olfactory bulb network model. J Neurophysiol, 90(3), 
1921-1935. doi: 10.1152/jn.00623.2002 
 
De Marchis, S., Bovetti, S., Carletti, B., Hsieh, Y. C., Garzotto, D., Peretto, P., . . . Rossi, 
F. (2007). Generation of distinct types of periglomerular olfactory bulb 
interneurons during development and in adult mice: implication for intrinsic 
properties of the subventricular zone progenitor population. J Neurosci, 27(3), 
	  142	  	  
657-664. doi: 10.1523/JNEUROSCI.2870-06.2007 
 
Debarbieux, F., Audinat, E., & Charpak, S. (2003). Action potential propagation in 
dendrites of rat mitral cells in vivo. J Neurosci, 23(13), 5553-5560.  
 
Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006). The quantification of 
COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, 
methylation and expression. BMC Med Genet, 7, 10. doi: 10.1186/1471-2350-7-
10 
 
Dempster, E. L., Pidsley, R., Schalkwyk, L. C., Owens, S., Georgiades, A., Kane, F., . . . 
Mill, J. (2011). Disease-associated epigenetic changes in monozygotic twins 
discordant for schizophrenia and bipolar disorder. Hum Mol Genet, 20(24), 4786-
4796. doi: 10.1093/hmg/ddr416 
 
Di Cristo, G. (2007). Development of cortical GABAergic circuits and its implications 
for neurodevelopmental disorders. Clin Genet, 72(1), 1-8. doi: 10.1111/j.1399-
0004.2007.00822.x 
 
Di Cristo, G., Pizzorusso, T., Cancedda, L., & Sernagor, E. (2011). GABAergic circuit 
development and its implication for CNS disorders. Neural Plast, 2011, 623705. 
doi: 10.1155/2011/623705 
 
Diaz-Veliz, G., Soto, V., Dussaubat, N., & Mora, S. (1989). Influence of the estrous 
cycle, ovariectomy and estradiol replacement upon the acquisition of conditioned 
avoidance responses in rats. Physiol Behav, 46(3), 397-401.  
 
Diaz-Veliz, G., Urresta, F., Dussaubat, N., & Mora, S. (1991). Effects of estradiol 
replacement in ovariectomized rats on conditioned avoidance responses and other 
behaviors. Physiol Behav, 50(1), 61-65.  
 
Diwadkar, V. A., Montrose, D. M., Dworakowski, D., Sweeney, J. A., & Keshavan, M. 
S. (2006). Genetically predisposed offspring with schizotypal features: an ultra 
high-risk group for schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry, 
30(2), 230-238. doi: 10.1016/j.pnpbp.2005.10.019 
 
Doetsch, F., & Alvarez-Buylla, A. (1996). Network of tangential pathways for neuronal 
migration in adult mammalian brain. Proc Natl Acad Sci U S A, 93(25), 14895-
14900.  
 
Doetsch, F., Caille, I., Lim, D. A., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1999). 
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. 
Cell, 97(6), 703-716.  
 
Doherty, J. L., O'Donovan, M. C., & Owen, M. J. (2012). Recent genomic advances in 
schizophrenia. Clin Genet, 81(2), 103-109. doi: 10.1111/j.1399-
	  143	  	  
0004.2011.01773.x 
 
Dolinoy, D. C., Weidman, J. R., & Jirtle, R. L. (2007). Epigenetic gene regulation: 
linking early developmental environment to adult disease. Reprod Toxicol, 23(3), 
297-307. doi: 10.1016/j.reprotox.2006.08.012 
 
Dong, E., Agis-Balboa, R. C., Simonini, M. V., Grayson, D. R., Costa, E., & Guidotti, A. 
(2005). Reelin and glutamic acid decarboxylase67 promoter remodeling in an 
epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad 
Sci U S A, 102(35), 12578-12583. doi: 10.1073/pnas.0505394102 
 
Doop, M. L., & Park, S. (2006). On knowing and judging smells: identification and 
hedonic judgment of odors in schizophrenia. Schizophr Res, 81(2-3), 317-319. 
doi: S0920-9964(05)00363-4 [pii] 
10.1016/j.schres.2005.08.006 
 
Doucette, J. R. (1984). The glial cells in the nerve fiber layer of the rat olfactory bulb. 
Anat Rec, 210(2), 385-391. doi: 10.1002/ar.1092100214 
 
Dreifuss, J. J., Kelly, J. S., & Krnjevic, K. (1969). Cortical inhibition and gamma-
aminobutyric acid. Exp Brain Res, 9(2), 137-154.  
 
Duan, J., Sanders, A. R., & Gejman, P. V. (2010). Genome-wide approaches to 
schizophrenia. Brain Res Bull, 83(3-4), 93-102. doi: 
10.1016/j.brainresbull.2010.04.009 
 
Duffy, L., Cappas, E., Scimone, A., Schofield, P. R., & Karl, T. (2008). Behavioral 
profile of a heterozygous mutant mouse model for EGF-like domain neuregulin 1. 
Behav Neurosci, 122(4), 748-759. doi: 10.1037/0735-7044.122.4.748 
 
Duncan, G. E., Zorn, S., & Lieberman, J. A. (1999). Mechanisms of typical and atypical 
antipsychotic drug action in relation to dopamine and NMDA receptor 
hypofunction hypotheses of schizophrenia. Mol Psychiatry, 4(5), 418-428.  
 
Dunn, T. P., & Weller, M. P. (1989). Olfaction in schizophrenia. Percept Mot Skills, 69(3 
Pt 1), 833-834.  
 
Emamian, E. S. (2012). AKT/GSK3 signaling pathway and schizophrenia. Front Mol 
Neurosci, 5, 33. doi: 10.3389/fnmol.2012.00033 
 
Emsley, J. G., Mitchell, B. D., Kempermann, G., & Macklis, J. D. (2005). Adult 
neurogenesis and repair of the adult CNS with neural progenitors, precursors, and 
stem cells. Prog Neurobiol, 75(5), 321-341. doi: 10.1016/j.pneurobio.2005.04.002 
 
Eom, T. Y., Li, J., & Anton, E. S. (2010). Going tubular in the rostral migratory stream: 
neurons remodel astrocyte tubes to promote directional migration in the adult 
	  144	  	  
brain. Neuron, 67(2), 173-175. doi: 10.1016/j.neuron.2010.07.013 
 
Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res, 
284(1), 14-30.  
 
Faludi, G., & Mirnics, K. (2011). Synaptic changes in the brain of subjects with 
schizophrenia. Int J Dev Neurosci, 29(3), 305-309. doi: 
10.1016/j.ijdevneu.2011.02.013 
 
Fan, Y., Gur, R. E., Gur, R. C., Wu, X., Shen, D., Calkins, M. E., & Davatzikos, C. 
(2008). Unaffected family members and schizophrenia patients share brain 
structure patterns: a high-dimensional pattern classification study. Biol 
Psychiatry, 63(1), 118-124. doi: 10.1016/j.biopsych.2007.03.015 
 
Faraone, S. V., Seidman, L. J., Kremen, W. S., Pepple, J. R., Lyons, M. J., & Tsuang, M. 
T. (1995). Neuropsychological functioning among the nonpsychotic relatives of 
schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol, 
104(2), 286-304.  
 
Feinberg, I. (1982). Schizophrenia: caused by a fault in programmed synaptic elimination 
during adolescence? J Psychiatr Res, 17(4), 319-334.  
 
Felthous, A. R., Robinson, D. B., & Conroy, R. W. (1980). Prevention of recurrent 
menstrual psychosis by an oral contraceptive. Am J Psychiatry, 137(2), 245-246.  
 
Feng, J., & Fan, G. (2009). The role of DNA methylation in the central nervous system 
and neuropsychiatric disorders. Int Rev Neurobiol, 89, 67-84. doi: 10.1016/S0074-
7742(09)89004-1 
 
Firestein, S. (2001). How the olfactory system makes sense of scents. Nature, 413(6852), 
211-218. doi: 10.1038/35093026 
 
Flames, N., Long, J. E., Garratt, A. N., Fischer, T. M., Gassmann, M., Birchmeier, C., . . . 
Marin, O. (2004). Short- and long-range attraction of cortical GABAergic 
interneurons by neuregulin-1. Neuron, 44(2), 251-261. doi: 
10.1016/j.neuron.2004.09.028 
 
Flames, N., & Marin, O. (2005). Developmental mechanisms underlying the generation 
of cortical interneuron diversity. Neuron, 46(3), 377-381. doi: 
10.1016/j.neuron.2005.04.020 
 
Flanagan, J. M., Popendikyte, V., Pozdniakovaite, N., Sobolev, M., Assadzadeh, A., 
Schumacher, A., . . . Petronis, A. (2006). Intra- and interindividual epigenetic 
variation in human germ cells. Am J Hum Genet, 79(1), 67-84. doi: 
10.1086/504729 
 
	  145	  	  
Foldi, C. J., Eyles, D. W., McGrath, J. J., & Burne, T. H. (2010). Advanced paternal age 
is associated with alterations in discrete behavioural domains and cortical 
neuroanatomy of C57BL/6J mice. Eur J Neurosci, 31(3), 556-564. doi: 
10.1111/j.1460-9568.2010.07074.x 
 
Fonnum, F., & Storm-Mathisen, J. (1969). GABA synthesis in rat hippocampus 
correlated to the distribution of inhibitory neurons. Acta Physiol Scand, 76(1), 
35A-36A.  
 
Frans, E. M., Sandin, S., Reichenberg, A., Lichtenstein, P., Langstrom, N., & Hultman, 
C. M. (2008). Advancing paternal age and bipolar disorder. Arch Gen Psychiatry, 
65(9), 1034-1040. doi: 65/9/1034 [pii] 
10.1001/archpsyc.65.9.1034 
 
Freundlieb, N., Francois, C., Tande, D., Oertel, W. H., Hirsch, E. C., & Hoglinger, G. U. 
(2006). Dopaminergic substantia nigra neurons project topographically organized 
to the subventricular zone and stimulate precursor cell proliferation in aged 
primates. J Neurosci, 26(8), 2321-2325. doi: 10.1523/JNEUROSCI.4859-05.2006 
 
Friedrich, R. W., & Korsching, S. I. (1997). Combinatorial and chemotopic odorant 
coding in the zebrafish olfactory bulb visualized by optical imaging. Neuron, 
18(5), 737-752.  
 
Fu, A. K., Fu, W. Y., Cheung, J., Tsim, K. W., Ip, F. C., Wang, J. H., & Ip, N. Y. (2001). 
Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular 
junction. Nat Neurosci, 4(4), 374-381. doi: 10.1038/86019 
 
Gainetdinov, R. R., Mohn, A. R., & Caron, M. G. (2001). Genetic animal models: focus 
on schizophrenia. Trends Neurosci, 24(9), 527-533.  
 
Gallicano, G. I., Yousef, M. C., & Capco, D. G. (1997). PKC--a pivotal regulator of early 
development. Bioessays, 19(1), 29-36. doi: 10.1002/bies.950190107 
 
Garcia-Palomares, S., Pertusa, J. F., Minarro, J., Garcia-Perez, M. A., Hermenegildo, C., 
Rausell, F., . . . Tarin, J. J. (2009). Long-term effects of delayed fatherhood in 
mice on postnatal development and behavioral traits of offspring. Biol Reprod, 
80(2), 337-342. doi: 10.1095/biolreprod.108.072066 
 
 
Garey, L. (2010). When cortical development goes wrong: schizophrenia as a 
neurodevelopmental disease of microcircuits. J Anat, 217(4), 324-333. doi: 
10.1111/j.1469-7580.2010.01231.x 
 
Gavrilov, L. A., Gavrilova, N. S., Kroutko, V. N., Evdokushkina, G. N., Semyonova, V. 
G., Gavrilova, A. L., . . . Kushnareva, Y. E. (1997). Mutation load and human 
longevity. Mutat Res, 377(1), 61-62. doi: S0027-5107(97)00058-4 [pii] 
	  146	  	  
 
Geddes, J., Huws, R., & Pratt, P. (1991). Olfactory acuity in the positive and negative 
syndromes of schizophrenia. Biol Psychiatry, 29(8), 774-778. doi: 0006-
3223(91)90196-S [pii] 
 
Gejman, P. V., Sanders, A. R., & Kendler, K. S. (2011). Genetics of schizophrenia: new 
findings and challenges. Annu Rev Genomics Hum Genet, 12, 121-144. doi: 
10.1146/annurev-genom-082410-101459 
 
Genomes Project, Consortium, Abecasis, G. R., Altshuler, D., Auton, A., Brooks, L. D., 
Durbin, R. M., . . . McVean, G. A. (2010). A map of human genome variation 
from population-scale sequencing. Nature, 467(7319), 1061-1073. doi: 
10.1038/nature09534 
 
Gerlai, R., Pisacane, P., & Erickson, S. (2000). Heregulin, but not ErbB2 or ErbB3, 
heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. 
Behav Brain Res, 109(2), 219-227.  
 
Geyer, M. A., Swerdlow, N. R., Mansbach, R. S., & Braff, D. L. (1990). Startle response 
models of sensorimotor gating and habituation deficits in schizophrenia. Brain 
Res Bull, 25(3), 485-498. doi: 0361-9230(90)90241-Q [pii] 
 
Ghashghaei, H. T., Weber, J., Pevny, L., Schmid, R., Schwab, M. H., Lloyd, K. C., . . . 
Anton, E. S. (2006). The role of neuregulin-ErbB4 interactions on the 
proliferation and organization of cells in the subventricular zone. Proc Natl Acad 
Sci U S A, 103(6), 1930-1935. doi: 10.1073/pnas.0510410103 
 
Gheusi, G., Cremer, H., McLean, H., Chazal, G., Vincent, J. D., & Lledo, P. M. (2000). 
Importance of newly generated neurons in the adult olfactory bulb for odor 
discrimination. Proc Natl Acad Sci U S A, 97(4), 1823-1828.  
 
Giakoumaki, S. G., Roussos, P., Rogdaki, M., Karli, C., Bitsios, P., & Frangou, S. 
(2007). Evidence of disrupted prepulse inhibition in unaffected siblings of bipolar 




Gibbs, R. B., Burke, A. M., & Johnson, D. A. (1998). Estrogen replacement attenuates 
effects of scopolamine and lorazepam on memory acquisition and retention. Horm 
Behav, 34(2), 112-125. doi: 10.1006/hbeh.1998.1452 
 
Gire, D. H., & Schoppa, N. E. (2009). Control of on/off glomerular signaling by a local 
GABAergic microcircuit in the olfactory bulb. J Neurosci, 29(43), 13454-13464. 
doi: 10.1523/JNEUROSCI.2368-09.2009 
 
Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal 
	  147	  	  
cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry, 57(1), 65-73.  
 
Goldstein, J. M., Cohen, L. S., Horton, N. J., Lee, H., Andersen, S., Tohen, M., . . . 
Tollefson, G. (2002). Sex differences in clinical response to olanzapine compared 
with haloperidol. Psychiatry Res, 110(1), 27-37.  
 
Goldstein, J. M., Seidman, L. J., O'Brien, L. M., Horton, N. J., Kennedy, D. N., Makris, 
N., . . . Tsuang, M. T. (2002). Impact of normal sexual dimorphisms on sex 
differences in structural brain abnormalities in schizophrenia assessed by 
magnetic resonance imaging. Arch Gen Psychiatry, 59(2), 154-164.  
 
Good, K. P., Tibbo, P., Milliken, H., Whitehorn, D., Alexiadis, M., Robertson, N., & 
Kopala, L. C. (2010). An investigation of a possible relationship between 
olfactory identification deficits at first episode and four-year outcomes in patients 




Good, K. P., Whitehorn, D., Rui, Q., Milliken, H., & Kopala, L. C. (2006). Olfactory 
identification deficits in first-episode psychosis may predict patients at risk for 
persistent negative and disorganized or cognitive symptoms. Am J Psychiatry, 
163(5), 932-933. doi: 163/5/932 [pii] 
10.1176/appi.ajp.163.5.932 
 
Goriely, A., McGrath, J. J., Hultman, C. M., Wilkie, A. O., & Malaspina, D. (2013). 
"Selfish spermatogonial selection": a novel mechanism for the association 
between advanced paternal age and neurodevelopmental disorders. Am J 
Psychiatry, 170(6), 599-608. doi: 10.1176/appi.ajp.2013.12101352 
 
Goriely, A., & Wilkie, A. O. (2012). Paternal age effect mutations and selfish 
spermatogonial selection: causes and consequences for human disease. Am J Hum 
Genet, 90(2), 175-200. doi: 10.1016/j.ajhg.2011.12.017 
 
Gottesman, II, & Bertelsen, A. (1989). Confirming unexpressed genotypes for 
schizophrenia. Risks in the offspring of Fischer's Danish identical and fraternal 
discordant twins. Arch Gen Psychiatry, 46(10), 867-872.  
 
Gottesman, II, & Erlenmeyer-Kimling, L. (2001). Family and twin strategies as a head 
start in defining prodromes and endophenotypes for hypothetical early-
interventions in schizophrenia. Schizophr Res, 51(1), 93-102.  
 
Gottesman, II, & Gould, T. D. (2003). The endophenotype concept in psychiatry: 
etymology and strategic intentions. Am J Psychiatry, 160(4), 636-645.  
 
Gottesman, II, & Shields, J. (1973). Genetic theorizing and schizophrenia. Br J 
Psychiatry, 122(566), 15-30.  
	  148	  	  
 
Graziadei, P. P., & Graziadei, G. A. (1979). Neurogenesis and neuron regeneration in the 
olfactory system of mammals. I. Morphological aspects of differentiation and 
structural organization of the olfactory sensory neurons. J Neurocytol, 8(1), 1-18.  
 
Green, M. F., Bracha, H. S., Satz, P., & Christenson, C. D. (1994). Preliminary evidence 
for an association between minor physical anomalies and second trimester 
neurodevelopment in schizophrenia. Psychiatry Res, 53(2), 119-127.  
 
Green, W., Patil, P., Marsden, C. A., Bennett, G. W., & Wigmore, P. M. (2006). 
Treatment with olanzapine increases cell proliferation in the subventricular zone 




Greer, C. A. (1987). Golgi analyses of dendritic organization among denervated olfactory 
bulb granule cells. J Comp Neurol, 257(3), 442-452. doi: 10.1002/cne.902570311 
 
Gregg, C., Zhang, J., Weissbourd, B., Luo, S., Schroth, G. P., Haig, D., & Dulac, C. 
(2010). High-resolution analysis of parent-of-origin allelic expression in the 
mouse brain. Science, 329(5992), 643-648. doi: 10.1126/science.1190830 
 
Grove, W. M., Lebow, B. S., Clementz, B. A., Cerri, A., Medus, C., & Iacono, W. G. 
(1991). Familial prevalence and coaggregation of schizotypy indicators: a 
multitrait family study. J Abnorm Psychol, 100(2), 115-121.  
 
Gualtieri, C. T., Adams, A., Shen, C. D., & Loiselle, D. (1982). Minor physical 
anomalies in alcoholic and schizophrenic adults and hyperactive and autistic 
children. Am J Psychiatry, 139(5), 640-643.  
 
Guidotti, A., Ruzicka, W., Grayson, D. R., Veldic, M., Pinna, G., Davis, J. M., & Costa, 
E. (2007). S-adenosyl methionine and DNA methyltransferase-1 mRNA 
overexpression in psychosis. Neuroreport, 18(1), 57-60. doi: 
10.1097/WNR.0b013e32800fefd7 
 
Gur, R. E., Cowell, P. E., Latshaw, A., Turetsky, B. I., Grossman, R. I., Arnold, S. E., . . . 
Gur, R. C. (2000). Reduced dorsal and orbital prefrontal gray matter volumes in 
schizophrenia. Arch Gen Psychiatry, 57(8), 761-768.  
 
Gur, R. E., Kohler, C., Turetsky, B. I., Siegel, S. J., Kanes, S. J., Bilker, W. B., . . . Gur, 
R. C. (2004). A sexually dimorphic ratio of orbitofrontal to amygdala volume is 
altered in schizophrenia. Biol Psychiatry, 55(5), 512-517. doi: 
10.1016/j.biopsych.2003.10.009 
 
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L., 3rd. (1994). 
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. 
	  149	  	  
Proc Natl Acad Sci U S A, 91(17), 8132-8136.  
 
Hafner, H., Behrens, S., De Vry, J., & Gattaz, W. F. (1991). Oestradiol enhances the 
vulnerability threshold for schizophrenia in women by an early effect on 
dopaminergic neurotransmission. Evidence from an epidemiological study and 
from animal experiments. Eur Arch Psychiatry Clin Neurosci, 241(1), 65-68.  
 
Hafner, H., Maurer, K., Loffler, W., & Riecher-Rossler, A. (1993). The influence of age 
and sex on the onset and early course of schizophrenia. Br J Psychiatry, 162, 80-
86.  
 
Hafner, H., Riecher-Rossler, A., An Der Heiden, W., Maurer, K., Fatkenheuer, B., & 
Loffler, W. (1993). Generating and testing a causal explanation of the gender 
difference in age at first onset of schizophrenia. Psychol Med, 23(4), 925-940.  
 
Hahn, C. G., Wang, H. Y., Cho, D. S., Talbot, K., Gur, R. E., Berrettini, W. H., . . . 
Arnold, S. E. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA 
receptor hypofunction in schizophrenia. Nat Med, 12(7), 824-828. doi: 
10.1038/nm1418 
 
Haidemenos, A., Kontis, D., Gazi, A., Kallai, E., Allin, M., & Lucia, B. (2007). Plasma 
homocysteine, folate and B12 in chronic schizophrenia. Prog 
Neuropsychopharmacol Biol Psychiatry, 31(6), 1289-1296. doi: 
10.1016/j.pnpbp.2007.05.011 
 
Halim, N. D., Weickert, C. S., McClintock, B. W., Weinberger, D. R., & Lipska, B. K. 
(2004). Effects of chronic haloperidol and clozapine treatment on neurogenesis in 
the adult rat hippocampus. Neuropsychopharmacology, 29(6), 1063-1069. doi: 
10.1038/sj.npp.1300422 
 
Hall, D., Gogos, J. A., & Karayiorgou, M. (2004). The contribution of three strong 
candidate schizophrenia susceptibility genes in demographically distinct 
populations. Genes Brain Behav, 3(4), 240-248. doi: 10.1111/j.1601-
183X.2004.00078.x 
 
Hallonquist, J. D., Seeman, M. V., Lang, M., & Rector, N. A. (1993). Variation in 
symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry, 
33(3), 207-209.  
 
Hardy, J., & Singleton, A. (2009). Genomewide association studies and human disease. N 
Engl J Med, 360(17), 1759-1768. doi: 10.1056/NEJMra0808700 
 
Harrison, P. J., & Law, A. J. (2006). Neuregulin 1 and schizophrenia: genetics, gene 
expression, and neurobiology. Biol Psychiatry, 60(2), 132-140. doi: 
10.1016/j.biopsych.2005.11.002 
 
	  150	  	  
Harrison, T. A., & Scott, J. W. (1986). Olfactory bulb responses to odor stimulation: 
analysis of response pattern and intensity relationships. J Neurophysiol, 56(6), 
1571-1589.  
 
Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., & 
Weinberger, D. R. (2004). Expression analysis of neuregulin-1 in the dorsolateral 
prefrontal cortex in schizophrenia. Mol Psychiatry, 9(3), 299-307. doi: 
10.1038/sj.mp.4001434 
 
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., . . . Lewis, 
D. A. (2003). Gene expression deficits in a subclass of GABA neurons in the 
prefrontal cortex of subjects with schizophrenia. J Neurosci, 23(15), 6315-6326.  
 
Hehir-Kwa, J. Y., Rodriguez-Santiago, B., Vissers, L. E., de Leeuw, N., Pfundt, R., 
Buitelaar, J. K., . . . Veltman, J. A. (2011). De novo copy number variants 
associated with intellectual disability have a paternal origin and age bias. J Med 
Genet, 48(11), 776-778. doi: 10.1136/jmedgenet-2011-100147 
 
Henquet, C., Di Forti, M., Morrison, P., Kuepper, R., & Murray, R. M. (2008). Gene-
environment interplay between cannabis and psychosis. Schizophr Bull, 34(6), 
1111-1121. doi: 10.1093/schbul/sbn108 
 
Heston, L. L. (1966). Psychiatric disorders in foster home reared children of 
schizophrenic mothers. Br J Psychiatry, 112(489), 819-825.  
 
Higgins, J. (1976). Effects of child rearing by schizophrenic mothers: a follow-up. J 
Psychiatr Res, 13(1), 1-9.  
 
Hoglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., & 
Hirsch, E. C. (2004). Dopamine depletion impairs precursor cell proliferation in 
Parkinson disease. Nat Neurosci, 7(7), 726-735. doi: 10.1038/nn1265 
 
Hong, C. J., Huo, S. J., Liao, D. L., Lee, K., Wu, J. Y., & Tsai, S. J. (2004). Case-control 
and family-based association studies between the neuregulin 1 (Arg38Gln) 
polymorphism and schizophrenia. Neurosci Lett, 366(2), 158-161. doi: 
10.1016/j.neulet.2004.05.027 
 
Hosak, L., Silhan, P., & Hosakova, J. (2012). Genome-wide association studies in 
schizophrenia, and potential etiological and functional implications of their  
results. Acta Medica (Hradec Kralove), 55(1), 3-11.  
 
Houlihan, D. J., Flaum, M., Arnold, S. E., Keshavan, M., & Alliger, R. (1994). Further 
evidence for olfactory identification deficits in schizophrenia. Schizophr Res, 
12(2), 179-182. doi: 0920-9964(94)90075-2 [pii] 
 
Howes, O. D., McDonald, C., Cannon, M., Arseneault, L., Boydell, J., & Murray, R. M. 
	  151	  	  
(2004). Pathways to schizophrenia: the impact of environmental factors. Int J 
Neuropsychopharmacol, 7 Suppl 1, S7-S13. doi: 10.1017/S1461145704004122 
 
Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., & Yan, R. (2006). 
Bace1 modulates myelination in the central and peripheral nervous system. Nat 
Neurosci, 9(12), 1520-1525. doi: 10.1038/nn1797 
 
Hua, J. Y., & Smith, S. J. (2004). Neural activity and the dynamics of central nervous 
system development. Nat Neurosci, 7(4), 327-332. doi: 10.1038/nn1218 
 
Huang, Z. (2009). Molecular regulation of neuronal migration during neocortical 
development. Mol Cell Neurosci, 42(1), 11-22. doi: 10.1016/j.mcn.2009.06.003 
 
Hughes, Z. A., Liu, F., Marquis, K., Muniz, L., Pangalos, M. N., Ring, R. H., . . . 
Brandon, N. J. (2009). Estrogen receptor neurobiology and its potential for 
translation into broad spectrum therapeutics for CNS disorders. Curr Mol 
Pharmacol, 2(3), 215-236.  
 
Hurwitz, T., Kopala, L., Clark, C., & Jones, B. (1988). Olfactory deficits in 
schizophrenia. Biol Psychiatry, 23(2), 123-128.  
 
Huttenlocher, P. R. (1979). Synaptic density in human frontal cortex - developmental 
changes and effects of aging. Brain Res, 163(2), 195-205.  
 
Huttenlocher, P. R., & Dabholkar, A. S. (1997). Regional differences in synaptogenesis 
in human cerebral cortex. J Comp Neurol, 387(2), 167-178.  
 
Ihrie, R. A., & Alvarez-Buylla, A. (2011). Lake-front property: a unique germinal niche 
by the lateral ventricles of the adult brain. Neuron, 70(4), 674-686. doi: 
10.1016/j.neuron.2011.05.004 
 
Ikeda, M., Aleksic, B., Kinoshita, Y., Okochi, T., Kawashima, K., Kushima, I., . . . Iwata, 
N. (2011). Genome-wide association study of schizophrenia in a Japanese 
population. Biol Psychiatry, 69(5), 472-478. doi: 10.1016/j.biopsych.2010.07.010 
 
Illig, K. R., & Eudy, J. D. (2009). Contralateral projections of the rat anterior olfactory 
nucleus. J Comp Neurol, 512(1), 115-123. doi: 10.1002/cne.21900 
 
Imamura, F., Nagao, H., Naritsuka, H., Murata, Y., Taniguchi, H., & Mori, K. (2006). A 
leucine-rich repeat membrane protein, 5T4, is expressed by a subtype of granule 
cells with dendritic arbors in specific strata of the mouse olfactory bulb. J Comp 
Neurol, 495(6), 754-768. doi: 10.1002/cne.20896 
 
Imayoshi, I., Sakamoto, M., Ohtsuka, T., Takao, K., Miyakawa, T., Yamaguchi, M., . . . 
Kageyama, R. (2008). Roles of continuous neurogenesis in the structural and 
functional integrity of the adult forebrain. Nat Neurosci, 11(10), 1153-1161. doi: 
	  152	  	  
10.1038/nn.2185 
 
Imura, T., Kornblum, H. I., & Sofroniew, M. V. (2003). The predominant neural stem 
cell isolated from postnatal and adult forebrain but not early embryonic forebrain 
expresses GFAP. J Neurosci, 23(7), 2824-2832.  
 
International Schizophrenia, Consortium. (2008). Rare chromosomal deletions and 
duplications increase risk of schizophrenia. Nature, 455(7210), 237-241. doi: 
10.1038/nature07239 
 
International Schizophrenia, Consortium, Purcell, S. M., Wray, N. R., Stone, J. L., 
Visscher, P. M., O'Donovan, M. C., . . . Sklar, P. (2009). Common polygenic 
variation contributes to risk of schizophrenia and bipolar disorder. Nature, 
460(7256), 748-752. doi: 10.1038/nature08185 
 
Ishizuka, K., Tajinda, K., Colantuoni, C., Morita, M., Winicki, J., Le, C., . . . Cascella, N. 
G. (2010). Negative symptoms of schizophrenia correlate with impairment on the 
University of Pennsylvania smell identification test. Neurosci Res, 66(1), 106-
110. doi: S0168-0102(09)02004-5 [pii] 
10.1016/j.neures.2009.10.001 
 
Ismail, B., Cantor-Graae, E., & McNeil, T. F. (1998). Minor physical anomalies in 
schizophrenic patients and their siblings. Am J Psychiatry, 155(12), 1695-1702.  
 
Isseroff, R. G., Stoler, M., Ophir, D., Lancet, D., & Sirota, P. (1987). Olfactory 
sensitivity to androstenone in schizophrenic patients. Biol Psychiatry, 22(7), 922-
925. doi: 0006-3223(87)90093-X [pii] 
 
Iwata, Y., Suzuki, K., Wakuda, T., Seki, N., Thanseem, I., Matsuzaki, H., . . . Mori, N. 
(2008). Irradiation in adulthood as a new model of schizophrenia. PLoS One, 3(5), 
e2283. doi: 10.1371/journal.pone.0002283 
 
Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N. J., & Sawa, 
A. (2009). Neurodevelopmental mechanisms of schizophrenia: understanding 
disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. 
Trends Neurosci, 32(9), 485-495. doi: 10.1016/j.tins.2009.05.007 
 
Jenuwein, T., & Allis, C. D. (2001). Translating the histone code. Science, 293(5532), 
1074-1080. doi: 10.1126/science.1063127 
 
Job, D. E., Whalley, H. C., McConnell, S., Glabus, M., Johnstone, E. C., & Lawrie, S. M. 
(2003). Voxel-based morphometry of grey matter densities in subjects at high risk 
of schizophrenia. Schizophr Res, 64(1), 1-13.  
 
Johnson, B. A., & Leon, M. (2007). Chemotopic odorant coding in a mammalian 
olfactory system. J Comp Neurol, 503(1), 1-34. doi: 10.1002/cne.21396 
	  153	  	  
 
Johnson, B. A., Woo, C. C., & Leon, M. (1998). Spatial coding of odorant features in the 
glomerular layer of the rat olfactory bulb. J Comp Neurol, 393(4), 457-471.  
 
Johnstone, E. C., Crow, T. J., Frith, C. D., Husband, J., & Kreel, L. (1976). Cerebral 
ventricular size and cognitive impairment in chronic schizophrenia. Lancet, 
2(7992), 924-926.  
 
Kalus, P., Muller, T. J., Zuschratter, W., & Senitz, D. (2000). The dendritic architecture 
of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport, 11(16), 
3621-3625.  
 
Kamath, V., Turetsky, B. I., & Moberg, P. J. (2011). Identification of pleasant, neutral, 




Kammer, T., Bellemann, M. E., Guckel, F., Brix, G., Gass, A., Schlemmer, H., & Spitzer, 
M. (1997). Functional MR imaging of the prefrontal cortex: specific activation in 
a working memory task. Magn Reson Imaging, 15(8), 879-889.  
 
Karl, T., Duffy, L., Scimone, A., Harvey, R. P., & Schofield, P. R. (2007). Altered motor 
activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: 
implications for understanding schizophrenia. Genes Brain Behav, 6(7), 677-687. 
doi: 10.1111/j.1601-183X.2006.00298.x 
 
Kelsch, W., Mosley, C. P., Lin, C. W., & Lois, C. (2007). Distinct mammalian precursors 
are committed to generate neurons with defined dendritic projection patterns. 
PLoS Biol, 5(11), e300. doi: 10.1371/journal.pbio.0050300 
 
Kendell, R. E., Chalmers, J. C., & Platz, C. (1987). Epidemiology of puerperal 
psychoses. Br J Psychiatry, 150, 662-673.  
 
Kendler, K. S. (1987). Sporadic vs familial classification given etiologic heterogeneity: I. 
Sensitivity, specificity, and positive and negative predictive value. Genet 
Epidemiol, 4(5), 313-330. doi: 10.1002/gepi.1370040502 
 
Keshavan, M. S., & Hogarty, G. E. (1999). Brain maturational processes and delayed 
onset in schizophrenia. Dev Psychopathol, 11(3), 525-543.  
 
Khashan, A. S., Abel, K. M., McNamee, R., Pedersen, M. G., Webb, R. T., Baker, P. N., . 
. . Mortensen, P. B. (2008). Higher risk of offspring schizophrenia following 
antenatal maternal exposure to severe adverse life events. Arch Gen Psychiatry, 
65(2), 146-152. doi: 10.1001/archgenpsychiatry.2007.20 
 
Kim, J. W., Lee, Y. S., Cho, E. Y., Jang, Y. L., Park, D. Y., Choi, K. S., . . . Hong, K. S. 
	  154	  	  
(2006). Linkage and association of schizophrenia with genetic variations in the 
locus of neuregulin 1 in Korean population. Am J Med Genet B Neuropsychiatr 
Genet, 141B(3), 281-286. doi: 10.1002/ajmg.b.30209 
 
Kim, W. R., Kim, Y., Eun, B., Park, O. H., Kim, H., Kim, K., . . . Sun, W. (2007). 
Impaired migration in the rostral migratory stream but spared olfactory function 
after the elimination of programmed cell death in Bax knock-out mice. J 
Neurosci, 27(52), 14392-14403. doi: 10.1523/JNEUROSCI.3903-07.2007 
 
Kinoshita, M., Numata, S., Tajima, A., Shimodera, S., Ono, S., Imamura, A., . . . Ohmori, 
T. (2013). DNA methylation signatures of peripheral leukocytes in schizophrenia. 
Neuromolecular Med, 15(1), 95-101. doi: 10.1007/s12017-012-8198-6 
 
Kippin, T. E., Kapur, S., & van der Kooy, D. (2005). Dopamine specifically inhibits 
forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic 
drugs. J Neurosci, 25(24), 5815-5823. doi: 10.1523/JNEUROSCI.1120-05.2005 
 
Kirkpatrick, B., & Galderisi, S. (2008). Deficit schizophrenia: an update. World 
Psychiatry, 7(3), 143-147.  
 
Kirkpatrick, B., Ross, D. E., Walsh, D., Karkowski, L., & Kendler, K. S. (2000). Family 
characteristics of deficit and nondeficit schizophrenia in the Roscommon Family 
Study. Schizophr Res, 45(1-2), 57-64.  
 
Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., . . . 
O'Donovan, M. C. (2009). Support for the involvement of large copy number 
variants in the pathogenesis of schizophrenia. Hum Mol Genet, 18(8), 1497-1503. 
doi: 10.1093/hmg/ddp043 
 
Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., . . . Ullmann, R. 
(2008). Comparative genome hybridization suggests a role for NRXN1 and 
APBA2 in schizophrenia. Hum Mol Genet, 17(3), 458-465. doi: 
10.1093/hmg/ddm323 
 
Kirov, G., Zaharieva, I., Georgieva, L., Moskvina, V., Nikolov, I., Cichon, S., . . . 
O'Donovan, M. C. (2009). A genome-wide association study in 574 schizophrenia 
trios using DNA pooling. Mol Psychiatry, 14(8), 796-803. doi: 
10.1038/mp.2008.33 
 
Kodama, M., Fujioka, T., & Duman, R. S. (2004). Chronic olanzapine or fluoxetine 
administration increases cell proliferation in hippocampus and prefrontal cortex of 
adult rat. Biol Psychiatry, 56(8), 570-580. doi: S0006-3223(04)00770-X [pii] 
10.1016/j.biopsych.2004.07.008 
 
Kohwi, M., Osumi, N., Rubenstein, J. L., & Alvarez-Buylla, A. (2005). Pax6 is required 
for making specific subpopulations of granule and periglomerular neurons in the 
	  155	  	  
olfactory bulb. J Neurosci, 25(30), 6997-7003. doi: 10.1523/JNEUROSCI.1435-
05.2005 
 
Kohwi, M., Petryniak, M. A., Long, J. E., Ekker, M., Obata, K., Yanagawa, Y., . . . 
Alvarez-Buylla, A. (2007). A subpopulation of olfactory bulb GABAergic 
interneurons is derived from Emx1- and Dlx5/6-expressing progenitors. J 
Neurosci, 27(26), 6878-6891. doi: 10.1523/JNEUROSCI.0254-07.2007 
 
Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors for 
autism: a review and integration of findings. Arch Pediatr Adolesc Med, 161(4), 
326-333. doi: 161/4/326 [pii] 
10.1001/archpedi.161.4.326 
 
Kopala, L. C., Clark, C., & Hurwitz, T. (1993). Olfactory deficits in neuroleptic naive 
patients with schizophrenia. Schizophr Res, 8(3), 245-250.  
 
Kopala, L. C., Good, K., & Honer, W. G. (1995). Olfactory identification ability in pre- 
and postmenopausal women with schizophrenia. Biol Psychiatry, 38(1), 57-63. 
doi: 0006-3223(94)00224-Q [pii] 
10.1016/0006-3223(94)00224-Q 
 
Kopala, L. C., Good, K. P., & Honer, W. G. (1994). Olfactory hallucinations and 
olfactory identification ability in patients with schizophrenia and other psychiatric 
disorders. Schizophr Res, 12(3), 205-211.  
 
Kopala, L. C., Good, K. P., Morrison, K., Bassett, A. S., Alda, M., & Honer, W. G. 
(2001). Impaired olfactory identification in relatives of patients with familial 
schizophrenia. Am J Psychiatry, 158(8), 1286-1290.  
 
Kopala, L., Clark, C., & Hurwitz, T. A. (1989). Sex differences in olfactory function in 
schizophrenia. Am J Psychiatry, 146(10), 1320-1322.  
 
Kopala, L., Good, K., Martzke, J., & Hurwitz, T. (1995). Olfactory deficits in 
schizophrenia are not a function of task complexity. Schizophr Res, 17(2), 195-
199. doi: 0920-9964(94)00085-M [pii] 
 
Kosaka, K., & Kosaka, T. (2005). synaptic organization of the glomerulus in the main 
olfactory bulb: compartments of the glomerulus and heterogeneity of the 
periglomerular cells. Anat Sci Int, 80(2), 80-90. doi: 10.1111/j.1447-
073x.2005.00092.x 
 
Kosaka, K., & Kosaka, T. (2007). Chemical properties of type 1 and type 2 
periglomerular cells in the mouse olfactory bulb are different from those in the rat 
olfactory bulb. Brain Res, 1167, 42-55. doi: 10.1016/j.brainres.2007.04.087 
 
Koulakov, A., Gelperin, A., & Rinberg, D. (2007). Olfactory coding with all-or-nothing 
	  156	  	  
glomeruli. J Neurophysiol, 98(6), 3134-3142. doi: 10.1152/jn.00560.2007 
 
Krabbendam, L., & van Os, J. (2005). Schizophrenia and urbanicity: a major 
environmental influence--conditional on genetic risk. Schizophr Bull, 31(4), 795-
799. doi: 10.1093/schbul/sbi060 
 
Kramer, R., Bucay, N., Kane, D. J., Martin, L. E., Tarpley, J. E., & Theill, L. E. (1996). 
Neuregulins with an Ig-like domain are essential for mouse myocardial and 
neuronal development. Proc Natl Acad Sci U S A, 93(10), 4833-4838.  
 
Kringlen, E., & Cramer, G. (1989). Offspring of monozygotic twins discordant for 
schizophrenia. Arch Gen Psychiatry, 46(10), 873-877.  
 
Lagace, D. C., Whitman, M. C., Noonan, M. A., Ables, J. L., DeCarolis, N. A., Arguello, 
A. A., . . . Eisch, A. J. (2007). Dynamic contribution of nestin-expressing stem 
cells to adult neurogenesis. J Neurosci, 27(46), 12623-12629. doi: 
10.1523/JNEUROSCI.3812-07.2007 
 
Lai, C., & Feng, L. (2004). Neuregulin induces proliferation of neural progenitor cells via 
PLC/PKC pathway. Biochem Biophys Res Commun, 319(2), 603-611. doi: 
10.1016/j.bbrc.2004.05.027 
 
Lane, N., Dean, W., Erhardt, S., Hajkova, P., Surani, A., Walter, J., & Reik, W. (2003). 
Resistance of IAPs to methylation reprogramming may provide a mechanism for 
epigenetic inheritance in the mouse. Genesis, 35(2), 88-93. doi: 
10.1002/gene.10168 
 
Lavdas, A. A., Grigoriou, M., Pachnis, V., & Parnavelas, J. G. (1999). The medial 
ganglionic eminence gives rise to a population of early neurons in the developing 
cerebral cortex. J Neurosci, 19(18), 7881-7888.  
 
Law, A. J., Kleinman, J. E., Weinberger, D. R., & Weickert, C. S. (2007). Disease-
associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-
variant expression in the brain in schizophrenia. Hum Mol Genet, 16(2), 129-141. 
doi: 10.1093/hmg/ddl449 
 
Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R., . . . 
Weinberger, D. R. (2006). Neuregulin 1 transcripts are differentially expressed in 
schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl 
Acad Sci U S A, 103(17), 6747-6752. doi: 10.1073/pnas.0602002103 
 
Laywell, E. D., Rakic, P., Kukekov, V. G., Holland, E. C., & Steindler, D. A. (2000). 
Identification of a multipotent astrocytic stem cell in the immature and adult 
mouse brain. Proc Natl Acad Sci U S A, 97(25), 13883-13888. doi: 
10.1073/pnas.250471697 
 
	  157	  	  
Lazarini, F., Mouthon, M. A., Gheusi, G., de Chaumont, F., Olivo-Marin, J. C., 
Lamarque, S., . . . Lledo, P. M. (2009). Cellular and behavioral effects of cranial 
irradiation of the subventricular zone in adult mice. PLoS One, 4(9), e7017. doi: 
10.1371/journal.pone.0007017 
 
Lee, S., Hjerling-Leffler, J., Zagha, E., Fishell, G., & Rudy, B. (2010). The largest group 
of superficial neocortical GABAergic interneurons expresses ionotropic serotonin 
receptors. J Neurosci, 30(50), 16796-16808. doi: 10.1523/JNEUROSCI.1869-
10.2010 
 
Lemasson, M., Saghatelyan, A., Olivo-Marin, J. C., & Lledo, P. M. (2005). Neonatal and 
adult neurogenesis provide two distinct populations of newborn neurons to the 
mouse olfactory bulb. J Neurosci, 25(29), 6816-6825. doi: 
10.1523/JNEUROSCI.1114-05.2005 
 
Lencz, T., Morgan, T. V., Athanasiou, M., Dain, B., Reed, C. R., Kane, J. M., . . . 
Malhotra, A. K. (2007). Converging evidence for a pseudoautosomal cytokine 
receptor gene locus in schizophrenia. Mol Psychiatry, 12(6), 572-580. doi: 
10.1038/sj.mp.4001983 
 
Leveteau, J., & MacLeod, P. (1966). Olfactory discrimination in the rabbit olfactory 
glomerulus. Science, 153(3732), 175-176.  
 
Levine, J., Sela, B. A., Osher, Y., & Belmaker, R. H. (2005). High homocysteine serum 
levels in young male schizophrenia and bipolar patients and in an animal model. 
Prog Neuropsychopharmacol Biol Psychiatry, 29(7), 1181-1191. doi: 
10.1016/j.pnpbp.2005.06.029 
 
Levine, J., Stahl, Z., Sela, B. A., Gavendo, S., Ruderman, V., & Belmaker, R. H. (2002). 
Elevated homocysteine levels in young male patients with schizophrenia. Am J 
Psychiatry, 159(10), 1790-1792.  
 
Levine, J., Stahl, Z., Sela, B. A., Ruderman, V., Shumaico, O., Babushkin, I., . . . 
Belmaker, R. H. (2006). Homocysteine-reducing strategies improve symptoms in 
chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry, 
60(3), 265-269. doi: 10.1016/j.biopsych.2005.10.009 
 
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., . . . 
Helgason, T. (2003). Genome scan meta-analysis of schizophrenia and bipolar 
disorder, part II: Schizophrenia. Am J Hum Genet, 73(1), 34-48. doi: 
10.1086/376549 
 
Lewis, D. A., & Lieberman, J. A. (2000). Catching up on schizophrenia: natural history 
and neurobiology. Neuron, 28(2), 325-334. doi: S0896-6273(00)00111-2 [pii] 
 
Li, T., Stefansson, H., Gudfinnsson, E., Cai, G., Liu, X., Murray, R. M., . . . Collier, D. 
	  158	  	  
A. (2004). Identification of a novel neuregulin 1 at-risk haplotype in Han 
schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk 
haplotype. Mol Psychiatry, 9(7), 698-704. doi: 10.1038/sj.mp.4001485 
 
Lie, D. C., Song, H., Colamarino, S. A., Ming, G. L., & Gage, F. H. (2004). 
Neurogenesis in the adult brain: new strategies for central nervous system 
diseases. Annu Rev Pharmacol Toxicol, 44, 399-421. doi: 
10.1146/annurev.pharmtox.44.101802.121631 
 
Lindamer, L. A., Lohr, J. B., Harris, M. J., & Jeste, D. V. (1997). Gender, estrogen, and 
schizophrenia. Psychopharmacol Bull, 33(2), 221-228.  
 
Lindholm, T., Cullheim, S., Deckner, M., Carlstedt, T., & Risling, M. (2002). Expression 
of neuregulin and ErbB3 and ErbB4 after a traumatic lesion in the ventral 
funiculus of the spinal cord and in the intact primary olfactory system. Exp Brain 
Res, 142(1), 81-90. doi: 10.1007/s00221-001-0922-7 
 
Linster, C., & Cleland, T. A. (2009). Glomerular microcircuits in the olfactory bulb. 
Neural Netw, 22(8), 1169-1173. doi: 10.1016/j.neunet.2009.07.013 
 
Linster, C., Johnson, B. A., Yue, E., Morse, A., Xu, Z., Hingco, E. E., . . . Leon, M. 
(2001). Perceptual correlates of neural representations evoked by odorant 
enantiomers. J Neurosci, 21(24), 9837-9843.  
 
Lipska, B. K., & Weinberger, D. R. (2000). To model a psychiatric disorder in animals: 
schizophrenia as a reality test. Neuropsychopharmacology, 23(3), 223-239. doi: 
10.1016/S0893-133X(00)00137-8 
 
Liu, C. M., Hwu, H. G., Fann, C. S., Lin, C. Y., Liu, Y. L., Ou-Yang, W. C., & Lee, S. F. 
(2005). Linkage evidence of schizophrenia to loci near neuregulin 1 gene on 
chromosome 8p21 in Taiwanese families. Am J Med Genet B Neuropsychiatr 
Genet, 134B(1), 79-83. doi: 10.1002/ajmg.b.20161 
 
Liu, X., Bates, R., Yin, D. M., Shen, C., Wang, F., Su, N., . . . Mei, L. (2011). Specific 
regulation of Nrg1 isoform expression by neuronal activity. J Neurosci, 31(23), 
8491-8501. doi: 10.1523/JNEUROSCI.5317-10.2011 
 
Liu, Y., Ford, B. D., Mann, M. A., & Fischbach, G. D. (2005). Neuregulin-1 increases the 
proliferation of neuronal progenitors from embryonic neural stem cells. Dev Biol, 
283(2), 437-445. doi: 10.1016/j.ydbio.2005.04.038 
 
Lledo, P. M., Merkle, F. T., & Alvarez-Buylla, A. (2008). Origin and function of 
olfactory bulb interneuron diversity. Trends Neurosci, 31(8), 392-400. doi: 
10.1016/j.tins.2008.05.006 
 
Lledo, P. M., Saghatelyan, A., & Lemasson, M. (2004). Inhibitory interneurons in the 
	  159	  	  
olfactory bulb: from development to function. Neuroscientist, 10(4), 292-303. doi: 
10.1177/1073858404263460 
 
Lloyd, T., Dazzan, P., Dean, K., Park, S. B., Fearon, P., Doody, G. A., . . . Jones, P. B. 
(2008). Minor physical anomalies in patients with first-episode psychosis: their 
frequency and diagnostic specificity. Psychol Med, 38(1), 71-77. doi: 
10.1017/S0033291707001158 
 
Loeb, J. A., Susanto, E. T., & Fischbach, G. D. (1998). The neuregulin precursor 
proARIA is processed to ARIA after expression on the cell surface by a protein 
kinase C-enhanced mechanism. Mol Cell Neurosci, 11(1-2), 77-91. doi: 
10.1006/mcne.1998.0676 
 
Lohr, J. B., & Flynn, K. (1993). Minor physical anomalies in schizophrenia and mood 
disorders. Schizophr Bull, 19(3), 551-556.  
 
Lois, C., & Alvarez-Buylla, A. (1994). Long-distance neuronal migration in the adult 
mammalian brain. Science, 264(5162), 1145-1148.  
 
Lois, C., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1996). Chain migration of 
neuronal precursors. Science, 271(5251), 978-981.  
 
Longe, O., Senior, C., & Rippon, G. (2009). The lateral and ventromedial prefrontal 
cortex work as a dynamic integrated system: evidence from FMRI connectivity 
analysis. J Cogn Neurosci, 21(1), 141-154. doi: 10.1162/jocn.2009.21012 
 
Luo, M., & Katz, L. C. (2001). Response correlation maps of neurons in the mammalian 
olfactory bulb. Neuron, 32(6), 1165-1179.  
 
Luzi, S., Morrison, P. D., Powell, J., di Forti, M., & Murray, R. M. (2008). What is the 
mechanism whereby cannabis use increases risk of psychosis? Neurotox Res, 
14(2-3), 105-112. doi: 10.1007/BF03033802 
 
Ma, J., & Lowe, G. (2004). Action potential backpropagation and multiglomerular 
signaling in the rat vomeronasal system. J Neurosci, 24(42), 9341-9352. doi: 
10.1523/JNEUROSCI.1782-04.2004 
 
Ma, L., Qiu, Q., Gradwohl, S., Scott, A., Yu, E. Q., Alexander, R., . . . Yu, C. R. (2012). 
Distributed representation of chemical features and tunotopic organization of 
glomeruli in the mouse olfactory bulb. Proc Natl Acad Sci U S A, 109(14), 5481-
5486. doi: 10.1073/pnas.1117491109 
 
Ma, T., Zhang, Q., Cai, Y., You, Y., Rubenstein, J. L., & Yang, Z. (2012). A 
subpopulation of dorsal lateral/caudal ganglionic eminence-derived neocortical 
interneurons expresses the transcription factor Sp8. Cereb Cortex, 22(9), 2120-
2130. doi: 10.1093/cercor/bhr296 
	  160	  	  
 
Ma, X., Deng, W., Liu, X., Li, M., Chen, Z., He, Z., . . . Li, T. (2011). A genome-wide 
association study for quantitative traits in schizophrenia in China. Genes Brain 
Behav, 10(7), 734-739. doi: 10.1111/j.1601-183X.2011.00712.x 
 
Magavi, S. S., Mitchell, B. D., Szentirmai, O., Carter, B. S., & Macklis, J. D. (2005). 
Adult-born and preexisting olfactory granule neurons undergo distinct experience-
dependent modifications of their olfactory responses in vivo. J Neurosci, 25(46), 
10729-10739. doi: 10.1523/JNEUROSCI.2250-05.2005 
 
Mahe, V., & Dumaine, A. (2001). Oestrogen withdrawal associated psychoses. Acta 
Psychiatr Scand, 104(5), 323-331.  
 
Malaspina, D. (2001). Paternal factors and schizophrenia risk: de novo mutations and 
imprinting. Schizophr Bull, 27(3), 379-393.  
 
Malaspina, D., & Coleman, E. (2003). Olfaction and social drive in schizophrenia. Arch 
Gen Psychiatry, 60(6), 578-584. doi: 10.1001/archpsyc.60.6.578 
60/6/578 [pii] 
 
Malaspina, D., Goetz, R. R., Yale, S., Berman, A., Friedman, J. H., Tremeau, F., . . . 
Gorman, J. M. (2000). Relation of familial schizophrenia to negative symptoms 
but not to the deficit syndrome. Am J Psychiatry, 157(6), 994-1003.  
 
Malaspina, D., Harlap, S., Fennig, S., Heiman, D., Nahon, D., Feldman, D., & Susser, E. 
S. (2001). Advancing paternal age and the risk of schizophrenia. Arch Gen 
Psychiatry, 58(4), 361-367.  
 
Malaspina, D., Wray, A. D., Friedman, J. H., Amador, X., Yale, S., Hasan, A., . . . 
Kaufmann, C. A. (1994). Odor discrimination deficits in schizophrenia: 
association with eye movement dysfunction. J Neuropsychiatry Clin Neurosci, 
6(3), 273-278.  
 
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant 
treatment increases neurogenesis in adult rat hippocampus. J Neurosci, 20(24), 
9104-9110. doi: 20/24/9104 [pii] 
 
Mandairon, N., & Linster, C. (2009). Odor perception and olfactory bulb plasticity in 
adult mammals. J Neurophysiol, 101(5), 2204-2209. doi: 10.1152/jn.00076.2009 
 
Marballi, K., Cruz, D., Thompson, P., & Walss-Bass, C. (2012). Differential neuregulin 1 
cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar 
disorder: preliminary findings. PLoS One, 7(5), e36431. doi: 
10.1371/journal.pone.0036431 
 
Margrie, T. W., Sakmann, B., & Urban, N. N. (2001). Action potential propagation in 
	  161	  	  
mitral cell lateral dendrites is decremental and controls recurrent and lateral 
inhibition in the mammalian olfactory bulb. Proc Natl Acad Sci U S A, 98(1), 
319-324. doi: 10.1073/pnas.011523098 
 
Marin, O., Anderson, S. A., & Rubenstein, J. L. (2000). Origin and molecular 
specification of striatal interneurons. J Neurosci, 20(16), 6063-6076.  
 
Marin, O., Plump, A. S., Flames, N., Sanchez-Camacho, C., Tessier-Lavigne, M., & 
Rubenstein, J. L. (2003). Directional guidance of interneuron migration to the 
cerebral cortex relies on subcortical Slit1/2-independent repulsion and cortical 
attraction. Development, 130(9), 1889-1901.  
 
Marin, O., Yaron, A., Bagri, A., Tessier-Lavigne, M., & Rubenstein, J. L. (2001). Sorting 
of striatal and cortical interneurons regulated by semaphorin-neuropilin 
interactions. Science, 293(5531), 872-875. doi: 10.1126/science.1061891 
 
Marutha Ravindran, C. R., & Ticku, M. K. (2004). Changes in methylation pattern of 
NMDA receptor NR2B gene in cortical neurons after chronic ethanol treatment in 
mice. Brain Res Mol Brain Res, 121(1-2), 19-27. doi: 
10.1016/j.molbrainres.2003.10.025 
 
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. 
P., & Hirschhorn, J. N. (2008). Genome-wide association studies for complex 
traits: consensus, uncertainty and challenges. Nat Rev Genet, 9(5), 356-369. doi: 
10.1038/nrg2344 
 
McDonald, C., Bullmore, E., Sham, P., Chitnis, X., Suckling, J., MacCabe, J., . . . 
Murray, R. M. (2005). Regional volume deviations of brain structure in 
schizophrenia and psychotic bipolar disorder: computational morphometry study. 
Br J Psychiatry, 186, 369-377. doi: 10.1192/bjp.186.5.369 
 
McGlashan, T. H., & Bardenstein, K. K. (1990). Gender differences in affective, 
schizoaffective, and schizophrenic disorders. Schizophr Bull, 16(2), 319-329.  
 
McGrath, J. J., van Os, J., Hoyos, C., Jones, P. B., Harvey, I., & Murray, R. M. (1995). 
Minor physical anomalies in psychoses: associations with clinical and putative 
aetiological variables. Schizophr Res, 18(1), 9-20.  
 
McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., & Chant, D. (2004). A 
systematic review of the incidence of schizophrenia: the distribution of rates and 
the influence of sex, urbanicity, migrant status and methodology. BMC Med, 2, 
13. doi: 10.1186/1741-7015-2-13 
 
McIntosh, A. M., Job, D. E., Moorhead, W. J., Harrison, L. K., Whalley, H. C., 
Johnstone, E. C., & Lawrie, S. M. (2006). Genetic liability to schizophrenia or 
bipolar disorder and its relationship to brain structure. Am J Med Genet B 
	  162	  	  
Neuropsychiatr Genet, 141B(1), 76-83. doi: 10.1002/ajmg.b.30254 
 
McNeil, T. F., Cantor-Graae, E., & Ismail, B. (2000). Obstetric complications and 
congenital malformation in schizophrenia. Brain Res Brain Res Rev, 31(2-3), 166-
178.  
 
McQuiston, A. R., & Katz, L. C. (2001). Electrophysiology of interneurons in the 
glomerular layer of the rat olfactory bulb. J Neurophysiol, 86(4), 1899-1907.  
 
Mei, L., & Xiong, W. C. (2008). Neuregulin 1 in neural development, synaptic plasticity 
and schizophrenia. Nat Rev Neurosci, 9(6), 437-452. doi: 10.1038/nrn2392 
 
Melas, P. A., Rogdaki, M., Osby, U., Schalling, M., Lavebratt, C., & Ekstrom, T. J. 
(2012). Epigenetic aberrations in leukocytes of patients with schizophrenia: 
association of global DNA methylation with antipsychotic drug treatment and 
disease onset. FASEB J, 26(6), 2712-2718. doi: 10.1096/fj.11-202069 
 
Menezes, J. R., Smith, C. M., Nelson, K. C., & Luskin, M. B. (1995). The division of 
neuronal progenitor cells during migration in the neonatal mammalian forebrain. 
Mol Cell Neurosci, 6(6), 496-508. doi: 10.1006/mcne.1995.0002 
 
Meredith, M. (1986). Patterned response to odor in mammalian olfactory bulb: the 
influence of intensity. J Neurophysiol, 56(3), 572-597.  
 
Merkle, F. T., & Alvarez-Buylla, A. (2006). Neural stem cells in mammalian 
development. Curr Opin Cell Biol, 18(6), 704-709. doi: 
10.1016/j.ceb.2006.09.008 
 
Merkle, F. T., Mirzadeh, Z., & Alvarez-Buylla, A. (2007). Mosaic organization of neural 
stem cells in the adult brain. Science, 317(5836), 381-384. doi: 
10.1126/science.1144914 
 
Merkle, F. T., Tramontin, A. D., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (2004). 
Radial glia give rise to adult neural stem cells in the subventricular zone. Proc 
Natl Acad Sci U S A, 101(50), 17528-17532. doi: 10.1073/pnas.0407893101 
 
Meyer, D., & Birchmeier, C. (1995). Multiple essential functions of neuregulin in 
development. Nature, 378(6555), 386-390. doi: 10.1038/378386a0 
 
Meyer, D., Yamaai, T., Garratt, A., Riethmacher-Sonnenberg, E., Kane, D., Theill, L. E., 
& Birchmeier, C. (1997). Isoform-specific expression and function of neuregulin. 
Development, 124(18), 3575-3586.  
 
Meyer, U., Knuesel, I., Nyffeler, M., & Feldon, J. (2010). Chronic clozapine treatment 
improves prenatal infection-induced working memory deficits without influencing 
adult hippocampal neurogenesis. Psychopharmacology (Berl), 208(4), 531-543. 
	  163	  	  
doi: 10.1007/s00213-009-1754-6 
 
Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., . . . Petronis, 
A. (2008). Epigenomic profiling reveals DNA-methylation changes associated 
with major psychosis. Am J Hum Genet, 82(3), 696-711. doi: 
10.1016/j.ajhg.2008.01.008 
 
Ming, G. L., & Song, H. (2005). Adult neurogenesis in the mammalian central nervous 
system. Annu Rev Neurosci, 28, 223-250. doi: 
10.1146/annurev.neuro.28.051804.101459 
 
Mirzadeh, Z., Merkle, F. T., Soriano-Navarro, M., Garcia-Verdugo, J. M., & Alvarez-
Buylla, A. (2008). Neural stem cells confer unique pinwheel architecture to the 
ventricular surface in neurogenic regions of the adult brain. Cell Stem Cell, 3(3), 
265-278. doi: 10.1016/j.stem.2008.07.004 
 
Mittal, V. A., Ellman, L. M., & Cannon, T. D. (2008). Gene-environment interaction and 
covariation in schizophrenia: the role of obstetric complications. Schizophr Bull, 
34(6), 1083-1094. doi: 10.1093/schbul/sbn080 
 
Miyata, T., Kawaguchi, A., Saito, K., Kawano, M., Muto, T., & Ogawa, M. (2004). 
Asymmetric production of surface-dividing and non-surface-dividing cortical 
progenitor cells. Development, 131(13), 3133-3145. doi: 10.1242/dev.01173 
 
Miyoshi, G., Butt, S. J., Takebayashi, H., & Fishell, G. (2007). Physiologically distinct 
temporal cohorts of cortical interneurons arise from telencephalic Olig2-
expressing precursors. J Neurosci, 27(29), 7786-7798. doi: 
10.1523/JNEUROSCI.1807-07.2007 
 
Miyoshi, G., Hjerling-Leffler, J., Karayannis, T., Sousa, V. H., Butt, S. J., Battiste, J., . . . 
Fishell, G. (2010). Genetic fate mapping reveals that the caudal ganglionic 
eminence produces a large and diverse population of superficial cortical 
interneurons. J Neurosci, 30(5), 1582-1594. doi: 10.1523/JNEUROSCI.4515-
09.2010 
 
Moberg, P. J., Arnold, S. E., Doty, R. L., Kohler, C., Kanes, S., Seigel, S., . . . Turetsky, 
B. I. (2003). Impairment of odor hedonics in men with schizophrenia. Am J 
Psychiatry, 160(10), 1784-1789.  
 
Moberg, P. J., Doty, R. L., Turetsky, B. I., Arnold, S. E., Mahr, R. N., Gur, R. C., . . . 
Gur, R. E. (1997). Olfactory identification deficits in schizophrenia: correlation 
with duration of illness. Am J Psychiatry, 154(7), 1016-1018.  
 
Mombaerts, P. (2001). How smell develops. Nat Neurosci, 4 Suppl, 1192-1198. doi: 
10.1038/nn751 
 
	  164	  	  
Mombaerts, P., Wang, F., Dulac, C., Chao, S. K., Nemes, A., Mendelsohn, M., . . . Axel, 
R. (1996). Visualizing an olfactory sensory map. Cell, 87(4), 675-686.  
 
Mombaerts, P., Wang, F., Dulac, C., Vassar, R., Chao, S. K., Nemes, A., . . . Axel, R. 
(1996). The molecular biology of olfactory perception. Cold Spring Harb Symp 
Quant Biol, 61, 135-145.  
 
Montcouquiol, M., & Corwin, J. T. (2001). Intracellular signals that control cell 
proliferation in mammalian balance epithelia: key roles for phosphatidylinositol-3 
kinase, mammalian target of rapamycin, and S6 kinases in preference to calcium, 
protein kinase C, and mitogen-activated protein kinase. J Neurosci, 21(2), 570-
580.  
 
Montero, J. C., Rodriguez-Barrueco, R., Yuste, L., Juanes, P. P., Borges, J., Esparis-
Ogando, A., & Pandiella, A. (2007). The extracellular linker of pro-neuregulin-
alpha2c is required for efficient sorting and juxtacrine function. Mol Biol Cell, 
18(2), 380-393. doi: 10.1091/mbc.E06-06-0511 
 
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & 
Lewis, G. (2007). Cannabis use and risk of psychotic or affective mental health 
outcomes: a systematic review. Lancet, 370(9584), 319-328. doi: 10.1016/S0140-
6736(07)61162-3 
 
Mora, S., Dussaubat, N., & Diaz-Veliz, G. (1996). Effects of the estrous cycle and 
ovarian hormones on behavioral indices of anxiety in female rats. 
Psychoneuroendocrinology, 21(7), 609-620.  
 
Moreno, M. M., Linster, C., Escanilla, O., Sacquet, J., Didier, A., & Mandairon, N. 
(2009). Olfactory perceptual learning requires adult neurogenesis. Proc Natl Acad 
Sci U S A, 106(42), 17980-17985. doi: 10.1073/pnas.0907063106 
 
Morgan, H. D., Sutherland, H. G., Martin, D. I., & Whitelaw, E. (1999). Epigenetic 
inheritance at the agouti locus in the mouse. Nat Genet, 23(3), 314-318. doi: 
10.1038/15490 
 
Morgan, M. A., & Pfaff, D. W. (2001). Effects of estrogen on activity and fear-related 
behaviors in mice. Horm Behav, 40(4), 472-482. doi: 10.1006/hbeh.2001.1716 
 
Morgan, M. A., & Pfaff, D. W. (2002). Estrogen's effects on activity, anxiety, and fear in 
two mouse strains. Behav Brain Res, 132(1), 85-93.  
 
Morgan, V. A., Castle, D. J., & Jablensky, A. V. (2008). Do women express and 
experience psychosis differently from men? Epidemiological evidence from the 
Australian National Study of Low Prevalence (Psychotic) Disorders. Aust N Z J 
Psychiatry, 42(1), 74-82. doi: 10.1080/00048670701732699 
 
	  165	  	  
Mori, K. (1987). Membrane and synaptic properties of identified neurons in the olfactory 
bulb. Prog Neurobiol, 29(3), 275-320.  
 
Mori, K., Kishi, K., & Ojima, H. (1983). Distribution of dendrites of mitral, displaced 
mitral, tufted, and granule cells in the rabbit olfactory bulb. J Comp Neurol, 
219(3), 339-355. doi: 10.1002/cne.902190308 
 
Moulton, D. G., & Beidler, L. M. (1967). Structure and function in the peripheral 
olfactory system. Physiol Rev, 47(1), 1-52.  
 
Mouret, A., Gheusi, G., Gabellec, M. M., de Chaumont, F., Olivo-Marin, J. C., & Lledo, 
P. M. (2008). Learning and survival of newly generated neurons: when time 
matters. J Neurosci, 28(45), 11511-11516. doi: 10.1523/JNEUROSCI.2954-
08.2008 
 
Mouret, A., Lepousez, G., Gras, J., Gabellec, M. M., & Lledo, P. M. (2009). Turnover of 
newborn olfactory bulb neurons optimizes olfaction. J Neurosci, 29(39), 12302-
12314. doi: 10.1523/JNEUROSCI.3383-09.2009 
 
Mulle, J. G. (2012). Schizophrenia genetics: progress, at last. Curr Opin Genet Dev, 
22(3), 238-244. doi: 10.1016/j.gde.2012.02.011 
 
Munafo, M. R., Thiselton, D. L., Clark, T. G., & Flint, J. (2006). Association of the Nrg1 
gene and schizophrenia: a meta-analysis. Mol Psychiatry, 11(6), 539-546. doi: 
10.1038/sj.mp.4001817 
 
Munk-Jorgensen, P. (1987). First-admission rates and marital status of schizophrenics. 
Acta Psychiatr Scand, 76(2), 210-216.  
 
Murray, R. M., Morrison, P. D., Henquet, C., & Di Forti, M. (2007). Cannabis, the mind 
and society: the hash realities. Nat Rev Neurosci, 8(11), 885-895. doi: 
10.1038/nrn2253 
 
Neddens, J., Vullhorst, D., Paredes, D., & Buonanno, A. (2009). Neuregulin links 
dopaminergic and glutamatergic neurotransmission to control hippocampal 
synaptic plasticity. Commun Integr Biol, 2(3), 261-264.  
 
Need, A. C., Ge, D., Weale, M. E., Maia, J., Feng, S., Heinzen, E. L., . . . Goldstein, D. 
B. (2009). A genome-wide investigation of SNPs and CNVs in schizophrenia. 
PLoS Genet, 5(2), e1000373. doi: 10.1371/journal.pgen.1000373 
 
Neelam, K., Garg, D., & Marshall, M. (2011). A systematic review and meta-analysis of 
neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry, 
11, 139. doi: 10.1186/1471-244X-11-139 
 
Newton, S. S., & Duman, R. S. (2007). Neurogenic actions of atypical antipsychotic 
	  166	  	  
drugs and therapeutic implications. CNS Drugs, 21(9), 715-725. doi: 2192 [pii] 
 
Nicodemus, K. K., Law, A. J., Luna, A., Vakkalanka, R., Straub, R. E., Kleinman, J. E., 
& Weinberger, D. R. (2009). A 5' promoter region SNP in Nrg1 is associated with 
schizophrenia risk and type III isoform expression. Mol Psychiatry, 14(8), 741-
743. doi: 10.1038/mp.2008.150 
 
Nicodemus, K. K., Law, A. J., Radulescu, E., Luna, A., Kolachana, B., Vakkalanka, R., . 
. . Weinberger, D. R. (2010). Biological validation of increased schizophrenia risk 
with Nrg1, ErbB4, and AKT1 epistasis via functional neuroimaging in healthy 
controls. Arch Gen Psychiatry, 67(10), 991-1001. doi: 
10.1001/archgenpsychiatry.2010.117 
 
Nicodemus, K. K., Luna, A., Vakkalanka, R., Goldberg, T., Egan, M., Straub, R. E., & 
Weinberger, D. R. (2006). Further evidence for association between ErbB4 and 
schizophrenia and influence on cognitive intermediate phenotypes in healthy 
controls. Mol Psychiatry, 11(12), 1062-1065. doi: 10.1038/sj.mp.4001878 
 
Nicodemus, K. K., Marenco, S., Batten, A. J., Vakkalanka, R., Egan, M. F., Straub, R. E., 
& Weinberger, D. R. (2008). Serious obstetric complications interact with 
hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol 
Psychiatry, 13(9), 873-877. doi: 10.1038/sj.mp.4002153 
 
Ninkovic, J., Mori, T., & Gotz, M. (2007). Distinct modes of neuron addition in adult 
mouse neurogenesis. J Neurosci, 27(40), 10906-10911. doi: 
10.1523/JNEUROSCI.2572-07.2007 
 
Nissant, A., Bardy, C., Katagiri, H., Murray, K., & Lledo, P. M. (2009). Adult 
neurogenesis promotes synaptic plasticity in the olfactory bulb. Nat Neurosci, 
12(6), 728-730. doi: 10.1038/nn.2298 
 
Nissant, A., & Pallotto, M. (2011). Integration and maturation of newborn neurons in the 
adult olfactory bulb--from synapses to function. Eur J Neurosci, 33(6), 1069-
1077. doi: 10.1111/j.1460-9568.2011.07605.x 
 
Noctor, S. C., Martinez-Cerdeno, V., Ivic, L., & Kriegstein, A. R. (2004). Cortical 
neurons arise in symmetric and asymmetric division zones and migrate through 
specific phases. Nat Neurosci, 7(2), 136-144. doi: 10.1038/nn1172 
 
Noh, D. Y., Shin, S. H., & Rhee, S. G. (1995). Phosphoinositide-specific phospholipase 
C and mitogenic signaling. Biochim Biophys Acta, 1242(2), 99-113.  
 
Nomikos, G. G., & Spyraki, C. (1988). Influence of oestrogen on spontaneous and 
diazepam-induced exploration of rats in an elevated plus maze. 
Neuropharmacology, 27(7), 691-696.  
 
	  167	  	  
Nordentoft, M., Thorup, A., Petersen, L., Ohlenschlaeger, J., Melau, M., Christensen, T. 
O., . . . Jeppesen, P. (2006). Transition rates from schizotypal disorder to 
psychotic disorder for first-contact patients included in the OPUS trial. A 
randomized clinical trial of integrated treatment and standard treatment. Schizophr 
Res, 83(1), 29-40. doi: 10.1016/j.schres.2006.01.002 
 
Norman, R. M., Malla, A. K., Manchanda, R., & Townsend, L. (2005). Premorbid 
adjustment in first episode schizophrenia and schizoaffective disorders: a 
comparison of social and academic domains. Acta Psychiatr Scand, 112(1), 30-
39. doi: 10.1111/j.1600-0447.2005.00555.x 
 
Norton, N., Moskvina, V., Morris, D. W., Bray, N. J., Zammit, S., Williams, N. M., . . . 
O'Donovan, M. C. (2006). Evidence that interaction between neuregulin 1 and its 
receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B 
Neuropsychiatr Genet, 141B(1), 96-101. doi: 10.1002/ajmg.b.30236 
 
Numachi, Y., Shen, H., Yoshida, S., Fujiyama, K., Toda, S., Matsuoka, H., . . . Sato, M. 
(2007). Methamphetamine alters expression of DNA methyltransferase 1 mRNA 
in rat brain. Neurosci Lett, 414(3), 213-217. doi: 10.1016/j.neulet.2006.12.052 
 
O'Callaghan, E., Larkin, C., Kinsella, A., & Waddington, J. L. (1991). Familial, obstetric, 
and other clinical correlates of minor physical anomalies in schizophrenia. Am J 
Psychiatry, 148(4), 479-483.  
 
O'Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., . . . 
Molecular Genetics of Schizophrenia, Collaboration. (2008). Identification of loci 
associated with schizophrenia by genome-wide association and follow-up. Nat 
Genet, 40(9), 1053-1055. doi: 10.1038/ng.201 
 
O'Tuathaigh, C. M., Babovic, D., O'Sullivan, G. J., Clifford, J. J., Tighe, O., Croke, D. T., 
. . . Waddington, J. L. (2007). Phenotypic characterization of spatial cognition and 
social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 
1. Neuroscience, 147(1), 18-27. doi: 10.1016/j.neuroscience.2007.03.051 
 
O'Tuathaigh, C. M., O'Connor, A. M., O'Sullivan, G. J., Lai, D., Harvey, R., Croke, D. 
T., & Waddington, J. L. (2008). Disruption to social dyadic interactions but not 
emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the 
schizophrenia risk gene neuregulin-1. Prog Neuropsychopharmacol Biol 
Psychiatry, 32(2), 462-466. doi: 10.1016/j.pnpbp.2007.09.018 
 
O'Tuathaigh, C. M., O'Sullivan, G. J., Kinsella, A., Harvey, R. P., Tighe, O., Croke, D. 
T., & Waddington, J. L. (2006). Sexually dimorphic changes in the exploratory 
and habituation profiles of heterozygous neuregulin-1 knockout mice. 
Neuroreport, 17(1), 79-83.  
 
Oakes, C. C., Smiraglia, D. J., Plass, C., Trasler, J. M., & Robaire, B. (2003). Aging 
	  168	  	  
results in hypermethylation of ribosomal DNA in sperm and liver of male rats. 
Proc Natl Acad Sci U S A, 100(4), 1775-1780. doi: 10.1073/pnas.0437971100 
 
Oberto, M., Soncin, I., Bovolin, P., Voyron, S., De Bortoli, M., Dati, C., . . . Perroteau, I. 
(2001). ErbB-4 and neuregulin expression in the adult mouse olfactory bulb after 
peripheral denervation. Eur J Neurosci, 14(3), 513-521.  
 
Ohtani, N., Goto, T., Waeber, C., & Bhide, P. G. (2003). Dopamine modulates cell cycle 
in the lateral ganglionic eminence. J Neurosci, 23(7), 2840-2850.  
 
Ono, S., Imamura, A., Tasaki, S., Kurotaki, N., Ozawa, H., Yoshiura, K., & Okazaki, Y. 
(2010). Failure to confirm CNVs as of aetiological significance in twin pairs 
discordant for schizophrenia. Twin Res Hum Genet, 13(5), 455-460. doi: 
10.1375/twin.13.5.455 
 
Orona, E., Scott, J. W., & Rainer, E. C. (1983). Different granule cell populations 
innervate superficial and deep regions of the external plexiform layer in rat 
olfactory bulb. J Comp Neurol, 217(2), 227-237. doi: 10.1002/cne.902170209 
 
Owen, M. J. (2012). Implications of genetic findings for understanding schizophrenia. 
Schizophr Bull, 38(5), 904-907. doi: 10.1093/schbul/sbs103 
 
Pagani, F., & Baralle, F. E. (2004). Genomic variants in exons and introns: identifying 
the splicing spoilers. Nat Rev Genet, 5(5), 389-396. doi: 10.1038/Nrg1327 
 
 
Palermo-Neto, J., & Dorce, V. A. (1990). Influences of estrogen and/or progesterone on 
some dopamine related behavior in rats. Gen Pharmacol, 21(1), 83-87.  
 
Park, S., Holzman, P. S., & Goldman-Rakic, P. S. (1995). Spatial working memory 
deficits in the relatives of schizophrenic patients. Arch Gen Psychiatry, 52(10), 
821-828.  
 
Parlapani, E., Schmitt, A., Wirths, O., Bauer, M., Sommer, C., Rueb, U., . . . Falkai, P. 
(2010). Gene expression of neuregulin-1 isoforms in different brain regions of 
elderly schizophrenia patients. World J Biol Psychiatry, 11(2 Pt 2), 243-250. doi: 
10.3109/15622970802022376 
 
Parmar, M., Sjoberg, A., Bjorklund, A., & Kokaia, Z. (2003). Phenotypic and molecular 
identity of cells in the adult subventricular zone. in vivo and after expansion in 
vitro. Mol Cell Neurosci, 24(3), 741-752.  
 
Parnavelas, J. G. (2000). The origin and migration of cortical neurones: new vistas. 
Trends Neurosci, 23(3), 126-131.  
 
Parnavelas, J. G., Barfield, J. A., Franke, E., & Luskin, M. B. (1991). Separate progenitor 
	  169	  	  
cells give rise to pyramidal and nonpyramidal neurons in the rat telencephalon. 
Cereb Cortex, 1(6), 463-468.  
 
Parrish-Aungst, S., Shipley, M. T., Erdelyi, F., Szabo, G., & Puche, A. C. (2007). 
Quantitative analysis of neuronal diversity in the mouse olfactory bulb. J Comp 
Neurol, 501(6), 825-836. doi: 10.1002/cne.21205 
 
Pearlson, G. D., Garbacz, D. J., Moberg, P. J., Ahn, H. S., & DePaulo, J. R. (1985). 
Symptomatic, familial, perinatal, and social correlates of computerized axial 
tomography (CAT) changes in schizophrenics and bipolars. J Nerv Ment Dis, 
173(1), 42-50.  
 
Pearlson, G. D., & Marsh, L. (1999). Structural brain imaging in schizophrenia: a 
selective review. Biol Psychiatry, 46(5), 627-649.  
 
Penrose, L. S. (1955). Parental age and mutation. Lancet, 269(6885), 312-313.  
 
Penrose, L. S. (1957). Parental age in acondroplasia and mongolism. Am J Hum Genet, 
9(3), 167-169.  
 
Perrin, M. C., Brown, A. S., & Malaspina, D. (2007). Aberrant epigenetic regulation 
could explain the relationship of paternal age to schizophrenia. Schizophr Bull, 
33(6), 1270-1273. doi: 10.1093/schbul/sbm093 
 
Perroteau, I., Oberto, M., Ieraci, A., Bovolin, P., & Fasolo, A. (1998). ErbB-3 and ErbB-
4 expression in the mouse olfactory system. Ann N Y Acad Sci, 855, 255-259.  
 
Perroteau, I., Oberto, M., Soncin, I., Voyron, S., De Bortoli, M., Bovolin, P., & Fasolo, 
A. (1999). Transregulation of erbB expression in the mouse olfactory bulb. Cell 
Mol Biol (Noisy-le-grand), 45(3), 293-301.  
 
Perry, W., Minassian, A., Lopez, B., Maron, L., & Lincoln, A. (2007). Sensorimotor 




Petanjek, Z., Judas, M., Simic, G., Rasin, M. R., Uylings, H. B., Rakic, P., & Kostovic, I. 
(2011). Extraordinary neoteny of synaptic spines in the human prefrontal cortex. 
Proc Natl Acad Sci U S A, 108(32), 13281-13286. doi: 10.1073/pnas.1105108108 
 
Petreanu, L., & Alvarez-Buylla, A. (2002). Maturation and death of adult-born olfactory 
bulb granule neurons: role of olfaction. J Neurosci, 22(14), 6106-6113. doi: 
20026588 
 
Petronijevic, N. D., Radonjic, N. V., Ivkovic, M. D., Marinkovic, D., Piperski, V. D., 
Duricic, B. M., & Paunovic, V. R. (2008). Plasma homocysteine levels in young 
	  170	  	  
male patients in the exacerbation and remission phase of schizophrenia. Prog 
Neuropsychopharmacol Biol Psychiatry, 32(8), 1921-1926. doi: 
10.1016/j.pnpbp.2008.09.009 
 
Petronis, A., Gottesman, II, Kan, P., Kennedy, J. L., Basile, V. S., Paterson, A. D., & 
Popendikyte, V. (2003). Monozygotic twins exhibit numerous epigenetic 
differences: clues to twin discordance? Schizophr Bull, 29(1), 169-178.  
 
Petryshen, T. L., Middleton, F. A., Kirby, A., Aldinger, K. A., Purcell, S., Tahl, A. R., . . 
. Sklar, P. (2005). Support for involvement of neuregulin 1 in schizophrenia 
pathophysiology. Mol Psychiatry, 10(4), 366-374, 328. doi: 
10.1038/sj.mp.4001608 
 
Pfefferbaum, A., & Marsh, L. (1995). Structural brain imaging in schizophrenia. Clin 
Neurosci, 3(2), 105-111.  
 
Pinching, A. J. (1970). Synaptic connexions in the glomerular layer of the olfactory bulb. 
J Physiol, 210(1), 14P-15P.  
 
Pinching, A. J., & Powell, T. P. (1971a). The neuron types of the glomerular layer of the 
olfactory bulb. J Cell Sci, 9(2), 305-345.  
 
Pinching, A. J., & Powell, T. P. (1971b). The neuropil of the glomeruli of the olfactory 
bulb. J Cell Sci, 9(2), 347-377.  
 
Plailly, J., d'Amato, T., Saoud, M., & Royet, J. P. (2006). Left temporo-limbic and orbital 
dysfunction in schizophrenia during odor familiarity and hedonicity judgments. 
Neuroimage, 29(1), 302-313. doi: S1053-8119(05)00484-2 [pii] 
10.1016/j.neuroimage.2005.06.056 
 
Pleasure, S. J., Anderson, S., Hevner, R., Bagri, A., Marin, O., Lowenstein, D. H., & 
Rubenstein, J. L. (2000). Cell migration from the ganglionic eminences is 
required for the development of hippocampal GABAergic interneurons. Neuron, 
28(3), 727-740.  
 
Polleux, F., Whitford, K. L., Dijkhuizen, P. A., Vitalis, T., & Ghosh, A. (2002). Control 
of cortical interneuron migration by neurotrophins and PI3-kinase signaling. 
Development, 129(13), 3147-3160.  
 
Pollin, W., Cardon, P. V., Jr., & Kety, S. S. (1961). Effects of amino acid feedings in 
schizophrenic patients treated with iproniazid. Science, 133(3446), 104-105.  
 
Preston, G. A., & Weinberger, D. R. (2005). Intermediate phenotypes in schizophrenia: a 
selective review. Dialogues Clin Neurosci, 7(2), 165-179.  
 
Price, J. L., & Powell, T. P. (1970). The morphology of the granule cells of the olfactory 
	  171	  	  
bulb. J Cell Sci, 7(1), 91-123.  
 
Quinlan, L. R., Faherty, S., & Kane, M. T. (2003). Phospholipase C and protein kinase C 
involvement in mouse embryonic stem-cell proliferation and apoptosis. 
Reproduction, 126(1), 121-131.  
 
Rakyan, V. K., Chong, S., Champ, M. E., Cuthbert, P. C., Morgan, H. D., Luu, K. V., & 
Whitelaw, E. (2003). Transgenerational inheritance of epigenetic states at the 
murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl 
Acad Sci U S A, 100(5), 2538-2543. doi: 10.1073/pnas.0436776100 
 
Rampon, C., Jiang, C. H., Dong, H., Tang, Y. P., Lockhart, D. J., Schultz, P. G., . . . Hu, 
Y. (2000). Effects of environmental enrichment on gene expression in the brain. 
Proc Natl Acad Sci U S A, 97(23), 12880-12884. doi: 10.1073/pnas.97.23.12880 
 
Raychaudhuri, S., Plenge, R. M., Rossin, E. J., Ng, A. C., International Schizophrenia, 
Consortium, Purcell, S. M., . . . Daly, M. J. (2009). Identifying relationships 
among genomic disease regions: predicting genes at pathogenic SNP associations 
and rare deletions. PLoS Genet, 5(6), e1000534. doi: 
10.1371/journal.pgen.1000534 
 
Regland, B., Johansson, B. V., Grenfeldt, B., Hjelmgren, L. T., & Medhus, M. (1995). 
Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen 
Sect, 100(2), 165-169.  
 
Reichenberg, A., Gross, R., Weiser, M., Bresnahan, M., Silverman, J., Harlap, S., . . . 
Susser, E. (2006). Advancing paternal age and autism. Arch Gen Psychiatry, 
63(9), 1026-1032. doi: 63/9/1026 [pii] 
10.1001/archpsyc.63.9.1026 
 
Reite, M., Sheeder, J., Teale, P., Adams, M., Richardson, D., Simon, J., . . . Rojas, D. C. 
(1997). Magnetic source imaging evidence of sex differences in cerebral 
lateralization in schizophrenia. Arch Gen Psychiatry, 54(5), 433-440.  
 
Ressler, K. J., Sullivan, S. L., & Buck, L. B. (1993). A zonal organization of odorant 
receptor gene expression in the olfactory epithelium. Cell, 73(3), 597-609.  
 
Ressler, K. J., Sullivan, S. L., & Buck, L. B. (1994). Information coding in the olfactory 
system: evidence for a stereotyped and highly organized epitope map in the 
olfactory bulb. Cell, 79(7), 1245-1255.  
 
Rico, B., & Marin, O. (2011). Neuregulin signaling, cortical circuitry development and 
schizophrenia. Curr Opin Genet Dev, 21(3), 262-270. doi: 
10.1016/j.gde.2010.12.010 
 
Riecher-Rossler, A., Hafner, H., Stumbaum, M., Maurer, K., & Schmidt, R. (1994). Can 
	  172	  	  
estradiol modulate schizophrenic symptomatology? Schizophr Bull, 20(1), 203-
214.  
 
Rietschel, M., Mattheisen, M., Degenhardt, F., Genetic, Risk, Outcome in, Psychosis, 
Muhleisen, T. W., . . . Cichon, S. (2012). Association between genetic variation in 
a region on chromosome 11 and schizophrenia in large samples from Europe. Mol 
Psychiatry, 17(9), 906-917. doi: 10.1038/mp.2011.80 
 
Rimer, M., Barrett, D. W., Maldonado, M. A., Vock, V. M., & Gonzalez-Lima, F. (2005). 
Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and 
impaired latent inhibition. Neuroreport, 16(3), 271-275.  
 
Risch, N., & Baron, M. (1984). Segregation analysis of schizophrenia and related 
disorders. Am J Hum Genet, 36(5), 1039-1059.  
 
Risch, N., Reich, E. W., Wishnick, M. M., & McCarthy, J. G. (1987). Spontaneous 
mutation and parental age in humans. Am J Hum Genet, 41(2), 218-248.  
 
Roalf, D. R., Turetsky, B. I., Owzar, K., Balderston, C. C., Johnson, S. C., Brensinger, C. 
M., . . . Moberg, P. J. (2006). Unirhinal olfactory function in schizophrenia 
patients and first-degree relatives. J Neuropsychiatry Clin Neurosci, 18(3), 389-
396. doi: 18/3/389 [pii] 
10.1176/appi.neuropsych.18.3.389 
 
Rochefort, C., Gheusi, G., Vincent, J. D., & Lledo, P. M. (2002). Enriched odor exposure 
increases the number of newborn neurons in the adult olfactory bulb and improves 
odor memory. J Neurosci, 22(7), 2679-2689. doi: 20026260 
 
Rochefort, C., & Lledo, P. M. (2005). Short-term survival of newborn neurons in the 
adult olfactory bulb after exposure to a complex odor environment. Eur J 
Neurosci, 22(11), 2863-2870. doi: 10.1111/j.1460-9568.2005.04486.x 
 
Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J. M., Maroteaux, P., . 
. . Munnich, A. (1994). Mutations in the gene encoding fibroblast growth factor 
receptor-3 in achondroplasia. Nature, 371(6494), 252-254. doi: 10.1038/371252a0 
 
Rousselot, P., Lois, C., & Alvarez-Buylla, A. (1995). Embryonic (PSA) N-CAM reveals 
chains of migrating neuroblasts between the lateral ventricle and the olfactory 
bulb of adult mice. J Comp Neurol, 351(1), 51-61. doi: 10.1002/cne.903510106 
 
Rubin, B. D., & Katz, L. C. (1999). Optical imaging of odorant representations in the 
mammalian olfactory bulb. Neuron, 23(3), 499-511.  
 
Rubin, B. D., & Katz, L. C. (2001). Spatial coding of enantiomers in the rat olfactory 
bulb. Nat Neurosci, 4(4), 355-356. doi: 10.1038/85997 
 
	  173	  	  
Rubin, L. H., Carter, C. S., Drogos, L., Pournajafi-Nazarloo, H., Sweeney, J. A., & Maki, 
P. M. (2010). Peripheral oxytocin is associated with reduced symptom severity in 
schizophrenia. Schizophr Res, 124(1-3), 13-21. doi: 10.1016/j.schres.2010.09.014 
 
Ruiz de Elvira, M. C., Persaud, R., & Coen, C. W. (1992). Use of running wheels 
regulates the effects of the ovaries on circadian rhythms. Physiol Behav, 52(2), 
277-284.  
 
Rutten, B. P., & Mill, J. (2009). Epigenetic mediation of environmental influences in 
major psychotic disorders. Schizophr Bull, 35(6), 1045-1056. doi: 
10.1093/schbul/sbp104 
 
Saha, S., Barnett, A. G., Foldi, C., Burne, T. H., Eyles, D. W., Buka, S. L., & McGrath, J. 
J. (2009). Advanced paternal age is associated with impaired neurocognitive 




Sahay, A., Wilson, D. A., & Hen, R. (2011). Pattern separation: a common function for 
new neurons in hippocampus and olfactory bulb. Neuron, 70(4), 582-588. doi: 
10.1016/j.neuron.2011.05.012 
 
Sams-Dodd, F. (1998). Effects of continuous D-amphetamine and phencyclidine 
administration on social behaviour, stereotyped behaviour, and locomotor activity 
in rats. Neuropsychopharmacology, 19(1), 18-25. doi: 10.1016/S0893-
133X(97)00200-5 
 
Sanai, N., Nguyen, T., Ihrie, R. A., Mirzadeh, Z., Tsai, H. H., Wong, M., . . . Alvarez-
Buylla, A. (2011). Corridors of migrating neurons in the human brain and their 
decline during infancy. Nature, 478(7369), 382-386. doi: 10.1038/nature10487 
 
Sato, K., Hayashi, T., Sasaki, C., Iwai, M., Li, F., Manabe, Y., . . . Abe, K. (2001). 
Temporal and spatial differences of PSA-NCAM expression between young-adult 
and aged rats in normal and ischemic brains. Brain Res, 922(1), 135-139.  
 
Sawada, M., Kaneko, N., Inada, H., Wake, H., Kato, Y., Yanagawa, Y., . . . Sawamoto, 
K. (2011). Sensory input regulates spatial and subtype-specific patterns of 
neuronal turnover in the adult olfactory bulb. J Neurosci, 31(32), 11587-11596. 
doi: 10.1523/JNEUROSCI.0614-11.2011 
 
Scala, S., Lasalvia, A., Cristofalo, D., Bonetto, C., & Ruggeri, M. (2012). Neurocognitive 
profile and its association with psychopathology in first-degree relatives of 
patients with schizophrenia. a case-control study. Psychiatry Res, 200(2-3), 137-
143. doi: 10.1016/j.psychres.2012.05.006 
 
Scala, S., Lasalvia, A., Seidman, L. J., Cristofalo, D., Bonetto, C., & Ruggeri, M. (2013). 
	  174	  	  
Executive functioning and psychopathological profile in relatives of individuals 
with deficit v. non-deficit schizophrenia: a pilot study. Epidemiol Psychiatr Sci, 1-
13. doi: 10.1017/S2045796013000140 
 
Schmitt, A., Parlapani, E., Gruber, O., Wobrock, T., & Falkai, P. (2008). Impact of 
neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem 
studies. Eur Arch Psychiatry Clin Neurosci, 258 Suppl 5, 35-39. doi: 
10.1007/s00406-008-5019-x 
 
Schoppa, N. E., & Urban, N. N. (2003). Dendritic processing within olfactory bulb 
circuits. Trends Neurosci, 26(9), 501-506. doi: 10.1016/S0166-2236(03)00228-5 
 
Schreier, A., Wolke, D., Thomas, K., Horwood, J., Hollis, C., Gunnell, D., . . . Harrison, 
G. (2009). Prospective study of peer victimization in childhood and psychotic 
symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry, 
66(5), 527-536. doi: 10.1001/archgenpsychiatry.2009.23 
 
Scolnick, E. M., Petryshen, T., & Sklar, P. (2006). Schizophrenia: do the genetics and 
neurobiology of neuregulin provide a pathogenesis model? Harv Rev Psychiatry, 
14(2), 64-77. doi: 10.1080/10673220600642960 
 
Seidman, L. J., Goldstein, J. M., Goodman, J. M., Koren, D., Turner, W. M., Faraone, S. 
V., & Tsuang, M. T. (1997). Sex differences in olfactory identification and 
Wisconsin Card Sorting performance in schizophrenia: relationship to attention 




Serby, M., Larson, P., & Kalkstein, D. (1990). Olfactory sense in psychoses. Biol 
Psychiatry, 28(9), 830.  
 
Serizawa, S., Miyamichi, K., Nakatani, H., Suzuki, M., Saito, M., Yoshihara, Y., & 
Sakano, H. (2003). Negative feedback regulation ensures the one receptor-one 
olfactory neuron rule in mouse. Science, 302(5653), 2088-2094. doi: 
10.1126/science.1089122 
 
Sfikakis, A., Spyraki, C., Sitaras, N., & Varonos, D. (1978). Implication of the estrous 
cycle on conditioned avoidance behavior in the rat. Physiol Behav, 21(3), 441-
446.  
 
Shepherd, G. M., Chen, W. R., Willhite, D., Migliore, M., & Greer, C. A. (2007). The 
olfactory granule cell: from classical enigma to central role in olfactory 
processing. Brain Res Rev, 55(2), 373-382. doi: 
10.1016/j.brainresrev.2007.03.005 
 
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe'er, I., . . . Gejman, P. V. 
	  175	  	  
(2009). Common variants on chromosome 6p22.1 are associated with 
schizophrenia. Nature, 460(7256), 753-757. doi: 10.1038/nature08192 
 
Shifman, S., Johannesson, M., Bronstein, M., Chen, S. X., Collier, D. A., Craddock, N. 
J., . . . Darvasi, A. (2008). Genome-wide association identifies a common variant 
in the reelin gene that increases the risk of schizophrenia only in women. PLoS 
Genet, 4(2), e28. doi: 10.1371/journal.pgen.0040028 
 
Shipley, M. T., & Ennis, M. (1996). Functional organization of olfactory system. J 
Neurobiol, 30(1), 123-176. doi: 10.1002/(SICI)1097-
4695(199605)30:1&lt;123::AID-NEU11&gt;3.0.CO;2-N 
 
Shors, T. J., Lewczyk, C., Pacynski, M., Mathew, P. R., & Pickett, J. (1998). Stages of 
estrous mediate the stress-induced impairment of associative learning in the 
female rat. Neuroreport, 9(3), 419-423.  
 
Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C., & Gur, R. C. (1992). Gender 
differences in the clinical expression of schizophrenia. Schizophr Res, 7(3), 225-
231.  
 
Si, J., Wang, Q., & Mei, L. (1999). Essential roles of c-JUN and c-JUN N-terminal kinase 
(JNK) in neuregulin-increased expression of the acetylcholine receptor epsilon-
subunit. J Neurosci, 19(19), 8498-8508.  
 
Siegmund, K. D., Connor, C. M., Campan, M., Long, T. I., Weisenberger, D. J., 
Biniszkiewicz, D., . . . Akbarian, S. (2007). DNA methylation in the human 
cerebral cortex is dynamically regulated throughout the life span and involves 
differentiated neurons. PLoS One, 2(9), e895. doi: 10.1371/journal.pone.0000895 
 
Silberberg, G., Darvasi, A., Pinkas-Kramarski, R., & Navon, R. (2006). The involvement 
of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet 
B Neuropsychiatr Genet, 141B(2), 142-148. doi: 10.1002/ajmg.b.30275 
 
Silberberg, G., Gupta, A., & Markram, H. (2002). Stereotypy in neocortical 
microcircuits. Trends Neurosci, 25(5), 227-230.  
 
Singh, M., Meyer, E. M., Millard, W. J., & Simpkins, J. W. (1994). Ovarian steroid 
deprivation results in a reversible learning impairment and compromised 
cholinergic function in female Sprague-Dawley rats. Brain Res, 644(2), 305-312.  
 
Slotnick, B., & Bisulco, S. (2003). Detection and discrimination of carvone enantiomers 
in rats with olfactory bulb lesions. Neuroscience, 121(2), 451-457.  
 
Smith, E. E., Jonides, J., Marshuetz, C., & Koeppe, R. A. (1998). Components of verbal 
working memory: evidence from neuroimaging. Proc Natl Acad Sci U S A, 95(3), 
876-882.  
	  176	  	  
 
Smith, R. G., Kember, R. L., Mill, J., Fernandes, C., Schalkwyk, L. C., Buxbaum, J. D., 
& Reichenberg, A. (2009). Advancing paternal age is associated with deficits in 
social and exploratory behaviors in the offspring: a mouse model. PLoS One, 
4(12), e8456. doi: 10.1371/journal.pone.0008456 
 
Smithies, O. (1993). Animal models of human genetic diseases. Trends Genet, 9(4), 112-
116.  
 
Snitz, B. E., Macdonald, A. W., 3rd, & Carter, C. S. (2006). Cognitive deficits in 
unaffected first-degree relatives of schizophrenia patients: a meta-analytic review 
of putative endophenotypes. Schizophr Bull, 32(1), 179-194. doi: 
10.1093/schbul/sbi048 
 
Somogyi, P., Freund, T. F., Wu, J. Y., & Smith, A. D. (1983). The section-Golgi 
impregnation procedure. 2. Immunocytochemical demonstration of glutamate 
decarboxylase in Golgi-impregnated neurons and in their afferent synaptic 
boutons in the visual cortex of the cat. Neuroscience, 9(3), 475-490.  
 
Somogyi, P., Tamas, G., Lujan, R., & Buhl, E. H. (1998). Salient features of synaptic 
organisation in the cerebral cortex. Brain Res Brain Res Rev, 26(2-3), 113-135.  
 
Spence, J. D., Howard, V. J., Chambless, L. E., Malinow, M. R., Pettigrew, L. C., 
Stampfer, M., & Toole, J. F. (2001). Vitamin Intervention for Stroke Prevention 
(VISP) trial: rationale and design. Neuroepidemiology, 20(1), 16-25. doi: 54753 
 
Sperber, G. H. (1992). First year of life: prenatal craniofacial development. Cleft Palate 
Craniofac J, 29(2), 109-111. doi: 10.1597/1545-
1569(1992)029<0109:FYOLPC>2.3.CO;2 
 
Spors, H., & Grinvald, A. (2002). Spatio-temporal dynamics of odor representations in 
the mammalian olfactory bulb. Neuron, 34(2), 301-315.  
 
Spors, H., Wachowiak, M., Cohen, L. B., & Friedrich, R. W. (2006). Temporal dynamics 
and latency patterns of receptor neuron input to the olfactory bulb. J Neurosci, 
26(4), 1247-1259. doi: 10.1523/JNEUROSCI.3100-05.2006 
 
Staal, W. G., Hulshoff Pol, H. E., Schnack, H. G., Hoogendoorn, M. L., Jellema, K., & 
Kahn, R. S. (2000). Structural brain abnormalities in patients with schizophrenia 
and their healthy siblings. Am J Psychiatry, 157(3), 416-421.  
 
Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., . 
. . Collier, D. A. (2009). Common variants conferring risk of schizophrenia. 
Nature, 460(7256), 744-747. doi: 10.1038/nature08186 
 
Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O. P., Ingason, A., Steinberg, S., . . . 
	  177	  	  
Stefansson, K. (2008). Large recurrent microdeletions associated with 
schizophrenia. Nature, 455(7210), 232-236. doi: 10.1038/nature07229 
 
Stefansson, H., Sarginson, J., Kong, A., Yates, P., Steinthorsdottir, V., Gudfinnsson, E., . 
. . St Clair, D. (2003). Association of neuregulin 1 with schizophrenia confirmed 
in a Scottish population. Am J Hum Genet, 72(1), 83-87.  
 
Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., 
Ghosh, S., . . . Stefansson, K. (2002). Neuregulin 1 and susceptibility to 




Steiner, H., Blum, M., Kitai, S. T., & Fedi, P. (1999). Differential expression of ErbB3 
and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the 
adult rat. Exp Neurol, 159(2), 494-503. doi: 10.1006/exnr.1999.7163 
S0014-4886(99)97163-7 [pii] 
 
Stenman, J., Toresson, H., & Campbell, K. (2003). Identification of two distinct 
progenitor populations in the lateral ganglionic eminence: implications for striatal 
and olfactory bulb neurogenesis. J Neurosci, 23(1), 167-174.  
 
Stewart, W. B., Kauer, J. S., & Shepherd, G. M. (1979). Functional organization of rat 
olfactory bulb analysed by the 2-deoxyglucose method. J Comp Neurol, 185(4), 
715-734. doi: 10.1002/cne.901850407 
 
Strauss, G. P., Allen, D. N., Ross, S. A., Duke, L. A., & Schwartz, J. (2010). Olfactory 
hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr 
Bull, 36(4), 860-868. doi: sbn178 [pii] 
10.1093/schbul/sbn178 
 
Sudhof, T. C. (2008). Neuroligins and neurexins link synaptic function to cognitive 
disease. Nature, 455(7215), 903-911. doi: 10.1038/nature07456 
 
Sui, Y., Horne, M. K., & Stanic, D. (2012). Reduced proliferation in the adult mouse 
subventricular zone increases survival of olfactory bulb interneurons. PLoS One, 
7(2), e31549. doi: 10.1371/journal.pone.0031549 
 
Sullivan, P. F., Lin, D., Tzeng, J. Y., van den Oord, E., Perkins, D., Stroup, T. S., . . . 
Close, S. L. (2008). Genomewide association for schizophrenia in the CATIE 
study: results of stage 1. Mol Psychiatry, 13(6), 570-584. doi: 
10.1038/mp.2008.25 
 
Sultan, S., Mandairon, N., Kermen, F., Garcia, S., Sacquet, J., & Didier, A. (2010). 
Learning-dependent neurogenesis in the olfactory bulb determines long-term 
olfactory memory. FASEB J, 24(7), 2355-2363. doi: 10.1096/fj.09-151456 
	  178	  	  
 
Sun, J. X., Helgason, A., Masson, G., Ebenesersdottir, S. S., Li, H., Mallick, S., . . . 
Stefansson, K. (2012). A direct characterization of human mutation based on 
microsatellites. Nat Genet, 44(10), 1161-1165. doi: 10.1038/ng.2398 
 
Sussel, L., Marin, O., Kimura, S., & Rubenstein, J. L. (1999). Loss of Nkx2.1 homeobox 
gene function results in a ventral to dorsal molecular respecification within the 
basal telencephalon: evidence for a transformation of the pallidum into the 
striatum. Development, 126(15), 3359-3370.  
 
Susser, E., Brown, A. S., Klonowski, E., Allen, R. H., & Lindenbaum, J. (1998). 
Schizophrenia and impaired homocysteine metabolism: a possible association. 
Biol Psychiatry, 44(2), 141-143.  
 
Susser, E., Neugebauer, R., Hoek, H. W., Brown, A. S., Lin, S., Labovitz, D., & Gorman, 
J. M. (1996). Schizophrenia after prenatal famine. Further evidence. Arch Gen 
Psychiatry, 53(1), 25-31.  
 
Swank, M. W., & Sweatt, J. D. (2001). Increased histone acetyltransferase and lysine 
acetyltransferase activity and biphasic activation of the ERK/RSK cascade in 
insular cortex during novel taste learning. J Neurosci, 21(10), 3383-3391.  
 
Swerdlow, N. R., & Geyer, M. A. (1998). Using an animal model of deficient 
sensorimotor gating to study the pathophysiology and new treatments of 
schizophrenia. Schizophr Bull, 24(2), 285-301.  
 
Szatkowska, I., Szymanska, O., & Grabowska, A. (2004). The role of the human 
ventromedial prefrontal cortex in memory for contextual information. Neurosci 
Lett, 364(2), 71-75. doi: 10.1016/j.neulet.2004.03.084 
 
Takahashi, T., Suzuki, M., Kawasaki, Y., Hagino, H., Yamashita, I., Nohara, S., . . . 
Kurachi, M. (2003). Perigenual cingulate gyrus volume in patients with 
schizophrenia: a magnetic resonance imaging study. Biol Psychiatry, 53(7), 593-
600.  
 
Talmage, D. A. (2008). Mechanisms of neuregulin action. Novartis Found Symp, 289, 
74-84; discussion 84-93.  
 
Tam, G. W., Redon, R., Carter, N. P., & Grant, S. G. (2009). The role of DNA copy 
number variation in schizophrenia. Biol Psychiatry, 66(11), 1005-1012. doi: 
10.1016/j.biopsych.2009.07.027 
 
Tamamaki, N. (2005). Origin of the neocortical subependymal cells speculated by Emx1 
and GAD67 expression. Chem Senses, 30 Suppl 1, i111-112. doi: 
10.1093/chemse/bjh139 
 
	  179	  	  
Tamminga, C. A. (1998). Schizophrenia and glutamatergic transmission. Crit Rev 
Neurobiol, 12(1-2), 21-36.  
 
Tang, J. X., Chen, W. Y., He, G., Zhou, J., Gu, N. F., Feng, G. Y., & He, L. (2004). 
Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated 
with schizophrenia in the Chinese population. Mol Psychiatry, 9(1), 11-12. doi: 
10.1038/sj.mp.4001436 
 
Tarantino, L. M., & Bucan, M. (2000). Dissection of behavior and psychiatric disorders 
using the mouse as a model. Hum Mol Genet, 9(6), 953-965.  
 
Tarrant, C. J., & Jones, P. B. (1999). Precursors to schizophrenia: do biological markers 
have specificity? Can J Psychiatry, 44(4), 335-349.  
 
Taylor, G. T., Maloney, S., Dearborn, J., & Weiss, J. (2009). Hormones in the mentally 
disturbed brain: steroids and peptides in the development and treatment of 
psychopathology. Cent Nerv Syst Agents Med Chem, 9(4), 331-360.  
 
Tek, C., Kirkpatrick, B., & Buchanan, R. W. (2001). A five-year followup study of 
deficit and nondeficit schizophrenia. Schizophr Res, 49(3), 253-260.  
 
Thiselton, D. L., Webb, B. T., Neale, B. M., Ribble, R. C., O'Neill, F. A., Walsh, D., . . . 
Kendler, K. S. (2004). No evidence for linkage or association of neuregulin-1 
(Nrg1) with disease in the Irish study of high-density schizophrenia families 
(ISHDSF). Mol Psychiatry, 9(8), 777-783; image 729. doi: 
10.1038/sj.mp.4001530 
 
Thomas, D. K., Storlien, L. H., Bellingham, W. P., & Gillette, K. (1986). Ovarian 
hormone effects on activity, glucoregulation and thyroid hormones in the rat. 
Physiol Behav, 36(3), 567-573.  
 
Tienari, P. (1991). Interaction between genetic vulnerability and family environment: the 
Finnish adoptive family study of schizophrenia. Acta Psychiatr Scand, 84(5), 460-
465.  
 
Tienari, P., Sorri, A., Lahti, I., Naarala, M., Wahlberg, K. E., Ronkko, T., . . . Moring, J. 
(1985). The Finnish adoptive family study of schizophrenia. Yale J Biol Med, 
58(3), 227-237.  
 
Tienari, P., Wynne, L. C., Moring, J., Lahti, I., Naarala, M., Sorri, A., . . . et al. (1994). 
The Finnish adoptive family study of schizophrenia. Implications for family 
research. Br J Psychiatry Suppl(23), 20-26.  
 
Tienari, P., Wynne, L. C., Sorri, A., Lahti, I., Laksy, K., Moring, J., . . . Wahlberg, K. E. 
(2004). Genotype-environment interaction in schizophrenia-spectrum disorder. 
Long-term follow-up study of Finnish adoptees. Br J Psychiatry, 184, 216-222.  
	  180	  	  
 
Toresson, H., Potter, S. S., & Campbell, K. (2000). Genetic control of dorsal-ventral 
identity in the telencephalon: opposing roles for Pax6 and Gsh2. Development, 
127(20), 4361-4371.  
 
Tremolizzo, L., Carboni, G., Ruzicka, W. B., Mitchell, C. P., Sugaya, I., Tueting, P., . . . 
Guidotti, A. (2002). An epigenetic mouse model for molecular and behavioral 
neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S 
A, 99(26), 17095-17100. doi: 10.1073/pnas.262658999 
 
Tsuang, M. T., Bucher, K. D., & Fleming, J. A. (1982). Testing the monogenic theory of 
schizophrenia: An application of segregation analysis to blind family study data. 
Br J Psychiatry, 140, 595-599.  
 
Tsuchiya, K. J., Takagai, S., Kawai, M., Matsumoto, H., Nakamura, K., Minabe, Y., . . . 
Takei, N. (2005). Advanced paternal age associated with an elevated risk for 
schizophrenia in offspring in a Japanese population. Schizophr Res, 76(2-3), 337-
342. doi: S0920-9964(05)00090-3 [pii] 
10.1016/j.schres.2005.03.004 
 
Turetsky, B. I., Moberg, P. J., Arnold, S. E., Doty, R. L., & Gur, R. E. (2003). Low 
olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am 
J Psychiatry, 160(4), 703-708.  
 
Turetsky, B. I., Moberg, P. J., Yousem, D. M., Doty, R. L., Arnold, S. E., & Gur, R. E. 
(2000). Reduced olfactory bulb volume in patients with schizophrenia. Am J 
Psychiatry, 157(5), 828-830.  
 
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., . . . 
Yarden, Y. (1996). A hierarchical network of interreceptor interactions 
determines signal transduction by Neu differentiation factor/neuregulin and 
epidermal growth factor. Mol Cell Biol, 16(10), 5276-5287.  
 
Uchida, N., & Mainen, Z. F. (2003). Speed and accuracy of olfactory discrimination in 
the rat. Nat Neurosci, 6(11), 1224-1229. doi: 10.1038/nn1142 
 
Uggerby, P., Nielsen, R. E., Correll, C. U., & Nielsen, J. (2011). Characteristics and 
predictors of long-term institutionalization in patients with schizophrenia. 
Schizophr Res, 131(1-3), 120-126. doi: 10.1016/j.schres.2011.03.001 
 
Ugur, T., Weisbrod, M., Franzek, E., Pfuller, U., & Sauer, H. (2005). Olfactory 
impairment in monozygotic twins discordant for schizophrenia. Eur Arch 
Psychiatry Clin Neurosci, 255(2), 94-98. doi: 10.1007/s00406-004-0536-8 
 
Usall, J., Ochoa, S., Araya, S., Marquez, M., & Group, Nedes. (2003). Gender differences 
and outcome in schizophrenia: a 2-year follow-up study in a large community 
	  181	  	  
sample. Eur Psychiatry, 18(6), 282-284.  
 
Usall, J., Suarez, D., Haro, J. M., & Group, Soho Study. (2007). Gender differences in 
response to antipsychotic treatment in outpatients with schizophrenia. Psychiatry 
Res, 153(3), 225-231. doi: 10.1016/j.psychres.2006.09.016 
 
Valcanis, H., & Tan, S. S. (2003). Layer specification of transplanted interneurons in 
developing mouse neocortex. J Neurosci, 23(12), 5113-5122.  
 
Valley, M. T., Mullen, T. R., Schultz, L. C., Sagdullaev, B. T., & Firestein, S. (2009). 
Ablation of mouse adult neurogenesis alters olfactory bulb structure and olfactory 
fear conditioning. Front Neurosci, 3, 51. doi: 10.3389/neuro.22.003.2009 
 




van Os, J., Kenis, G., & Rutten, B. P. (2010). The environment and schizophrenia. 
Nature, 468(7321), 203-212. doi: 10.1038/nature09563 
 
van Os, J., Pedersen, C. B., & Mortensen, P. B. (2004). Confirmation of synergy between 
urbanicity and familial liability in the causation of psychosis. Am J Psychiatry, 
161(12), 2312-2314. doi: 10.1176/appi.ajp.161.12.2312 
 
Vassar, R., Chao, S. K., Sitcheran, R., Nunez, J. M., Vosshall, L. B., & Axel, R. (1994). 
Topographic organization of sensory projections to the olfactory bulb. Cell, 79(6), 
981-991.  
 
Ventura, R. E., & Goldman, J. E. (2007). Dorsal radial glia generate olfactory bulb 
interneurons in the postnatal murine brain. J Neurosci, 27(16), 4297-4302. doi: 
10.1523/JNEUROSCI.0399-07.2007 
 
Verona, R. I., Mann, M. R., & Bartolomei, M. S. (2003). Genomic imprinting: intricacies 
of epigenetic regulation in clusters. Annu Rev Cell Dev Biol, 19, 237-259. doi: 
10.1146/annurev.cellbio.19.111401.092717 
 
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000). 
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset 
of prefrontal cortical gamma-aminobutyric acid neurons in subjects with 
schizophrenia. Arch Gen Psychiatry, 57(3), 237-245.  
 
Vucurovic, K., Gallopin, T., Ferezou, I., Rancillac, A., Chameau, P., van Hooft, J. A., . . . 
Vitalis, T. (2010). Serotonin 3A receptor subtype as an early and protracted 
marker of cortical interneuron subpopulations. Cereb Cortex, 20(10), 2333-2347. 
doi: 10.1093/cercor/bhp310 
 
	  182	  	  
Wachowiak, M., & Shipley, M. T. (2006). Coding and synaptic processing of sensory 
information in the glomerular layer of the olfactory bulb. Semin Cell Dev Biol, 
17(4), 411-423. doi: 10.1016/j.semcdb.2006.04.007 
 
Waclaw, R. R., Allen, Z. J., 2nd, Bell, S. M., Erdelyi, F., Szabo, G., Potter, S. S., & 
Campbell, K. (2006). The zinc finger transcription factor Sp8 regulates the 
generation and diversity of olfactory bulb interneurons. Neuron, 49(4), 503-516. 
doi: 10.1016/j.neuron.2006.01.018 
 
Wade, G. N., & Zucker, I. (1970). Modulation of food intake and locomotor activity in 
female rats by diencephalic hormone implants. J Comp Physiol Psychol, 72(2), 
328-336.  
 
Wakade, C. G., Mahadik, S. P., Waller, J. L., & Chiu, F. C. (2002). Atypical neuroleptics 
stimulate neurogenesis in adult rat brain. J Neurosci Res, 69(1), 72-79. doi: 
10.1002/jnr.10281 
 
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, 
G. M., . . . Sebat, J. (2008). Rare structural variants disrupt multiple genes in 
neurodevelopmental pathways in schizophrenia. Science, 320(5875), 539-543. 
doi: 10.1126/science.1155174 
 
Wang, Y., Toledo-Rodriguez, M., Gupta, A., Wu, C., Silberberg, G., Luo, J., & Markram, 
H. (2004). Anatomical, physiological and molecular properties of Martinotti cells 
in the somatosensory cortex of the juvenile rat. J Physiol, 561(Pt 1), 65-90. doi: 
10.1113/jphysiol.2004.073353 
 
Waterland, R. A. (2006). Assessing the effects of high methionine intake on DNA 
methylation. J Nutr, 136(6 Suppl), 1706S-1710S.  
 
Weaver, I. C., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., 
. . . Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nat 
Neurosci, 7(8), 847-854. doi: 10.1038/nn1276 
 
Weaver, I. C., D'Alessio, A. C., Brown, S. E., Hellstrom, I. C., Dymov, S., Sharma, S., . . 
. Meaney, M. J. (2007). The transcription factor nerve growth factor-inducible 
protein a mediates epigenetic programming: altering epigenetic marks by 
immediate-early genes. J Neurosci, 27(7), 1756-1768. doi: 
10.1523/JNEUROSCI.4164-06.2007 
 
Weickert, C. S., Tiwari, Y., Schofield, P. R., Mowry, B. J., & Fullerton, J. M. (2012). 
Schizophrenia-associated HapICE haplotype is associated with increased Nrg1 
type III expression and high nucleotide diversity. Transl Psychiatry, 2, e104. doi: 
10.1038/tp.2012.25 
 
Wender, P. H., Rosenthal, D., Kety, S. S., Schulsinger, F., & Welner, J. (1974). 
	  183	  	  
Crossfostering. A research strategy for clarifying the role of genetic and 
experiential factors in the etiology of schizophrenia. Arch Gen Psychiatry, 30(1), 
121-128.  
 
Whalley, H. C., Harris, J. C., & Lawrie, S. M. (2007). The neurobiological underpinnings 
of risk and conversion in relatives of patients with schizophrenia. Int Rev 
Psychiatry, 19(4), 383-397. doi: 10.1080/09540260701496869 
 
Whitman, M. C., & Greer, C. A. (2009). Adult neurogenesis and the olfactory system. 
Prog Neurobiol, 89(2), 162-175. doi: 10.1016/j.pneurobio.2009.07.003 
 
Wichterle, H., Alvarez-Dolado, M., Erskine, L., & Alvarez-Buylla, A. (2003). Permissive 
corridor and diffusible gradients direct medial ganglionic eminence cell migration 
to the neocortex. Proc Natl Acad Sci U S A, 100(2), 727-732. doi: 
10.1073/pnas.242721899 
 
Wichterle, H., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (1997). Direct evidence for 
homotypic, glia-independent neuronal migration. Neuron, 18(5), 779-791.  
 
Wichterle, H., Garcia-Verdugo, J. M., Herrera, D. G., & Alvarez-Buylla, A. (1999). 
Young neurons from medial ganglionic eminence disperse in adult and embryonic 
brain. Nat Neurosci, 2(5), 461-466. doi: 10.1038/8131 
 
Wichterle, H., Turnbull, D. H., Nery, S., Fishell, G., & Alvarez-Buylla, A. (2001). In 
utero fate mapping reveals distinct migratory pathways and fates of neurons born 
in the mammalian basal forebrain. Development, 128(19), 3759-3771.  
 
Wilkin, D. J., Szabo, J. K., Cameron, R., Henderson, S., Bellus, G. A., Mack, M. L., . . . 
Francomano, C. A. (1998). Mutations in fibroblast growth-factor receptor 3 in 
sporadic cases of achondroplasia occur exclusively on the paternally derived 




Willaime-Morawek, S., Seaberg, R. M., Batista, C., Labbe, E., Attisano, L., Gorski, J. A., 
. . . van der Kooy, D. (2006). Embryonic cortical neural stem cells migrate 
ventrally and persist as postnatal striatal stem cells. J Cell Biol, 175(1), 159-168. 
doi: 10.1083/jcb.200604123 
 
Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., . . . Haass, 
C. (2006). Control of peripheral nerve myelination by the beta-secretase BACE1. 
Science, 314(5799), 664-666. doi: 10.1126/science.1132341 
 
Willhite, D. C., Nguyen, K. T., Masurkar, A. V., Greer, C. A., Shepherd, G. M., & Chen, 
W. R. (2006). Viral tracing identifies distributed columnar organization in the 
olfactory bulb. Proc Natl Acad Sci U S A, 103(33), 12592-12597. doi: 
	  184	  	  
10.1073/pnas.0602032103 
 
Willhite, R. K., Niendam, T. A., Bearden, C. E., Zinberg, J., O'Brien, M. P., & Cannon, 
T. D. (2008). Gender differences in symptoms, functioning and social support in 
patients at ultra-high risk for developing a psychotic disorder. Schizophr Res, 
104(1-3), 237-245. doi: 10.1016/j.schres.2008.05.019 
 
Williams, N. M., Preece, A., Spurlock, G., Norton, N., Williams, H. J., Zammit, S., . . . 
Owen, M. J. (2003). Support for genetic variation in neuregulin 1 and 




Wilson, D. A., & Sullivan, R. M. (1995). The D2 antagonist spiperone mimics the effects 
of olfactory deprivation on mitral/tufted cell odor response patterns. J Neurosci, 
15(8), 5574-5581.  
 
Winner, B., Cooper-Kuhn, C. M., Aigner, R., Winkler, J., & Kuhn, H. G. (2002). Long-
term survival and cell death of newly generated neurons in the adult rat olfactory 
bulb. Eur J Neurosci, 16(9), 1681-1689.  
 
Winner, B., Desplats, P., Hagl, C., Klucken, J., Aigner, R., Ploetz, S., . . . Winkler, J. 
(2009). Dopamine receptor activation promotes adult neurogenesis in an acute 
Parkinson model. Exp Neurol, 219(2), 543-552. doi: 
10.1016/j.expneurol.2009.07.013 
 
Wise, P. M., & Cain, W. S. (2000). Latency and accuracy of discriminations of odor 
quality between binary mixtures and their components. Chem Senses, 25(3), 247-
265.  
 
Wolpowitz, D., Mason, T. B., Dietrich, P., Mendelsohn, M., Talmage, D. A., & Role, L. 
W. (2000). Cysteine-rich domain isoforms of the neuregulin-1 gene are required 
for maintenance of peripheral synapses. Neuron, 25(1), 79-91.  
 
Wu, J., Buchsbaum, M. S., Moy, K., Denlea, N., Kesslak, P., Tseng, H., . . . et al. (1993). 
Olfactory memory in unmedicated schizophrenics. Schizophr Res, 9(1), 41-47.  
 
Xiong, W., & Chen, W. R. (2002). Dynamic gating of spike propagation in the mitral cell 
lateral dendrites. Neuron, 34(1), 115-126.  
 
Xu, B., Roos, J. L., Levy, S., van Rensburg, E. J., Gogos, J. A., & Karayiorgou, M. 
(2008). Strong association of de novo copy number mutations with sporadic 
schizophrenia. Nat Genet, 40(7), 880-885. doi: 10.1038/ng.162 
 
Xu, F., Liu, N., Kida, I., Rothman, D. L., Hyder, F., & Shepherd, G. M. (2003). Odor 
maps of aldehydes and esters revealed by functional MRI in the glomerular layer 
	  185	  	  
of the mouse olfactory bulb. Proc Natl Acad Sci U S A, 100(19), 11029-11034. 
doi: 10.1073/pnas.1832864100 
 
Xu, M. Q., Sun, W. S., Liu, B. X., Feng, G. Y., Yu, L., Yang, L., . . . He, L. (2009). 
Prenatal malnutrition and adult schizophrenia: further evidence from the 1959-
1961 Chinese famine. Schizophr Bull, 35(3), 568-576. doi: 
10.1093/schbul/sbn168 
 
Xu, Q., Cobos, I., De La Cruz, E., Rubenstein, J. L., & Anderson, S. A. (2004). Origins 
of cortical interneuron subtypes. J Neurosci, 24(11), 2612-2622. doi: 
10.1523/JNEUROSCI.5667-03.2004 
 
Xu, T., Chan, R. C., & Compton, M. T. (2011). Minor physical anomalies in patients with 
schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-
analysis. PLoS One, 6(9), e24129. doi: 10.1371/journal.pone.0024129 
 
Yamada, K., Iwayama, Y., Hattori, E., Iwamoto, K., Toyota, T., Ohnishi, T., . . . 
Yoshikawa, T. (2011). Genome-wide association study of schizophrenia in 
Japanese population. PLoS One, 6(6), e20468. doi: 10.1371/journal.pone.0020468 
 
Yamaguchi, M., & Mori, K. (2005). Critical period for sensory experience-dependent 
survival of newly generated granule cells in the adult mouse olfactory bulb. Proc 
Natl Acad Sci U S A, 102(27), 9697-9702. doi: 10.1073/pnas.0406082102 
 
Yan, Z., Tan, J., Qin, C., Lu, Y., Ding, C., & Luo, M. (2008). Precise circuitry links 
bilaterally symmetric olfactory maps. Neuron, 58(4), 613-624. doi: 
10.1016/j.neuron.2008.03.012 
 
Yang, J., Visscher, P. M., & Wray, N. R. (2010). Sporadic cases are the norm for 
complex disease. Eur J Hum Genet, 18(9), 1039-1043. doi: 
10.1038/ejhg.2009.177 
 
Yang, X., Renken, R., Hyder, F., Siddeek, M., Greer, C. A., Shepherd, G. M., & 
Shulman, R. G. (1998). Dynamic mapping at the laminar level of odor-elicited 
responses in rat olfactory bulb by functional MRI. Proc Natl Acad Sci U S A, 
95(13), 7715-7720.  
 
Yarden, Y., & Sliwkowski, M. X. (2001). Untangling the ErbB signalling network. Nat 
Rev Mol Cell Biol, 2(2), 127-137. doi: 10.1038/35052073 
 
Yau, H. J., Wang, H. F., Lai, C., & Liu, F. C. (2003). Neural development of the 
neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: 
preferential expression by interneurons tangentially migrating from the ganglionic 
eminences. Cereb Cortex, 13(3), 252-264.  
 
Yokoi, M., Mori, K., & Nakanishi, S. (1995). Refinement of odor molecule tuning by 
	  186	  	  
dendrodendritic synaptic inhibition in the olfactory bulb. Proc Natl Acad Sci U S 
A, 92(8), 3371-3375.  
 
Yokozeki, T., Wakatsuki, S., Hatsuzawa, K., Black, R. A., Wada, I., & Sehara-Fujisawa, 
A. (2007). Meltrin beta (ADAM19) mediates ectodomain shedding of Neuregulin 
beta1 in the Golgi apparatus: fluorescence correlation spectroscopic observation 
of the dynamics of ectodomain shedding in living cells. Genes Cells, 12(3), 329-
343. doi: 10.1111/j.1365-2443.2007.01060.x 
 
Young, K. M., Fogarty, M., Kessaris, N., & Richardson, W. D. (2007). Subventricular 
zone stem cells are heterogeneous with respect to their embryonic origins and 
neurogenic fates in the adult olfactory bulb. J Neurosci, 27(31), 8286-8296. doi: 
10.1523/JNEUROSCI.0476-07.2007 
 
Youngson, N. A., & Whitelaw, E. (2008). Transgenerational epigenetic effects. Annu Rev 
Genomics Hum Genet, 9, 233-257. doi: 10.1146/annurev.genom.9.081307.164445 
 
Yun, K., Potter, S., & Rubenstein, J. L. (2001). Gsh2 and Pax6 play complementary roles 
in dorsoventral patterning of the mammalian telencephalon. Development, 128(2), 
193-205.  
 
Zhao, X., Shi, Y., Tang, J., Tang, R., Yu, L., Gu, N., . . . He, L. (2004). A case control 
and family based association study of the neuregulin1 gene and schizophrenia. J 
Med Genet, 41(1), 31-34.  
 
Zipursky, R. B., Lambe, E. K., Kapur, S., & Mikulis, D. J. (1998). Cerebral gray matter 
volume deficits in first episode psychosis. Arch Gen Psychiatry, 55(6), 540-546.  
 
Zipursky, R. B., Marsh, L., Lim, K. O., DeMent, S., Shear, P. K., Sullivan, E. V., . . . 
Pfefferbaum, A. (1994). Volumetric MRI assessment of temporal lobe structures 
in schizophrenia. Biol Psychiatry, 35(8), 501-516.  
 
Zou, D. J., Chesler, A., & Firestein, S. (2009). How the olfactory bulb got its glomeruli: a 
just so story? Nat Rev Neurosci, 10(8), 611-618. doi: 10.1038/nrn2666 
 
Zubkova, E. V., & Robaire, B. (2006). Effects of ageing on spermatozoal chromatin and 
its sensitivity to in vivo and in vitro oxidative challenge in the Brown Norway rat. 
Hum Reprod, 21(11), 2901-2910. doi: 10.1093/humrep/del193 
 
 
